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This study was undertaken in the light of the increasing importance of childhood asthma 
VlfOrldwide, an apparently large burden of asthma morbidity disease in Cape Town, high 
local smoking rates and a lack of epidemiologic information on childhood asthma in South 
Africa. 
TVlfO detailed literature revie'NS '\tY9re undertaken. The first covered epidemiologic aspects 
of asthma and allergy in South Africa, as inferred from allergen and atopy studies, clinical 
series, and studies of prevalence and mortality. The second addressed the international 
literature on vvhether environmental tobacco smoke is associated with asthma, vvheeze or 
bronchial hyperresponsiveness in general and asthmatic populations of children. 
This thesis is based on a self-administered questionnaire survey of the parents of 1 955 
sub-8 pupils (90% response rate), aged 7 to 9 years, in Mitchell's Plain, a large, VlfOrking 
class area of Cape Town 
Five empirical questions '\tY9re asked: 1) is the prevalence of asthma and vvheezing in 
primary school children ? (2) What is the reliability (across tVlfO questionnaires) of 
questions about vvheezing and asthma? 3) What are the household risk factors for 
vvheezing and asthma; in particular, to vvhat extent is household environmental tobacco 
smoke (ETS) a risk factor for asthma/wheeze? 4) Among children with asthma/wheeze, is 
there an association bet'\tY9en ETS exposure and bronchial hyper- responsiveness (BHR), 
and 5) To vvhat extent is asthma underrecognised and undertreated? 
To ans'\tY9r questions 2) to 5), a prevalent case group (defined on asthma symptoms on a 
standard questionnaire) and a control group '\tY9re identified from the initial survey. The 
parents of cases and controls '\tY9re intervie'\tY9d at home. All of the symptom questions '\tY9re 
repeated, and in addition information elicited on a variety of covariates, including household 
smoking and damp, medical and family history, and medical care. Urinary cotinine 
.Abstract XIII 
concentrations 'Nere measured in these children by radioimmunoassay. A case-control 
analysis was conducted of risk factors for asthma/wheeze. In MO separate analyses, the 
case group alone was analysed for the association bet'Neen ETS and BHR (i.e. for 
aggravation of asthma), and for the extent of underdiagnosis and undertreatment of 
asthma. 
Prevalence and reliability. The prevalence of wheeze in the previous 12 months (26.8%) 
was high by international comparison, but not that of asthma ever (10.8%). Symptom 
prevalences varied with the respondent's familial relationship to the child, while on some 
questions the interview produced higher wheeze prevalences than the self-administered 
questionnaire. Reliability of symptom questions varied: asthma ever (kappa= 0.69), recent 
wheeze (kappa= 0.59), and recent sleep disturbance by wheeze (kappa= 0.56) 'Nere the 
most reliable, while those covering exercise wheeze, speech disturbance and night cough 
proved less reliable. 
Household risk factors for wheezing and asthma. An exposure-response relationship 
bet'Neen the urinary cotinine creatinine ratio and asthma/wheeze was observed. In 
multivariate analysis, predictors of asthma/wheeze 'Nere hayfever (odds ratio [OR]= 5.30), 
eczema (OR = 2.19), parental asthma (OR = 1.77), absence of paternal contribution to 
income (OR = 1.72), maternal smoking in pregnancy (OR = 1.87), and each additional 
household smoker (OR = 1.15). Findings 'Nere similar, with higher odds ratios for most 
variables except number of household smokers, when the group was restricted to children 
with parent reported asthma. Household smoking is thus an important modifiable risk factor 
in asthma/wheeze among young schoolchildren, with maternal smoking in pregnancy and 
current household exposure independent contributors to this effect. 
ETS and BHR among children with asthma and wheeze. There was no association 
bet'Neen BHR and moderate levels of ETS exposure, but children with asthma/wheeze 
whose mother smoked ~ 15 cigarettes daily sho'Ned less BHR than those who smoked less 
or none. BHR was also less frequent among children sharing a house with 4 or more 
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smokers, and among those in the highest quartile of cotinine. BHR was unrelated to 
paternal smoking. In contrast, Forced Expiratory Volume in one Second (FEV1) was lower 
among children \Nhose mothers smoked currently. These results are consistent with a long-
term adverse effect of maternal smoking on lung function but not with a mechanism 
\Nhereby ETS exposure aggravates existing asthma by increasing BHR. This association 
may be masked, however, by the degree to \Nhich mothers of asthmatic children adjust their 
smoking. 
Underrecognition and undertreatment of asthma. Overall, any past or current asthma was 
acknowledged by respondents in only 53% of the case group, and current asthma in only 
37.1%. While most children had received treatment in the previous 12 months, 66.1% of 
the recognised group were on current treatment (23.2% on daily treatment), compared to 
37% of the unrecognised group (3% daily). Salbutamol and theophylline syrups were the 
most common types of medication, \Nhile inhalers and anti-inflammatory medications were 
underused. Only a minority reported the child ever having used a peak flow meter, or 
volunteered knowledge of preventive measures. Current treatment, and to a lesser degree 
asthma recognition, was greater among children on medical aid and of higher 
socioeconomic status. 
In conclusion, asthma has been neglected in the public health arena in South Africa, in 
contrast to initiatives emanating from the private medical and pharmaceutical sectors. 
Given our limited understanding of the forces underlying childhood asthma at the 
population level, the prospects of primary prevention of asthma are limited, especially in 
poor communities. Control of exposure of children to tobacco smoke remains, however, the 
single most practicable public health measure for both primary prevention of asthma, and 
as an important part of secondary prevention. 
Although secondary prevention appropriately emphasises patient and practitioner 
education, further research is required into management regimens practicable in poorer 
communities and public sector facilities. A plan for asthma management needs to be given 
.Abstract xv 
concrete form within the official national policy of primary health care. The importance of 
population level research in surveillance of the asthma epidemic, in assessing the 
effectiveness of various treatment approaches, and in the search for the causes of asthma 
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Fig. 1. 1 Interrelationship between asthma, wheezing and bronchial hyperresponsiveness 
1.1. Background 
The apparent increase in childhood asthma in its various manifestations over the past 
three decades in different parts of the world poses a challenge to epidemiologists 
(Burney 1988). This increase has been variously attributed to greater awareness of the 
disease and a shift from other diagnoses on the one hand, and to secular changes in 
environmental influences, diet and behaviour, as well as improved public health 
measures, on the other (Hendrick 1989, Buist 1990, Gergen 1992, Seaton 1994, 
Strachan 1995, Magnus 1997, Butland 1997, Hopkin 1997, Platts Mills 1997, Kemp 
1997). 
Whatever the explanation for its increase, asthma is now recognised as the most 
common chronic disease of childhood in developed societies, responsible for 
considerable morbidity, health service and medication use, school absence and family 
stress. Premature death is fortunately uncommon but remains a feared complication of 
asthma. 
While country wide estimates of the burden of asthma in South Africa are not available, 
estimates from developed countries suggest a large burden. For example in the United 
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States, the cumulative incidence of asthma or wheeze among children aged 3-11 years 
was estimated at around 10 percent in the 1980s (Evans 1987). The substantial 
morbidity of the disease was reflected in the approximately 163,000 children under 
seventeen years of age with a hospital discharge diagnosis of asthma in 1987, a rate -of 
257 per 100,000 population at risk (Gergen 1990). Hospitalisation increased during the 
1980s at a rate of about 4.5 percent per annum, with the greatest rate of increase in the 
0-4 year age group (Weiss 1990). Asthma in children was estimated to result in an 
additional 10.1 million days missed from school, and 12.9 million contacts with medical 
doctors (Taylor 1992). Mortality from asthma among children aged 5 to 14 years 
increased in the United States by ten percent per annum between 1979 and 1987 
(Gergen 1990). 
The costs of asthma to society include the direct medical costs of doctors' services, 
medication and hospital care, the indirect costs attributable to school days lost, work 
lost and premature mortality, and the intangible cost of the psychosocial effects of the 
disease (Weiss 1993). The direct medical costs (children and adults) in the USA in 1990 
were estimated at $3.6 billion, with a further$ 2.6 billion incurred in indirect costs (Clark 
1995). The combined figure of $ 6.2 billion is equivalent to one percent of the total 
health care expenditure in the USA. The corresponding direct and indirect cost 
estimates for Australia (1991) were $250 million and $ 207 million, and for the United 
Kingdom (1988) $722 million and $1.07 billion (ibid.). 
Research into asthma has burgeoned over the past two decades. There are many 
questions needing answers. The first concerns the frequency of asthma. Although 
asthma defies a gold standard definition, a reasonable picture of prevalence of 
wheezing illness is emerging, particularly as the studies comprising the International 
Study of Asthma and Allergies in Childhood (ISAAC) are starting to be published 
(ISAAC Steering Committee 1998). Research remains skewed towards the developed 
world, however. For example, of the 110 centres cited as participating in ISAAC, only 10 
are from Africa (ibid.) 
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Secular shifts in asthma prevalence are more difficult to measure, because of the 
problems of comparability, and time trend information has been slower in emerging. In 
almost all cases where information is available on time trends, an increase in some 
measure of asthma or wheezing has been noted (Gergen 1992, Anderson 1994, 
Strachan 1995, Nystad 1997, Goren 1997). The likelihood is that the increase in real, 
although it has been argued that the lack of comparable objective measures between 
study points renders this interpretation still inconclusive (Magnus 1997). 
A number of risk factors for asthma have received attention, although the distinction 
between factors inducing the disease and those triggering acute asthmatic episodes or 
maintaining chronicity remains a source of confusion. It is likely that while genetic 
inheritance lays down a predisposition to asthma in individuals, the early childhood 
environment, including in utero experience, determines the rate of expression of the 
disease. Its severity and chronicity may in turn be subject to a wider variety of 
household and community influences, including medical care, beyond the inducing 
ones. 
There appears to be a close association between childhood asthma and allergy. The 
interaction between immune predisposition and immune activation as a result of early 
challenges to the immune system by infection and antigens, has thus suggested a 
theory that may explain a rising prevalence of the disease (Shaheen 1995, Strachan 
1995, Hopkin 1997, Cookson 1997). Current speculation, supported by some empirical 
evidence (Shaheen 1996, Shirakawa 1997, Matricardi 1997), is that certain viral and 
bacterial infections in early life, including measles and tuberculosis, may protect against 
asthma through preferential activation of the T-Helper Type 1 (TH1) cell mediated 
immune response pathway. A decline in the incidence (or severity) of these diseases 
[including the protective effect of immunisation (Kemp 1997)] allows activation of the 
TH2 cell mediated pathway, which in turn regulates the production of lgE antibodies that 
underlie the immediate hypersensitivity response. The effect at the population level is 
an increase in the incidence of asthma. 
Introduction 
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Of other potential risk factors for childhood asthma, exposure of 
the child to 
environmental tobacco smoke or its products, particularly from maternal 
sources, is of 
great interest. In many developed countries, smoking rates among wom
en increased 
steadily after world war II, with declines only in recent years among be
tter educated 
women (Gergen 1992). In the developing world, the smoking habit amo
ng women in 
still relatively uncommon but is predicted to increase with urbanisation an
d aggressive 
marketing by the tobacco industry (Mackay 1994). Control of tobacco
 is already a 
public health policy goal, and although gains have been limited in ma
ny countries, 
reduction of exposure of children to environmental tobacco smoke may b
e one way of 
achieving some degree of both primary and secondary prevention of asthm
a. 
Although asthma cannot be cured, the quality of life of asthma sufferers c
an be greatly 
improved by appropriate management. There has been a refinement of d
rug treatment 
over the past three decades, including a shift from regimens which may
 have caused 
harm (Sears 1990). An understanding of trigger factors has created the
 potential for 
prescribing avoidance activities. Unfortunately, the quality of case manage
ment has not 
kept up with recommendations from the academic centres. Variations in q
uality of care 
typically follow lines of privilege and poverty in society. 
Epidemiologic research into allergy in South Africa received a promisin
g start in the 
work of Ordman (Ordman 1947, 1955) who described patterns of allergic il
lness which 
anticipated discovery of the house dust mite by Voorhorst and Spieksm
a in 1964. A 
comparative study of childhood asthma in the rural Transkei and urban
 Cape Town 
published in 1979 has become a classic migrant study contributing to 
the theory of 
asthma as a disease of urbanisation (Van Niekerk 1979). Since th
en very little 
population based research has been published from South Africa, so that 
much of what 
is believed about childhood asthma in South Africa is based on clinical exp
erience. 
Cape Town is a highly suitable site for asthma research. Cape Town w
as one of the 




is that Cape Town's environment is conducive to allergy and asthma. These views are 
based on utilisation patterns in public health services, and a few relatively small 
population studies. Larger scale population based data are lacking. Cape Town has the 
further advantage of sufficient infrastructure both to carry out population based research 
and to be able, at least potentially, to use the results to influence health promotion and 
health care interventions. 
This thesis is an attempt to answer some of the important questions about childhood 
asthma in Cape Town using the tools of epidemiology. 
1.2. Thesis Objectives and structure 
This thesis is based on a population study of asthma in primary school children carried 
out in Mitchell's Plain, a large suburban area of Cape Town. The area was chosen 
because it is held to be a high asthma prevalence area, with a large relatively stable 
population and network of primary schools accessible to ongoing research, an important 
consideration given the recent history of school turbulence in South Africa. The area's 
relatively poor socioeconomic profile raises questions of access to health services and 
quality of care, questions of public health importance in the current moves towards 
achieving greater equity in health in South Africa. Previous studies have measured high 
levels of smoking in the areas of which this community is a part (Steyn 1987). The area 
also has a relatively secure mix of private and public medical care services, potentially 
able to support future intervention research. 
The research project consisted of studies addressing five related questions: 
1. What is the prevalence of asthma and wheezing in primary school children in 
Mitchells Plain? 




3. What are the household risk factors for wheezing and asth
ma in this population? In 
particular, to what extent is household environmental tobac
co smoke a risk factor for 
asthma/wheeze? 
4. Among children identified with asthma and wheeze, is e
xposure to environmental 
tobacco smoke associated with increased bronchial hyperr
esponsiveness? 
5. To what extent is asthma underrecognised and undertreate
d in this population and 
what are the predictors of underrecognition and undertreatm
ent? 
Chapter 2 is a comprehensive review of what is known epide
miologically about asthma 
and allergy in South Africa. The aim is to provide a contex
t for this study and for the 
questions asked. Because of the importance of categor
isation by "race" in South 
African epidemiologic research and the problems in tryin
g to interpret and report 
epidemiologic data by "race" (or conversely without reference
 to "race"), a brief 
discussion of the subject is included. 
Chapter 3 is a literature review of epidemiologic studies o
f the association between 
environmental tobacco smoke and asthma and wheezing in
 childhood. The aim is to 
determine the current weight of epidemiologic evidence on w
hether, to what extent and 
how environmental tobacco smoke causes the various ma
nifestations of asthma and 
wheezing. 
Chapter 4 describes the geography, climate and social chara
cteristics of Mitchell's Plain 
and its population. The aim is to provide readers with a 
basis for comparison with 
studies of other populations. The chapter follows with a d
escription of the sampling 
procedures for the various phases of the study. Sample size
 calculations are provided 
to enable an evaluation of the statistical power to answer the 
questions posed. Ethical 
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considerations are discussed. 
The next four chapters present the methods, results and discussion of each of the 
study phases, namely: prevalence and reliability of asthma symptoms (Chapter 5), 
association of environmental tobacco smoke and other household risk factors with 
asthma/wheeze in the population (Chapter 6), association of environmental tobacco 
smoke with bronchial hyperresponsiveness in children with asthma/wheeze (Chapter 7), 
and underrecognition and undertreatment of asthma (Chapter 8). 
Chapter 9 concludes with a consideration of the implications of the main findings and 
their limitations, a discussion of prospects for public health use of the results in primary 
and secondary prevention of asthma, and recommendations for future research. 
The appendices contain the questionnaires used in the study. 
1.3. A note on nomenclature and style 
1.3.1. Asthma and wheeze 
There is no single definition of asthma for epidemiologic purposes, nor any definitive 
test or gold standard. As a result, identification of a group of children in epidemiologic 
studies using questionnaires (with or without bronchial hyperresponsiveness testing) will 
result in some heterogeneity within such a group. For example, while most childhood 
asthmatics wheeze at some stage, not all wheezing in childhood is asthma (Fig. 1.1 ). 
Conversely, cough rather than wheeze may characterise asthma in a minority of 
children. Although the asthma/wheeze distinction is less problematic in primary school 
children than in infants and toddlers, in anticipation of objections to the lack specificity of 
the term asthma, the term asthma/wheeze or the phrase asthma and wheezing is used 
in Chapters 6 and 7, in which a "case" group is defined. These chapters address 
Introduction 
questions of aetiology rather than clinical specificity and define the case group on 
the 
basis of a symptom questionnaire. 
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In Chapter 8, in which inferences are drawn about diagnosis and treatment, the st
ronger 
assumption is made that the study group is asthmatic for practical clinical purpose
s. The 
children are thus referred to simply as asthmatic. In that chapter, the case gr
oup is 
defined on the basis of a stronger definition (based on two consecutive sy
mptom 
questionnaires) and is likely to be somewhat more specific than the group stud
ied in 
Chapters 6 and 7. In contrast, the term asthma recognition refers to a parental res
ponse 
to the question "has the child ever had asthma". 
1.3.2 Environmental tobacco smoke (ETS) 
The term ETS exposure is used in the main, rather than passive smoking, and in
cludes 
in some contexts in utero absorption of tobacco constituents by the foetus. The fo
cus in 
this study is on parental and other household smoking, which can be assumed
 to the 
major sources of ETS exposure of young schoolchildren. 
1.3.3. Bronchial hyperresponsiveness (BHR) 
Non-specific bronchial hyperresponsiveness refers to an abnormal tendency f
or the 
airways to constrict in response to certain pharmacologic and physiologic stimu
li at a 
dose or level at which most people would not react. 
The interrelationship between BHR, asthma and wheezing is itself the sub
ject of 
contention, and our understanding of this relationship has changed as population 
based 
data have become available. A schematic representation of the interrelations
hip is 
displayed as a Venn diagram in Fig. 1.1. While many children with recognised as
thma 
have BHR, this trait may vary over time between "normal" and "abnormal" in ind
ividual 
asthmatic children. Conversely, BHR may be demonstrable in otherwise asympt
omatic 




Figure 1.1 Relationship between asthma, wheezing and bronchial 





Referencing is by first author and year of publication in parentheses in the text. When a 
study is mentioned in the narrative, only the first author is cited, without the rather 
cumbersome et al. An alphabetic bibliography, in the Vancouver style, is appended to 
each chapter. Although this entails overlap of chapter lists, it provides a more focused 
bibliography for each chapter. 
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Table 2.1 Previous South African studies of the prevalence of asthma and bronchial 
hyperresponsiveness 
2.1 Introduction 
Early publications on asthma in Africa and other parts of the developing world reflected 
the belief that childhood asthma in Africa and the tropics was uncommon, and/or that the 
age of onset of asthma was later than in the Western world (Godfrey 1979, Cooksen 
1987, Weinberg 1989). This was based, inter alia, on the relative scarcity of asthmatics in 
hospital and clinic populations (Van Niekerk 1977, Abdurrahman 1982, Cooksen 1987). 
Prior to the early 1990s, relatively few prevalence studies from Africa had been reported. 
These suggested an effect of urbanisation on increasing the prevalence of a condition 
that was rare in rural populations. Godfrey (1975) could find virtually no asthmatics in 
rural Gambian villages (1975), while a number were identified in urban areas. In a 1980 
report from semi-urban Zimbabwe, Cooksen reported a (cumulative) prevalence of 
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asthma symptoms of 1.2 percent in children and adolescents and 1.57 percent in adults. 
A later study of Zimbabwean schoolchildren (Keeley 1991 ), found an urban prevalence of 
reversible airways obstruction of approximately 3 to 6 percent compared to 0.1 percent in 
a rural population. Similar findings in the Transkei area of South Africa were reported by 
Van Niekerk (1979), discussed further in section 2.4. In contrast to the above studies, 
Carswell (1976) reported a prevalence of asthma in 3.3 percent of rural Tanzanian 
schoolchildren. 
Even allowing for the variation in the definition of asthma or of bronchial 
hyperresponsiveness (BHR), it is clear from recent studies that one cannot treat Africa as 
a homogeneous entity. In a study by Ng'ang'a (1998), asthma symptoms were reported 
by 26.0 percent of Nairobi schoolchildren compared to 10.9 percent of rural 
schoolchildren. The urban rural difference in exercise induced bronchospasm (fall in 
FEV1 of 15 percent or more) was in 9.8 vs 6.1 percent. In contrast, Yemaneberhan 
(1997) reported a prevalence of recent childhood wheeze of only 2.4 percent in children 
under 9 years in a provincial Ethiopian town, and 1.1 percent in subsistence rural children. 
South Africa appears to offer fertile ground for the study of chronic diseases, including 
asthma (Mann 1982). Differences between rural populations with persistent traditional 
features and their "urbanised" counterparts have offered the opportunity for studying risk 
factors for asthma associated with urbanisation and migration. Differences in asthma or 
allergy between groups defined by race or ethnicity have also attracted attention as 
providing possible clues to aetiology. Asthma has also become a common enough clinical 
disease in the community and in medical practice to be regarded by practitioners, 
teachers and parents as needing study. 
To date there has, however, been relatively little in the way of epidemiologic study of 
asthma in South Africa. Most of the published literature has taken the form of clinical 
series derived from specialised clinics in teaching hospitals or paediatric practices, or 
small comparative samples derived from a single facility. 
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Reasons for the paucity of published population 
based studies are speculative. The 
shortage of epidemiologic expertise in South Afric
a has possibly meant a concentration 
on clinical series. There also seems to be a lack of 
imperative to publish studies that have 
been carried out.
1 Violence and uncertainty in many communities
 during the late 
apartheid era (Hoffman 1986) are another possible 
reason. 
2.2. Ordman and the distribution of allergens in 
South Africa 
David Ordman pioneered the ecological study of all
ergy in South Africa in the 1940's, 50's 
and 60's and his work merits specific description on
 both scientific and historical grounds 
(Potter 1996). 
In a series of studies Ordman established the basic
 pattern of environmental allergens in 
South Africa (Ordman 1947, 1955, 1970, 1971). 
Although he was concerned with all 
atopic phenomena, i.e. allergies of the upper respir
atory tract, bronchial tree and skin, his 
observations are of obvious relevance to asthma. H
e contributed two sets of fundamental 
observations to the study of allergy in South Africa. 
The first were those pertaining to seasonal allergy, 
which he related to seasonal patterns 
of aeroallergens, i.e. pollen grains and fungal sp
ores (Ordman 1947, 1970). These 
patterns were based on regional distributions of th
ese aeroallergens and corresponding 
patterns of skin prick allergies seen in clinical and l
aboratory practice. He identified grass 
pollens as the most important of the aeroallergens
, at least in relation to nasal allergy, 
with their flowering period occurring between Octob
er and March. Of lesser importance in 
inducing allergic symptoms were tree, compositae 
and weed allergens, depending on the 
degree of contact with the plant. 
1
Two large studies, one of Transkeian schoolchildre
n conducted in the mid 1980s, and 
another in the 1990s of Cape Town schoolchil
dren with a Transkeian comparison, 
remain unpublished. 
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Ordman's other major epidemiologic observation was that allergy was often worse at the 
coast and improved when the sufferer moved inland (Ordman 1955, 1971 ). He 
hypothesised initially that there were specific climatic features that were responsible for 
this phenomenon, acting either directly on the bronchi or by promoting some allergenic 
agent. He showed that coastal towns had in common narrow ranges of both temperature 
and humidity at the high end of the scale, in other words, warm, moist climates. Following 
the identification in 1964 of the housedust mite by Verhoor et al., Ordman was able to 
show that the distribution of house dust mites correlated well with the distribution of 
relative humidity in South African towns (Ordman 1971 ). Coastal towns and some inland 
towns with high relative humidities (Louis Trichardt, Vryheid) all showed high mite counts. 
Ordman's environmental observations in the Transvaal have been updated by Cadman, 
who studied aeroallergens in the Pretoria-Witwatersrand-Verneeniging area between 
1986 and 1987 (Cadman 1991 ). She confirmed that grass pollens were the single most 
important component of airborne pollen, comprising 52 percent of the total. Of the total 
airborne pollen, almost 60 percent was perennial, auguring badly for grass sensitive 
individuals in this region. 
Porter (1991) examined distributions of aeroallergens in the Cape. In apparent contrast to 
the Reef, he found that mould spore concentrations exceeded those of pollens 
throughout the year except October and November. However, as on the reef, grass and 
compositae pollens in concentrations of >50 spores/m3
 were found perennially, with a 
seasonal peak from October to December. 
However, the studies of aeroallergens, like any environmental agent, must be 
accompanied by laboratory, clinical and epidemiologic studies on human populations in 
order to decide their importance. For example, Potter (1991) has pointed out that of 8 000 
flowering species in the Cape Peninsula only a few are of known clinical importance, 
while the allergenicity of a number of other local grasses is unknown. 
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There has been little attempt to correlate aeroallergen patterns with the population 
distribution of atopy or asthma in South Africa. Even where atopy is measured in the 
community, however, its distribution does not necessarily explain the distribution of 
asthma, and atopy and asthma are best conceptualised as distinct phenomena for 
epidemiologic purposes (Burney 1992). 
2.3. Hospital case series of asthmatics 
Case series contribute to the epidemiologic study of asthma by identifying features of 
the disease among people reaching teaching hospitals and specialist practices and by 
suggesting hypotheses for further study. 
The selected nature of these samples entails a number of limitations which should 
counsel caution in attempting to generalise to larger source populations. In South Africa, 
income and race based patterns of health care use determine the population seen at a 
given hospital. There may be further selection effects determining who gets referred to a 
teaching hospital, and within the hospital, who are seen at specialised clinics. 
Problematically, the very features that may be of interest as outcomes, (eg. severe 
allergy, atypical features) may be among the factors determining referral to a particular 
clinic. 
It is the exception for hospital cases in South Africa to be related to a population 
denominator and expressed as population rates. The main reason is that the base 
population using the hospital is unknown. Teaching hospitals, in particular, may have 
wide catchment areas. A steady and in recent years rapid process of urbanisation among 
a large section of the population makes assumptions about base populations hazardous. 
The absence of rates makes it difficult to use these data for comparative purposes, either 
spatially or temporally. 
Comparability among studies is compromised by a number of differences between them. 
Secular changes may distinguish samples drawn in different years. There is no standard 
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way of taking histories, which, in the clinical context, are never blind of the diagnosis, 
introducing spurious correlations. While standardisation is possible in skin-prick testing, 
the antigenic preparation, the definition of a positive test and the range of allergens tested 
may all vary. 
Nevertheless some attributes of the populations using a given hospital, as well as broad 
regional differences may be inferred from the various studies. Two sets of observations, 
in particular, are of interest. The first is the distribution of specific allergic reactivities by 
region or population, and the second concerns the relative scarcity or otherwise of black2 
asthmatic cases. 
2.3.1. Distribution of specific reactivity to allergens 
Van Niekerk (1977) noted that house dust and house dust mite elicited by far the most 
frequent positive reactions in skin testing of 103 asthmatic Cape Town children aged one 
to 13 years. While about a quarter reacted to house-dust mite, only 10 percent responded 
to cat dander, 7 percent to grasses and 6 percent to parasites (Ascaris lumbricoides). 
Potter (1991) confirmed the relative importance of house dust reactivity in allergic children 
in Cape Town, with much lower rates of skin prick reactivity to grasses and cat allergen 
and feathers. 
Similar findings regarding the importance of reactivity to house dust mite among adult 
asthmatics in the Cape were made by Walls (1983) and by Joubert (1988) at Tygerberg 
hospital. In the former study, of adults, over 90 percent of asthmatics with clinical allergic 
features showed skin reactivity to housedust mite D. Pteronyssimus, although over 80 
percent also reacted to danders and about 60 percent to grass pollens. 
2 See section 2. 7 for a general discussion on the use of race categories in 
epidemiologic research. In what follows, race categories are reported in the way they are 
used by the authors. In most cases, differences in clinical features between race groups 
seem to be attributed to differences in urbanisation and environmental conditions. 
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Joubert (1988) compared coloured and white asthmatics aged 12 to 40 years with respect 
to skin reactivity. While the two groups showed no difference in mite reactivity (about 70 
percent), the white sample had a much greater proportion with sensitivity to animal 
danders and grasses than the coloured asthmatics. The reverse held for fungal antigen 
(Aspergillus fumigatus) and parasite (Ascaris). 
Evidence from Durban, another coastal city, was provided by Fraser (1979) who reported 
on a small group of mainly teenage asthmatics from the Allergy Clinic at Addington 
Hospital. Over 80 percent reacted to house dust and dust mite, but only 30 percent to 
"dust and animal hair'' and 7 percent to grasses. Besides the high dust mite: grass ratio 
(even higher than at the Cape), of further interest was that 30 percent reacted to 
cockroach. Very similar findings were reported two decades later by Manjra (1995). 
Inland, Mercer (1991) reported on allergic features of a group of children seen in the 
paediatric allergy clinic in Bloemfontein in the Free State province. In contrast to the Cape 
findings, only 32 percent of these children reacted to "house-dust" and only 26 percent to 
D. pteronyssimus The most common response was to Bermuda grass allergen (56 
percent of children) and to cat hair (55 percent of children). 
On the Transvaal highveld, Luyt (1994) and Green (1997) described two case series of 
children and adolescents (ages 1 month to 18 years), one (black) from the Baragwanath 
teaching hospital in Soweto, the other (white) presenting to private paediatricians in 
Johannesburg. Between 40 and 50 percent of all asthmatics responded positively to 
grass and maize (com) pollens and to house dust mite. The main difference was that the 
white asthmatics showed much higher positive response proportions to mould antigens 
(53% of subjects), and cat and dog antigens than the black subjects. Surprisingly, in a 
similar study of young asthmatics in Durban, where average humidity is much higher than 
around Johannesburg, only 4 percent of subjects had skin prick reactivity to mould 
(Manra 1995). However, the mould antigen preparations used varied in these studies 
from indoor species (Luyt 1995) to unspecified mixtures (Green 1997, Manjra 1995 ), thus 
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limiting comparison. 
Potter (1998) investigating specific lgE to cockroach antigen among atopic patients in two 
coastal cities (Cape Town and Durban) and two Highveld cities (Pretoria and 
Johannesburg), found the rate of sensitisation to be about the same in all four centres (of 
the order of 30 to 40 percent). 
These findings confirm Ordman's observations that house dust mite is more likely to be a 
cause of allergic asthma at the coast where the climate is conducive. Grass and grain 
aeroallergens take on a larger relative role inland. Reactivity to cat and dog dander would 
seem to be related to higher degrees of indoor pet ownership which is a feature of better 
off homes. Study of the distribution of mould allergy requires the standardisation of 
method and materials before any firm conclusions can be drawn. 
2.3.2. Relative underrepresentation of black asthmatics 
Interest in the relative scarcity of asthma in rural African populations is reflected in studies 
of clinic populations. Wesley (1969) reported that paediatric admissions for asthma to a 
Durban hospital between 1963 and 1967 were uncommon. Asthma made up 0.8 percent 
of white paediatric admissions and only 0.02 percent of black admissions, a relative 
proportion of 40: 1. 
In contrast, a more recent study of admissions in 1992 and 1993 to the predominantly 
black Baragwanath hospital in Johannesburg found that asthma constituted 3.8 percent 
of all paediatric admissions. Although from different regions, these data suggest that 
asthma has become more commonplace among black children in South Africa. 
Early underrepresentation of black children with asthma in Cape Town was similarly 
reported made by Van Niekerk (1977). While black children accounted for 17 percent of 
all outpatient attendances at the Red Cross Children's hospital in Cape Town, they 
represented only 0.36 percent of the allergy (asthma) clinic attenders. Ehrlich (1994b) 
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examined admissions to the same hospital between 1984 and 1990: black ch
ildren 
contributed 37% of bronchiolitis and 48% of pneumonia admissions, but only 1
2% of 
asthma admissions. 
Two accounts from Groote Schuur Hospital in Cape Town point to possible bia
ses in 
specialist clinic populations, however. Walls ( 1982) reported on 304 adult asthm
atics 
seen at the Allergy Clinic between 1973 and 1976, of whom apparently only 
8 (2.5 
percent) were black. Yet of 1 020 patients admitted with acute asthma to the G
roote 
Schuur Hospital casualty department between August 1975 and July 1976 one sixth
 (16.6 
percent) were black (Westerman 1978), which was probably not far off the re
lative 
representation of blacks in the population of Cape Town at that time. One can spe
culate 
about the reasons for this anomaly, but it shows that specialist clinic populations m
ay be 
highly selected and not too much should be inferred from them about the true unde
rlying 
distribution of the condition. 
2.4. Population based prevalence studies 
Although descriptive, local prevalence surveys are of interest because they enab
le the 
importance of the disease in the community to be weighed. Their results are of va
lue to 
those arguing for health care resources to be devoted to prevention and care 
of the 
disease. Furthermore, differences in prevalence between groups, typically defin
ed by 
age, sex, geography, race, education or income, are the starting point of observa
tional 
epidemiology by suggesting aetiologic hypotheses which can be tested in analytic st
udies. 
There is a scarcity of sound prevalence data in South Africa. Until 1994, there had
 been 
only five published studies, and one published in non peer reviewed form, 
which 
contributed population prevalence data. These vary in the populations studied, the
ir age 
range and the measures of asthma used, and are summarised in Table 2.1. 
In 1979 Van Niekerk et al. published their much cited comparative study of rural and
 
urban Xhosa-speaking children. The rural children were drawn from the Tsolo area, 
a hilly 
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grassland area 1100 m above sea-level with a summer rainfa
ll climate. The urban sample 
was recruited in Guguletu, a township of Cape Town
 22 km inland. Bronchial 
hyperresponsiveness was measured, and defined as a fall in
 Forced expiratory volume in 
one second (FEV1) or Peak expiratory flow (PEF) of 15
 percent or more following 
running for six minutes at maximum effort. The results showe
d a 3. 17 percent prevalence 
among the urban children compared to 0.14 percent am
ong the rural children (A 
prevalence odds ratio of 22; 95 percent confidence interval 3
.5 to 906, can be calculated 
from their data). 
Some caution is in order regarding the point estimate prevale
nces Van Niekerk obtained, 
and to some extent the size of the urban rural difference. E
xercise testing is a relatively 
insensitive measure of asthma, or at least reflects differen
t airway characteristics from 
that of other tests of BHR (Clough 1991 ). Also, if rural ch
ildren were fitter than urban 
children, a given exertion might imply a different cardiorespir
atory load in the two groups 
and therefore differential sensitivity of the test. 
Vermeulen, in a study whose results have thus far appeare
d only as a brief summary, 
(Vermeulen 1990) took another research team to the rural T
ranskei in 1988. Unlike the 
previous study, he used histamine challenge as a measure
 of BHR, requiring a greater 
than 20 percent fall in FEV1 for a positive test. Among 1014
 children aged 8 to 16 years, 
he found 14.2 percent with BHR. Among the children with 
BHR thus identified, 62 (43 
percent) were considered to be asthmatic on clinical evaluat
ion, giving an overall asthma 
prevalence of 62/1014 or 6.1 percent. 
There are a number of possible explanations for the d
ifference between the two 
Transkeian studies. The first is that they used different tests.
 While exercise testing may 
be relatively insensitive to asthma, histamine challenge ma
y lack specificity, identifying, 
for example, children with infective bronchitis, which may be m
ore common in rural 
populations. 
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The second explanation is that there was a large secular increase in BHR among 
Transkeian children over the decade. This might be explained by the penetration of 
"western" habits and specifically, beds, mattresses and associated soft furnishings into 
remote Transkeian villages. Alternatively, if the TH1/TH2 hypothesis is true, the increase 
may be related to increased access to immunisation services and/or decline in family 
size. 
A third possible explanation is that as Vermeulen studied teenagers as well as pre-teens 
he might have picked up the later-onset asthmatics missed by the Van Niekerk study. 
These are, however, speculations and their development must await the publication of 
Vermeulen's study. 
Stewart (1990) also used exercise challenge to study BHR among white and coloured 
school children in Cape Town. He used a less stringent criterion level: a 10 percent fall in 
FEV1. Overall, BHR was more common among white than coloured adolescents (5.8 
percent vs. 4.1 percent). However, in their age stratified data, coloured pre-teens (6 to 9 
years) had a higher prevalence of BHR than whites. The authors speculate that these 
differences may be due to a higher school drop-out rate among coloured asthmatic 
children. However, there is no evidence for this thesis. 
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Table 2.1 Previous South African studies of the prevalence of asthma 
and bronchial hyperresponsiveness 
CHILDREN 
Study n (population, ages) Measure of outcome 
Van Niekerk 671 Transkei (rural) Exercise challenge: 
(1979) 694 Gugulethu* (urban) ,?: 15% fall in FEV1 or PEF 
(6 - 9 years) 
Vermeulen 1041 Transkei (a) Histamine challenge: 
(1990) (8 - 16 years) ,?:20% fall in FEV1 
(b) Clinical asthma 
Terblanche 494 coloured Exercise challenge: 
(1990)* 698 white > 10% fall in FEV1 
( 8 -17 years) 
Nagel 1180 white Exercise challenge: 
(1995)* (12 years) ,?: 15% fall in FEV1 
ADULTS 
Wicht 507 white Self-reported asthma 
(1979)* (20 - 80 years) 
FEV1: Forced expiratory volume in one second. 
PEF: Peak expiratory flow 
* Cape Town 
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A similar study of 12 year old white schoolchildren in Cape Town (Nagel 1992, Burr 1994) 
found a prevalence of BHR on exercise testing of 4.1 percent, using a -15 percent fall in 
PEF as the criterion. A parent reported prevalence of "current asthma" of 8. 7 percent 
was also recorded in this study. 
These studies of children and teenagers tell us that the prevalence of exercise-induced 
bronchoconstriction in Cape Town, using different definitions, is of the same order of 
magnitude, varying between about 3 and 6 percent. It is difficult to make any confident 
inferences about race differences, because of the differences in era, BHR criteria or age 
groups in these studies. 
Regarding asthma, Vermeulen's Transkei study provided an estimate of the prevalence 
of clinical asthma (6.1 percent). Nagel's study of white schoolchildren was part of a 
cross-national comparison with New Zealand, Wales and Sweden (Burr 1994). Wheeze 
in the past year was reported as commonly in his group (17.8%) as in New Zealand and 
Wales, and asthma ever (11.5%) on a par with that of Wales but somewhat less than in 
New Zealand. Swedish prevalences were the lowest. 
There has been only one adult prevalence study. As part of a large study of obstructive 
airways disease in white adults in the Bellville area of Cape Town, Wicht (1990) used a 
modified version of the Medical Research Council (UK) questionnaire. Asthma was 
defined in different ways, but one set of figures was based on a positive response to the 
question: "Is there any history of bronchial asthma?" The prevalences derived are the 
highest among any of the studies they cite from a number of countries. This should be 
seen against the background of the very high prevalence of 45 percent for the "diffuse 
obstructive pulmonary syndrome" (including a range of syndromes and symptoms) found 
in the same study. Their asthma measure is a cumulative prevalence which depends on 
quality of recall, access to medical care and physician practices in the area. Besides 
these sources of differences between this and other studies, there is the conceptual 
problem of distinguishing asthma from other forms of chronic obstructive airways disease 
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in adults, particularly that due to smoking. Nevertheless, in the absence of comparative 
South African data, the Wicht study remains the only population based estimate of adult 
asthma available. 
2.5. Studies of mortality 
There have been two studies of asthma mortality, each of a limited nature. The first, by 
Benatar (1986) was restricted to deaths in Cape Town. He noted that whites had a 
considerably lower risk of asthma deaths than blacks and coloureds. 
Ehrlich (1994a) examined national death certification in the white and coloured 
populations to determine whether South Africa had experienced the same rise in asthma 
mortality observed in other countries, and whether mortality rates differed by 
socioeconomic status using race as a proxy. (Black death certification was considered too 
inaccurate for longitudinal analysis [Botha 1985]). Caution must be exercised about 
inferences from death certification, and from examination of time series. However, there 
does appear to have been an increase in death rates during the 1960s in both groups. 
Among whites, the trend since then has been downwards, with a possible small peak 
among older ages in the late 1970s. Among coloureds, the high rates of the early 1970s 
have persisted. 
A striking finding was the high relative risk of death from asthma among coloureds 
compared to whites (in 1988: 4 to 5 fold for all ages; 2.5 fold among those aged 5 to 34 
years). Over the period 1970 to 1987, white rates in the younger age group were 
comparable to those reported for the United Kingdom, while rates in the coloured 
population were comparable to (even higher in some years) than those reported from 
New Zealand. The authors speculate that the difference in mortality between the two 
groups is likely to be due to greater severity of asthma and differential quality of asthma 
management associated with socioeconomic disparities. 
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2.6. Aetiologic studies 
Eloff (1990) conducted an ecologic correlational study which aimed to relate the 
prevalence of asthma serious enough to warrant restricted training among white military 
conscripts, with air pollution indices by region. (The study is available as a report in a 
conference Proceedings only). Of interest was the geographic distribution of these rates. 
The study has the advantage of large numbers, a relatively homogeneous population and 
the ability to generate geographical rates. A possible bias is that conscripts may 
exaggerate their afflictions, and that such exaggeration may be unequally distributed 
among men from different towns. Further, but unpredictable biases may arise from 
different criteria for medical restriction used in different training centres. 
Nevertheless the data are interesting and essentially confirm Ordman's observation of 40 
years ago that asthma is more common at the coast. The major exception is the Central 
Rand (now Gauteng) with a rate second only to that of Durban. This is unexplained as 
areas with higher pollution levels such as the far east Rand has just over one third of the 
asthma prevalence. There was no correlation between asthma prevalence and measures 
of ambient air pollution by city or area. The study raises a number of interesting 
questions, and is a creative use of routinely collected data. 
Potter (1990) used a case control design to examine the precipitants of acute asthma 
among children admitted to the Red Cross Children's Hospital in Cape Town over a one 
month period. He found no association between meteorological variables, recent 
exposure to allergen, skin prick sensitivity and likelihood of admission. The only difference 
between cases and controls was the higher rate of acute respiratory infection in the 
cases. However, the study was small with low statistical power. In addition, the use of 
well asthmatic controls from a specialist clinic creates potential biases. For example, 
respiratory infections not precipitating an asthmatic episode may have kept controls away 
from the clinic on any given day. As the clinical examinations were unblinded as to 
acute/well status there is likely to be relative overreading of signs in the acute cases. 
Signs such as "coryza" and "bronchitis" in the acute cases do not necessarily indicate 
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infection, and may merely be manifestations of the allergic asthmatic response. 
Richards (1996) examined the association between passive smoking and a variety of 
outcomes, including reported respiratory disease and lung function, among 726 high 
school children aged 16 years in the Vanderbijlpark area of the Transvaal. He found 
associations between exposure to parental smoking and reports of respiratory illnesses, 
symptoms such as cough and earache, low birth weight and learning difficulties. No 
significant association between parental smoking and reported asthma or allergy, lung 
function (n=395) nor serum lgE concentrations (n=363) was found. 
2. 7. Conclusions 
Allowing for the variability in quality and method of the epidemiologic evidence that is 
available, certain tentative conclusions can be drawn about asthma in South Africa. 
1. The nature of the allergic response underlying asthma in South Africa varies 
geographically, with house dust mite a major contributor at the coast, and grasses more 
common inland. Although there is one study (other than Ordman's clinically based 
observations) suggesting that asthma is more prevalent at the coast (Eloff 1990), there 
are also anomalous data and the difference remains to be confirmed. 
2. Although the evidence is indirect, the hospital studies and serial Transkei studies are 
compatible with the widely held view that childhood asthma is much more common now 
than two to three decades ago. This accords with the trends noted in a number of other 
countries. 
3. Urbanisation, or at least the changes associated with "westernisation", underlie an 
increased prevalence of asthma over time in the black South African children. The nature 
of these changes is speculative. 
4. Race as used in these studies is a proxy (to some extent implicit) for access to health 
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services, socioeconomic status, environmental conditions and urban status. Apart from 
the effect of urbanisation mentioned above, the evidence for consistent interpretable 
differences between race groups in prevalence of asthma symptoms, BHR or immune 
markers is scanty. 
5. Asthma mortality shows a pattern most suggestive of relative socioeconomic 
advantage in the population, with a recent decline among whites and a high level among 
coloureds. 
2.8. Postscript: A note on the use of race categories in epidemiology 
In seeking to describe the distribution of disease in South Africa, epidemiologists have 
frequently used a categorisation which seemed obvious on biological and sociological 
grounds, namely that of "race". (Quotation marks will be used in this section to signal that 
the meaning and use of terms are under discussion). 
Much of the descriptive epidemiology (of a number of diseases) undertaken over the past 
four decades in South Africa has thus sought to describe, and less commonly to explain, 
the distribution of disease among the four "races" that formed the legal basis of apartheid 
regulation. These four "races" (alternatively termed "population groups" and more 
recently "ethnic groups") are: black (alternatively African), white (Caucasian), coloured 
(mixed race) and Asian (Indian). 
The uncritical use of race categories in health research in South Africa (Ellison 1996, 
1997a, 1997b, 1997c) and elsewhere (Muntaner 1996, National Institutes of Health 1998) 
has recently been the subject of a persuasive critique, with some qualification (Walker 
1997a, 1997b). 
A number of arguments have been adduced against the use of race categories in 
epidemiologic research. First, it needs to be recognised that the division of the human 
species into "races" is a social construction, varying historically with political and 
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geographic circumstances (National Institutes of Health 1998). This is well illustrated by 
the South African four group classification. (It is notable that no biologistic definition of 
race was ever attempted in apartheid law). 
A major problem with the use of race categories in epidemiology is the explicit or implicit 
inference that phenotypic differences between "races" are coterminous with genetic 
differences which determine predisposition to disease (Ellison 1997c). As distinct from 
the ways in which groups defined as "races" are treated differently in a given society, the 
biologic basis for the division of humankind into 3 or 4 "races" has been shown to be 
arbitrary (Diamond 1994). Humans are remarkably alike. Within the relatively small 
amount of human genetic variability, interindividual rather than intergroup variation 
accounts for 85% of the variation observed. Only about 6 percent of the variability 
represents differences between "races" as conventionally classified. (Hoffman 1994, 
National Institutes of Health 1998). Because of the importance of mean appearance 
phenotype (skin colour, eye shape, hair type, height) in the social construction of groups, 
it is a short but fallacious step to infer a genetic basis to any measurable disease 
difference between these groups. 
An example of this type of biologistic inference is the study of serum lgE levels in 52 
"white", 58 "coloured" and 53 "black" mother-newborn pairs drawn from public sector 
maternity units attached to a teaching hospital in Cape Town (Haus 1988). No further 
individual level data are given, other than that the black mothers had to have lived in the 
urban area for at least a year to enter the study. The main finding of the baseline study 
was that, contrary to expectation, "black" neonates had a mean and median cord blood 
serum lgE that was higher than that of the other two groups, particularly among those 
with no atopic family history. The authors go on to conclude that" .... newborn infant(s) in 
black Third World populations .... appear to represent a pool of genetic high lgE-responder 
phenotypes". While the authors emphasise that recent urbanisation may be an important 
environmental influence on the mothers of black infants, the results are also taken to 
reflect genetic differences between the groups, with wide generalisability. 
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While "race" categories have been used in a variety of ways in the South African medical 
and epidemiologic literature (Ellison 1997b), the most defensible usage is to reflect 
environmental and social stratification. The reality of apartheid as it evolved in South 
Africa over 350 years has been the reinforcement or creation of sharp social, economic 
and geographic divisions between "races". This has been overlaid with historical 
differences in cultural and religious practice, which correspond to varying degrees to the 
political categorisation. There are thus real mean differences between the "races" in 
income, education, occupation, geography, urbanisation, early nutritional and infective 
experience, diet, housing quality and quality of medical and public health services. 
Differences between "races" can thus be taken to signify the workings of these 
environmental influences, and hence an important subject of aetiological inquiry. 
The problem with this approach is that the more differences there are between groups, 
the more difficult it is to identify which one is responsible for the observed differences in 
disease - a problem of collinearity and confounding. Given that comparisons are often 
ecological (as in speculating about causes of mortality rate difference between the 
"races"), the unpredictable influence of confounding and effect modification (Greenland 
1989) (the ecologic fallacy) further reduces the likelihood of reaching aetiologic 
conclusions. One is thus left more or less permanently at the level of hypothesis 
generation. 
There is a more overtly political argument in favour of studying "race" differences in 
disease, which has wide acceptance. In order to monitor progress towards greater social 
equity, it is necessary to retain the classification which was originally the basis of that 
inequity (Walker 1997a, Ellison 1997c). This is the (unpublished) but apparent position of 
most official and non-governmental agencies concerned with collection of health data. A 
counterargument, however, is that the reliance on "race" inhibits (the admittedly more 
difficult) measurement of health relevant individual level characteristics such as diet and 
housing, as well as social descriptors related to wealth, power, and discrimination (Ellison 
1996). 
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This author is broadly in sympathy with the current critique of the use of racial categories 
in epidemiology, while recognising some limitations. There is very little that can be done 
about historical data sets where "race" is one of the few variables by which death and 
disease outcomes can be stratified. Such stratification has and can still tell us something 
about our society and the role of the environment. However, the tendency to make 
unsupported inferences about genetic differences between "races" should be challenged. 
Further, this author believes that the research programme comparing disease outcomes 
by "race" is approaching intellectual exhaustion, especially as social and economic 
change is producing increasing heterogeneity within "races". The time has come for 
speculation about the nature of environmental or cultural differences between "races" to 
be replaced by research which tests specific hypotheses, either by collecting individual 
level data or by using more sociologically informed ecologic variables. 
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3.1. Importance of the question 
The rising tide of childhood asthma has encouraged the search for preventable 
causes of this condition. The apparent increase in both childhood asthma and 
tobacco smoking in adults in many populations has focused attention on a possible 
association between the two phenomena, which if causal, would be of inordinate 
public health importance (Weiss 1992). 
As discussed in Chapter 2, asthma is probably more common among South African 
schoolchildren than three decades ago. Tobacco usage in South Africa, while 
common and recognised as a major cause of ill health in adults (Yach 1988, 1992), 
is unevenly distributed in the population. Smoking surveys in recent years have 
tabulated smoking prevalences by age, sex and race (a surrogate for social class, 
cultural acceptance of smoking, and probably differential marketing by the tobacco 
industry) (Steyn 1987, 1997, Yach 1988, Reddy 1996). 111 the latest national survey 
(Reddy 1996), overall smoking rates among South African men and women 
respectively were: Asian: 48%, 7%; black: 53%, 10%; coloured: 58%, 59%, and 
white: 43%, 27%. These differences were confirmed by a study of volunteer 
population of women attending antenatal services in four South African cities. Among 
the sample attending public sector clinics, 46 percent of coloured women reported 
smoking during their pregnancies, compared to 3.6 percent of black women and 2.6 
percent of Asian women. Among women attending private practices (i.e. of higher 
socioeconomic class), 27.6 percent reported smoking in pregnancy. 
Smoking trends over time in South Africa have not been published, but were 
obtained by the author from a market survey company which polls an annual national 
random sample of South Africans. Between 1975 and 1992, prevalence of tobacco 
usage ( defined by use of at least one packet of 20 cigarettes per week) declined only 
among white men and women, while remaining constant or rising among the rest of 
the population. (South African Advertising Research Foundation - personal 
communication). 
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In the light of the above, even a modest association between ETS and childhood 
asthma could have a substantial public health impact in some South African 
communities. 
3.2. Strategy of this chapter 
The great interest in the subject of ETS and its influence on childhood respiratory 
illness has resulted in a large number of studies and literature reviews over the past 
15 years or so. This literature was reviewed by the author in 1992 (Ehrlich 1992). 
Since then, a sizeable number of further studies on the subject have appeared. 
A series of systematic reviews of the association between ETS and asthma, 
wheezing, BHR and allergic sensitisation has recently been published by Strachan 
and Cook in a five article series in Thorax (Strachan 1997, Cook 1997, Strachan 
1998a, 1998b, Cook 1998). The authors reviewed approximately 170 relevant 
studies, including some unpublished work. Where possible, they summarised results 
quantitatively in the form of pooled estimates of effect. (The used odds ratios for 
comparability across all study designs). Heterogeneity of individual study findings 
were tested statistically, and pooling was done according to random effects or fixed 
effects model assumptions. Covariates adjusted for in the various studies were 
reported in summary form. Publication bias was assessed by examining results from 
some large unpublished studies, and by noting whether smaller studies tended to 
show mainly positive findings. 
Meta-analysis of observational studies is a way of reducing a large amount of data to 
interpretable form for comparison purposes and for examining patterns of divergence 
(Greenland 1987, 1994). However, this type of meta-analysis has been criticised for 
conferring spurious precision on biased estimates (Shapiro 1994). Pooled measures 
of effect do not in fact reduce the need for critical qualitative appraisal of sources of 
bias and confounding. 
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The problem of this chapter is to reduce a large amount of heterogeneous material to 
digestable form. It was decided that this would not be served by either a de nova 
review or a reproduction of tables summarising every study. The objectives of this 
chapter are instead twofold. First, to re-examine the findings of the author's 1992 
review (Ehrlich 1992) in the light of Strachan and Cook's recent meta-analyses and 
other relevant publications. This will also provide a temporal view of the evolution of 
evidence on the subject. The second aim is to examine the evidence qualitatively 
within an epidemiologic framework of confounding, effect modification and 
misclassification, i.e. threats to validity. 
Earlier reviews of the evidence linking ETS to childhood respiratory illness 
concluded that parental, and particularly maternal, smoking is associated with both 
an elevated risk of lower respiratory illness in children under two years of age, and 
with a small decrement in lung function or rate of lung growth in childhood (Weiss 
1983, Guyatt 1985, Fielding 1988, National Research Council 1986, US Department 
of Health and Human Services 1986, Samet 1987a, Spitzer 1990). This conclusion 
regarding lower respiratory illness in infancy and early childhood was supported by 
Strachan and Cook's meta-analysis (Cook 1997). 
There was less confidence in the earlier reviews about imputing a role to ETS in the 
development of paediatric asthma. To focus this review on the questions set in 
Chapter 1 , the emphasis is on the occurrence and exacerbation of asthma and 
persistent or recurrent wheezing in primary school children. This review thus covers 
aetiologic studies in which asthma, wheezing or BHR in children were examined as 
outcomes. The different outcomes of interest reflect the view of asthma as a 
heterogeneous condition encompassing most recurrent or chronic wheezing in 
children, at least in those over two years of age (Lee 1983, Konig 1987). Studies of 
non-specific BHR are included as this attribute is an important physiologic character-
istic of asthma. 
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Studies which reported on cough, which may be the only symptom of asthma in a 
minority of children (Konig 1987), on non-specific respiratory symptoms such 
as breathlessness or "chestiness" , or on a composite index of respiratory 
outcomes, have not been included in the primary review. There is also a substantial 
literature on ETS and reduction of lung function or lung growth in children. While lung 
function deficits are a manifestation and complication of asthma, this literature is also 
not reviewed in any detail. 
In what follows, biologic plausibility is considered briefly as background to the 
epidemiologic review. The epidemiologic reports are grouped and their findings 
summarised by study design. The Discussion section deals with methodological 
considerations which might be invoked to explain differences between study findings. 
The Conclusions section attempts to tie the foregoing together including a brief 
discussion of causal pathways. The chapter concludes with estimates of the burden 
of disease attributable to ETS in the USA. 
3.3. Plausibility 
An association between ETS exposure and paediatric asthma has biologic plausibili-
ty. Environmental tobacco smoke is a complex mixture of particulates and gases 
(Schmeltz 1975) which could function as irritants or as antigens (Lehrer 1978), initiat-
ing or worsening inflammatory or immunologic responses in airway walls of exposed 
children. Either by altering resistance to infection or by increasing permeability of the 
epithelial barrier to allergens and irritants (Hulbert 1981 ), ETS may enhance BHR, 
stimulate an lgE response, or cause airways narrowing directly through mucus hyper-
secretion or stimulation of irritant receptors (Holt 1984). 
Maternal smoking during pregnancy provides an alternative route of absorption of 
tobacco smoke ingredients by the child. Smoking by the mother in pregnancy is 
associated with lower birth weight (Sexton 1984, Nilsen 1984) and increased foetal 
and infant mortality (Kleinman 1988, Cnattingius 1988). Effects of nicotine on foetal 
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airway structure (Wang 1894) and on foetal lung growth (Collins 1985) have been 
shown in rodents. While maternal smoking in pregnancy appears to accelerate 
human foetal lung maturity and decrease the risk of neonatal respiratory distress 
syndrome, the mechanics of this process may entail other abnormalities of growth in 
the respiratory system (Lieberman 1992). An association with elevated serum lgE 
levels in newborns has also been suggested (Magnusson 1986). 
In adults, active smoking does not appear to be a consistent predictor of asthma 
(Welty 1984, McWhorter 1989, Vesterinen 1988, Strachan 1996). This may be due in 
part to the methodological difficulties of disentangling asthma from other forms of 
obstructive airways disease. Strong selection factors may be present as well, as 
asthmatics may be less given to start smoking or be more likely to quit. The 
association of active smoking with total serum lgE level and specific lgE responses in 
adults is also inconsistent (Gerrard 1980a, Burrows 1981, Zetterstrom 1981, Jarvis 
1995), with an apparent protective influence in the case of certain antigens (Jarvis 
1995). Active smoking seems to be associated with elevated BHR (Gerrard 1980b, 
Welty 1984), although age (Burney 1987) and atopy (O'Connor 1989) may be 
important effect modifiers of this relationship. 
The relation between ETS exposure and asthma in adults is also unclear. This 
association was recently reviewed by Coultas (1988), who concluded that limited 
evidence from a relatively small number of studies pointed to small increase in risk of 
asthma among passively exposed adults, and to exacerbation of asthma among 
those already diagnosed. 
Nonetheless, there are a number of reasons why an effect of ETS exposure on 
asthma may be observable in children and not in adults. In utero or early exposure 
of the growing and maturing respiratory system to products of tobacco smoke may 
occur during critical periods of susceptibility to such agents. Further, as younger 
children spend a high proportion of their time indoors at home and have little control 
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over their exposure, they are likely to have significant continuous exposure to 
household smoking. Finally, an association in children may be easier to discern 
before occupational exposures, active smoking, and self-selection effects exert their 
impact. 
3.4. Epidemiologic studies of parental smoking and asthma, wheeze and 
bronchial hyperresponsiveness in children 
The majority of studies have used a general population study base, with either 
prospective or cross-sectional (prevalence or "prevalent case control") analysis. This 
approach has been complemented by a relatively small number of incident case 
control studies, in which newly diagnosed asthmatics are compared to non-asthmatic 
controls. The hypothesis examined is whether ETS exposure is associated with the 
occurrence of asthma or wheezing, rather than with their exacerbation or severity 
(although a few studies have attempted both). Studies of asthmatic populations 
alone, which are more clearly able to answer questions of exacerbation, are fewer in 
number. 
The studies are summarized under four headings, according to study design or 
outcome. Table 3.1 summarises, in anticipation, the main conclusions under each 
heading. 
3.4.1. Cohort studies of asthma and wheeze 
Cohort studies should be less subject to bias than cross-sectional or case-control 
studies, as they are able to record parental smoking status in advance of the diagno-
sis or symptoms (including during the important periods of pregnancy and infancy), 
and to make more than one measurement of exposure. Loss to follow-up remains a 
problem, while retrospective reporting by parents of earlier exposures may still suffer 
from recall bias. Cohort studies are also able to measure directly incidence and 
measures of risk or burden of disease derived from incidence. 
43 
Literature review: ETS and asthma 
3.4.1.1. Cohort studies: 1992 review 
Two large prospective birth cohort studies, one from Britain (Leeder 1974) and one 
from New Zealand (Horwood 1985) showed little or no association between parental 
smoking and asthma or wheezing after adjustment for covariates. Two smaller cohort 
studies, one following children to 12 months of age (Arshad 1992a), the other to five 
years of age (Cogswell 1987), found a significant excess of wheezing among 
children of smoking parents. Only the former (Arshad 1992a) adjusted for potential 
confounders; a significant effect remained only among infants whose parents both 
smoked. 
Among prospective studies that separated maternal smoking from other sources of 
smoking, all found some association between maternal smoking and wheezing. 
Those that examined children one to two years of age have found a consistent 
relationship (Fergusson 1985, Anderson 1987, Wright 1991, Arshad 1992b). The 
effect was not detectable among older children in two of the longer-term studies 
(Fergusson 1985, Anderson 1987) although in the latter study smoking in pregnancy 
was the only exposure variable available. McConnochie (1989) did, however, find an 
effect of maternal smoking on the incidence of new wheezing in older children. 
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TABLE 3.1 Effect of environmental tobacco smoke (mainly 
parental smoking) on asthma and related features: summary of 
epidemiologic evidence 
Outcome I study design 
Asthma and wheezing 
Cohort studies 
Case control and prevalence studies 
BHR 
Allergic sensitisation 
Aggravation of existing asthma 
Findings 
Consistent positive association parental 
smoking with wheezing in early childhood. 
In older children, maternal smoking 
associated with wheezing; less so for 
diagnosed asthma. 
Large body of evidence: smoking by 
mother and by both parents associated 
with asthma and wheezing. Less so for 
father's smoking. 
Evidence suggests that parental smoking 
increases BHR, but publication bias a 
possibility. 
Evidence inconsistent; overall suggests 
no association with parental smoking. 
Suggestive association parental smoking 
with various indices of severity. Few 
studies of any one outcome, e.g. BHR 
among asthmatics. 
The evidence with regard to maternal smoking and diagnosed or reported asthma in 
these studies was equivocal, however. Fergusson (1985) and Sherman (1990) 
found no association, while Neuspiel (1988) found an effect of maternal smoking on 
wheezy bronchitis (based on maternal reporting) but none on asthma. By stratifying 
by years of maternal education, Martinez (1992) was able to demonstrate an 
association between maternal smoking and diagnosed asthma that was restricted to 
children of less educated mothers. 
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3.4.1.2. Cohort studies: 1998 update 
Strachan and Cook (Strachan 1998b) reviewed 10 papers reporting on six cohort 
studies, including four of the cohorts included above. An association of maternal 
smoking with incidence of wheezing has persisted, while the findings regarding 
diagnosed asthma have remained contradictory. In their meta-analysis, a stronger 
association with "asthma or wheezing" was found in cohorts covering the ages from 
birth to early school years (pooled odds ratio 1.31, 95% C.I. 1.22-1.41), than in those 
covering the school years or the whole of childhood excluding infancy (pooled odds 
ratio 1.13, 95% C.I. 1.04-1.22). 
3.4.2 Cross-sectional and case-control studies of asthma and wheeze 
Survey based cross-sectional studies and clinic based case-control studies are 
easier to do than cohort studies and therefore more numerous. They suffer the 
disadvantage of collecting symptom and diagnosis information contemporaneously 
with smoking data. Parents of symptomatic or diagnosed children may alter their 
smoking habits or report such habits differently from parents of asymptomatic or 
undiagnosed children. Also, smoking during later childhood may not reflect the 
child's exposure at critical earlier periods. 
3.4.2.1. Cross-sectional/case control studies: 1992 review 
Among reports which did not separate out maternal smoking, considerable variability 
of findings was apparent. A number showed a significant positive effect, particularly 
if both parents were smokers, (Weiss 1980, Dodge 1982, Burchfiel 1986, Somerville 
1988, Dekker 1991, Chinn 1991 ). However, there were important studies in this 
group showing little or no positive effect even with large samples (Schilling 1977, 
Schenker 1983, Strachan 1988, Strachan 1990, Dijkstra 1990). In others, the effect 
appeared only in one sex (Burchfiel 1986, Somerville 1988) or in some large 
geographic subsamples but not others (Chinn 1991 ), was observable only if a 
cofactor such as dampness at home was present (Andrae 1988), or became 
insignificant after adjusting for parental symptoms (Lebowitz 1976). 
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Studies which were able to separate maternal smoking from smoking from other 
sources were notably consistent in their findings. Almost all found an association of 
maternal smoking and childhood asthma (Gortmaker 1982, Kershaw 1987, 
Weitzman 1990, Goren 1991, Willers 1991, Ehrlich 1992), some form of wheezing 
(Ekwo 1983, Ware 1984, McConnochie 1987), or a combination of asthma and 
wheeze (Forastiere 1992). Exceptions were Schenker (1983) who reported no sig-
nificant relationship between maternal smoking and diagnosed asthma or persistent 
wheeze, and Goren (1992) who found an association with asthma but not with 
wheeze. 
3.4.2.2. Cross-sectional/case control studies: 1998 update 
There are now a large number of studies in this category. Strachan and Cook (Cook 
1997, Strachan 1998b) have divided them into "case-control" studies ( asthma 
defined either in a health service setting or by some measure of greater severity if 
survey based), and prevalence studies (typically survey based with a variety of 
questionnaire derived wheeze or asthma outcomes). 
Of the 19 case-control studies reviewed by Strachan and Cook, three were included 
in the earlier review. Strachan and Cook refer to these case-control studies as 
prevalence based. In theory, case control studies based on incident cases are 
clearer to interpret for purposes of aetiologic inference than studies based on 
prevalent cases, since in the latter type incidence may be entangled with duration of 
the disease. There is in fact limited evidence from a number of small studies that 
ETS increases the risk of wheeze persistence (duration of disease) from early to 
mid-childhood, although this effect is not seen in large cohorts followed into 
adolescence (Strachan 1998b). However, since asthma follows a chronic or 
recurrent course with variable delays to presentation and diagnosis, the distinction 
between incident and prevalent cases studied in health service settings is not 
necessarily a clear one. 
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Strachan and Cook's conclusion from case control studies is similar to that of the 
author's 1992 review. Smoking by either parent (or presumably by both, although 
this is not explicit) is associated with asthma (pooled odds ratio 1.37, 95% C.I. 1.15-
1.64), with a fair bit of heterogeneity. When maternal smoking is examined 
separately the association is slighty stronger (pooled odds ratio 1.59, 95% C.I. 1.27-
1.99) with less heterogeneity. Paternal asthma shows no association with asthma. 
The prevalence studies reviewed by Cook and Strachan (Cook 1997) are mainly 
population surveys based on self-administered questionnaires to parents, and 
include 25 papers with asthma as the outcome, and 41 with some form of wheeze as 
the outcome. Of these, 14 were included in the 1992 review (which included some 
not in the later review). In the studies reviewed, the reported asthma definition varied 
between asthma that was parent reported, doctor diagnosed, current, recent or 
"ever", while the wheeze description varied broadly among current, ever or persistent 
wheezing. 
In these cross-sectional studies, smoking by the mother only (versus neither parent) 
was consistently associated with an odds ratio greater than one, with few exceptions 
[pooled odds ratios: asthma = 1.36 (95% C.I. 1.20-1.55); wheeze = 1.28 (95% C.I. 
1.19-1. 38]. These odds ratios increased to approximately 1. 50 when both parents 
smoked. Again, there was greater variation among the findings for smoking by the 
father only (versus neither parent), with only the pooled odds ratio for wheeze (1.14, 
95% C.I. 1.06 -1.23) being significant. 
3.4.3. Studies of bronchial hyperresponsiveness (general population) 
3.4.3.1. BHR studies: 1992 review 
Five studies of the relation between BHR and parental smoking or ETS exposure in 
general populations of children were included. The children in these studies were 
necessarily older (6 years and up) than in the studies reviewed in the previous 
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sections because of the need to be able to complete a BHR test. Three of these 
studies, which related bronchoconstrictor challenges to maternal smoking (O'Connor 
1987, Martinez 1988, Frischer 1992) found strong associations between maternal 
smoking and BHR among asthmatics. Among non-asthmatics, however, the 
association was absent (O'Connor 1987) or weaker (Frischer 1992), while Martinez 
(1988) demonstrated it only among boys. No association between ETS exposure 
smoking and exercise-induced bronchospasm was found by Strachan (1990), using 
salivary cotinine as a marker of ETS exposure. One study measured BHR among 
infants aged two to ten weeks (Young 1992): an association with parental smoking 
was demonstrable, but only in the absence of a family history of asthma. 
3.4.3.2. BHR studies: 1998 update 
Apart from the neonatal study (Young 1992), Strachan and Cook (Cook 1998) were 
able to find 1 O studies from which odds ratios for the association between ETS and 
BHR in schoolchildren could be calculated. Of these, five were included in the 
author's 1992 review. The later review is more suggestive than the earlier one of an 
association between parental smoking (in most cases maternal smoking) and BHR 
(pooled odds ratio 1. 29, 95% C. I. 1. 10-1. 50). However, Strachan and Cook point 
out that in a further five studies from which only p values could be derived, the 
associations were all non-significant while in another four studies in which BHR and 
ETS were measured inter alia, no findings were given in the published reports. They 
conclude that publication bias may well explain the small positive association found 
overall. 
3.4.4. Studies of asthmatic populations 
Studies of asthmatic children address the relationship between ETS exposure and 
exacerbation or severity of asthma rather than occurrence of asthma. 
In the 1992 review, direct evidence of aggravation was more limited than for 
occurrence, as relatively few asthmatic populations had been carefully studied in this 
49 
Literature review: ETS and asthma 
regard. The available data suggested that asthmatic children whose mothers 
smoked had more severe asthma, were more likely to be on medication and to have 
more frequent visits to the Casualty department (Emergency Room) than those 
whose mothers did not (Murray 1988, Evans 1987, Murray 1986, Murray 1989, 
Weitzman 1990a). 
Further, a consistent finding in four separate populations including two small sub-
populations described in the previous section, is that parental smoking was associat-
ed with a greater frequency of BHR among asthmatics (Murray 1986, 1988, 1989, 
O'Connor 1987, Martinez 1988), and with lower lung function indices among 
wheezing or asthmatic children (Sherrill 1992). 
In contrast, frequency of symptomatic days (Evans 1987) and hospital admissions 
(Evans 1987, Weitzman 1990b) among asthmatic childre.n were not related to either 
household or maternal smoking. Similarly, ETS exposure could not be shown to 
provoke acute airflow limitation or increased BHR in a chamber study of a small 
group of asthmatic children (Oldigs 1991 ). 
In their 1998 review, Strachan and Cook (Strachan 1998b) have extended the 
evidence but have noted the same inconsistencies. In general, clinic based studies 
of asthmatic children are more likely to show an association between ETS exposure 
and severity or exacerbation indices than subpopulations with asthma or wheeze 
identified in surveys (e.g. Henderson 1995). This may reflect the greater 
heterogeneity and inclusion of milder forms of wheezing in survey based compared 
to clinic based studies. 
3.4.5. Allergic sensitisation 
Because of the importance of atopy in childhood asthma, studies addressing the 
association between ETS exposure and markers of allergic sensitisation could throw 
light on a possible mechanism. Allergic sensitisation may thus be an intervening 
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variable in the association between ETS and asthma. 
3.4.5.1. Allergy: 1992 review 
The evidence that ETS exposure in children is positively associated with immune 
markers was mixed. Atopy as manifested by skin test reactivity was found to be 
related to maternal smoking by Martinez (1988) and by Weiss (1985). The former 
group also reported increased lgE levels and eosinophil counts and percentages in 
male children of smokers. Elevated lgE levels were also found in the cord blood of 
newborns of smoking mothers (Magnusson 1986), and in infants of smoking parents 
(Kjellman 1980). In contrast to these findings, Oryszczyn (1991) found no 
association between maternal smoking in pregnancy and cord blood lgE. Similarly 
no association between parental smoking and total lgE was found in a small cohort 
of children followed from birth to five years of age (Cogswell 1987), or between such 
smoking and either total lgE or specific lgE to common all_ergens in a study of older 
children (Ownby 1988). 
3.4.5.2. Allergy: 1998 update 
Strachan and Cook (Strachan 1998a) reviewed 28 papers in which associations 
between parental smoking and cord blood lgE, postnatal serum lgE (almost all total 
rather than specific), or skin prick tests were examined. Summary of the evidence is 
made difficult by small sample sizes, lack of adjustment for confounders in a number 
of studies, and inconsistency and heterogeneity among studies. However, the 
reviewers conclude that the evidence is against any positive association between 
maternal smoking and total lgE, whether in the perinatal period or in later childhood. 
Similarly, there is unlikely to be an association between perinatal ETS exposure and 
specific skin prick test reactivity in older children - if anything such exposure appears 
protective. No conclusion could be reached regarding concurrent ETS exposure and 
skin prick test results in older children. 
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3.5. Discussion 
The large number of studies to date point to an association between maternal 
smoking and asthma or wheezing in children. The effect size is relatively small. 
There is greater inconsistency with regard to the influence of sources of ETS other 
than maternal, the timing of effect and a possible differential impact on "wheezing" 
compared to that on "asthma". 
Considered below are methodological factors which might produce bias in studying 
this association, either generating negative findings in the presence of a real as-
sociation, or contributing to a spurious positive association. These factors are 
discussed under the following headings: (1) exposure variation and misclassification 
(2) outcome variation and misclassification (3) confounding, and (4) effect 
modification. 
3.5.1. Variation in and misclassification of ETS exposure 
Validation studies have suggested that parental reporting of their smoking status is 
reasonably accurate (Emerson 1995). However, some misclassification of the child's 
actual dose of tobacco smoke ingredients is inevitable. Important factors other than 
parental smoking status affecting the child's dose include the number of cigarettes 
smoked in actual proximity to the child by each parent, the number, size and ventila-
tion of rooms in the home, and the child's age and possibly sex. Smokers other than 
parents (at home or elsewhere) could be the source of important exposure. 
Season or climate may substantially affect the degree of exposure. In a study of 
asthmatic children in Vancouver, an association between maternal smoking and 
asthmatic severity was demonstrable only in the cold, wet season but not in the 
warm, dry season (Murray 1988). This seasonal effect could be explained by a 
greater exposure to tobacco smoke in cold wet weather, when ventilation is reduced 
to conserve energy and when children spend more time indoors. Among children in 
Edinburgh, salivary cotinine concentrations measured in spring were about 70% 
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lower than in winter (Jarvis 1992). This source of variation in true exposure may 
explain differences between studies from different climatic regions. 
To the extent that misclassification of exposure in a given study is unrelated to the 
occurrence of asthma, i.e. non-differential; it would usually weaken the observed 
relation between ETS exposure and asthma. Differential misclassification would 
arise if misclassification of ETS exposure status or dose were related to asthma or 
wheezing. This might occur, for example, if parents of symptomatic children denied 
or understated their smoking; this too would bias the association towards the null. 
It is in distinguishing between maternal and paternal smoking that critical differences 
in effect are observed. Almost all of the studies examined in the earlier review that 
separated the two sources of ETS exposure found a maternal effect that exceeded 
the paternal effect (Murray 1988, Murray 1989, Burchfiel 1986, Neuspiel 1989, 
McConnochie 1986, McConnochie 1989, Gortmaker 1982, Ekwo 1983, Ware 1984, 
O'Connor 1984, Forastiere 1992). The importance of maternal smoking is supported 
by studies which were able to quantitate maternal smoking. Among the five studies 
(Murray 1988, Fergusson 1985, Neuspiel 1989, Ware 1984, Weitzmann 1990) in 
which cigarettes smoked daily by the mother was used as the exposure variable, 
exposure-response relationships were observed in four (Murray 1988, Neuspiel 
1989, Ware 1984, Weitzmann 1990). 
This predominance of the maternal effect may also explain why smoking by "one 
parent alone" is frequently observed to have little or no significant effect on wheezing 
or asthma whereas an effect appears if both parents smoke (Leeder 197 4, Dodge 
1982, Burchfiel 1986, Arshad 1992, Forastiere 1992). Given that the smoking habit 
is still more common among men than among women in most social strata (Marcus 
1987, Covey 1992) and that the single smoker is thus more likely to be the father, the 
"one parent smoking" category will more often reflect the weaker impact of parental 
smoking. Studies that fail to separate out maternal smoking will thus dilute or 
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understate the true association. 
3.5.1.1. Cotinine as a biomarker of ETS exposure 
Some biochemical evidence of the relative contribution of maternal and paternal ( or 
nonmaternal) smoking to tobacco smoke absorption by children has been obtained 
by measuring cotinine, a metabolite of nicotine, in the serum, urine or saliva of the 
child. Chilmonczyk (1990) found that median urinary cotinine level among non-
breast fed infants was much higher if the mother alone smoked (25 ug/L) than if only 
other household members smoked (8.9 ug/L). Greenberg (1989) and Patishall 
(1985) were also able to show a greater contribution of maternal than nonmaternal 
smoking to cotinine levels in infants. Jarvis (1985) measuring salivary cotinine in 11-
16 year-olds found that the median salivary cotinine was also higher if the mother 
was the only smoker (1.35 ng/ml) than if the father was the only smoker (1.00 ng/ml). 
The ratio of "maternal" to "paternal-derived" cotinine (1.35) in this study was less 
than that found in infants by Chilmonzcyk (2.8) and suggests that the difference in 
cotinine contribution from the two parental sources probably declines with age. 
Cotinine has been used also as a means of refining measurement of exposure in 
studies of ETS exposure and asthma, with inconsistent results. Strachan (1990) 
found no relationship between wheeze in the past year or exercise-induced reduction 
in FEV1 and salivary cotinine in seven year old Scottish children. Similarly, Reese 
(1992) found no difference in urine cotinine levels between Australian asthmatic 
children admitted to hospital and nonrespiratory controls. In contrast, Ehrlich (1992) 
found elevated urinary cotinine levels in asthmatic children compared to controls in a 
hospital based study in New York city, as did Willers (1991) in comparing asthmatic 
children from a Swedish hospital with school based controls. 
The use of cotinine as a biomarker of ETS exposure in children is not without 
interpretational problems, however. A single cotinine concentration provides a 
measure of recent exposure. The reliability of cotinine. as a marker of usual or 
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chronic exposure has been the subject of conflicting evidence (Jarvis 1987, 
Henderson 1989, Coultas 1990, Emerson 1995), as has its relationship to 
environmental measures of nicotine concentration (Henderson 1989, Coultas 1990). 
Furthermore, while correlation of cotinine with reported exposure has been confirmed 
in a number of studies in children (Greenberg 1984, Chilmonczyk 1990, Rylander 
1989, Patishall 1985, Jarvis 1985, Coultas 1987), there is a considerable interindivi-
dual variation for any given smoking status. 
Urinary cotinine may reflect a number of influences other than reported parental 
smoking status, including the child's age (Reese 1992) and sex (Strachan 1990), 
which need to be controlled for. It has been argued that dietary contribution to 
nicotine and cotinine levels, mainly from vegetables and tea, may confuse inferences 
about ETS exposure (Idle 1990). However, it appears that improbably large intakes 
of vegetables (or tea) by children would be needed to have a measurable effect on 
cotinine (Davis 1991 ). 
3.5.2. Variation in definition and misclassification of asthma and wheezing 
There is no single definition of asthma for epidemiologic purposes (Samet 1987b). A 
wide variety of outcomes have thus been examined, including parent reported 
asthma (with or without a doctor's diagnosis), health service use for acute asthma, 
past wheezing over various periods, persistent wheezing, wheezing only with colds, 
etc. Of these, wheezing has been shown to be associated with ETS exposure more 
frequently or more strongly than has "asthma". These include studies showing an 
association with wheezing where there was clearly no association between ETS 
exposure and asthma (Somerville 1988, Neuspiel 1989, McConnochie 1989), and 
others in which the odds ratio for asthma was elevated but lacked statistical signifi-
cance (Dodge 1982, Burchfiel 1986, McConnochie 1986). 
The heterogeneity of outcomes and effects in these studie~ has two implications. 
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First, outcomes may differ in their degree of misclassification, arising from faulty 
parental recall and varying diagnostic practices in that population. Misclassification 
of outcome, if non-differential with respect to ETS exposure, will usually reduce the 
effects observed (Rothman 1986). Second, given the diversity of risk factors 
underlying asthma or wheezing in children, ETS exposure may affect certain forms of 
wheezing but not others. Each of these possibilities will be considered in turn. 
3.5.2.1. Misclassification of outcome 
With respect to recall of wheezing, a wide range of prevalences has been reported in 
different questionnaire studies using differently worded questions. Responses 
regarding recent or persistent wheezing are likely to be subject to less error than 
recall of any past episode of the condition. A number of the studies reviewed 
inquired about "persistent" wheeze using questions from (or similar to) the American 
Thoracic Society, Division of Lung Disease questionnair~ (Ferris 1978) (Weiss 1980, 
Schenker 1983, Somerville 1988, McConnochie 1986, Ekwo 1983, Ware 1984, Rona 
1991). Of these, most found a positive association with parental smoking (Weiss 
1980, McConnochie 1986, Ware 1984, Somerville 1988, Rona 1991), one a negative 
relation (Schenker 1983), while one was equivocal (Ekwo 1983). 
Wheezing reports are also likely to be less accurate the longer the period of recall 
required. For example, in a cohort study with interviews when the child was 7, 11 and 
16 years of age, the lifetime incidence of "asthma or wheezing" recalled by parents 
at the third interview (11.6 percent) was only half that of the cumulative incidence 
(24. 7 percent) over the three interviews (Anderson 1987). 
Recall of diagnosed asthma by parents may be more accurate because it is regarded 
as a more serious condition by both parents and physicians. Although few ETS 
exposure studies have directly validated parental reports of asthma, there is some 
evidence that questionnaire-based reports of physician diagnoses are reasonably 
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accurate (Gortmaker 1982, Samet 1987b) and reliable (Forastiere 1992, Frischer 
1992). The prevalence of reported wheezing or asthma may vary also according to 
the respondent: in one study prevalences were higher when the respondent was 
female (Dekker 1991 ). Mothers may thus report more illness in children than do 
fathers. 
A more serious problem arises from underdiagnosis of asthma. Almost all surveys of 
asthma and wheezing have found wheezing prevalences twofold or more higher than 
those of asthma. The relationship between the two in any population presumably 
reflects factors relating to the distribution of risk factors, as well as local clinical 
practice and acceptance of the diagnosis of asthma. In general, substantial 
underdiagnosis of childhood asthma occurs (Speight 1983, Bauman 1992). 
Misclassification of asthma will be non-differential if the f_actors affecting underdiagn-
osis are unrelated to ETS exposure. In this case, the power of these studies to 
detect a real association with diagnosed asthma may be lower than those using 
wheeze as the outcome. Underdiagnosis of asthma is probably not non-differential, 
however. Children from lower socioeconomic class backgrounds may be less likely 
to be diagnosed asthmatic or be reported as asthmatic by their parents (Leeder 
1976). Since smoking is more common among those of lower socioeconomic status 
as measured by education (Pierce 1989) and occupation (Covey 1992), this 
difference in diagnostic labelling will introduce differential misclassification. The 
effect would also be to bias the association of ETS and asthma towards the null. 
3.5.2.2. Differential effect of ETS by type of wheezing 
There is some evidence for the view that maternal smoking may affect certain types 
of wheezing more than others, in particular wheezing related to respiratory infection 
("wheezy bronchitis"). Neuspiel found that maternal smoking was related to a 
diagnosis of post-infancy wheezy bronchitis but not to that of asthma. Similarly, 
Ekwo (1983) found maternal smoking to be associated with "wheezing with colds" 
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but not to "wheezing without colds". Despite controversy about the separability of 
wheezy bronchitis and asthma (Williams 1969, Lee 1983, Wilson 1989), the 
distinction is still used by medical practitioners and would be reflected in responses 
in questionnaire studies. If ETS exposure causes wheezing by increasing the 
likelihood of respiratory infection, the subgroup of wheezers affected by ETS 
exposure may thus be less likely to be diagnosed as asthmatic. This may partly 
explain the more frequent (and often stronger) association of ETS exposure with 
reported wheezing than with asthma in epidemiological studies. 
3.5.3 Confounding 
Positive confounding has to be considered as an explanation for some or all of the 
elevation in risk observed. There are a number of possible confounders. This 
section focuses on some identified as being particular importance (1) active smoking 
by the child, (2) parental symptoms, (3) socioeconomic status (SES), (4) use of fuels 
such as gas in the home, or some combination of these. Any of these factors could 
be associated with increased childhood asthma or wheezing independently of the 
effect of ETS exposure on such asthma or wheezing. Confounding would arise if the 
factor were in addition distributed differently between the children of smokers and 
non-smokers. These will be considered in turn. 
3.5.3.1. Active smoking by the child 
Children whose parents smoke are more likely to smoke themselves (U.S. 
Department of Health, Education and Welfare 1979). Active smoking by older 
children, as a cause of wheezing (Withers 1998), might thus result in confounding of 
the relation between ETS exposure and asthma. Active smoking cannot conceivably 
account for the positive association between parental smoking and wheeze found in 
studies of children under eight years of age. This includes most of the longitudinal 
studies. In the cross-sectional or case-control studies of older children, four inquired 
about active smoking by the child (Weiss 1980, Dodge 1982, Ware 1984, Ehrlich 
1992). Of these, Weiss (1980) controlled for active smoking, while admitting to 
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smoking was rare or absent in the children or young adolescents in the the other 
three studies. Similarly, among the studies of asthmatic populations, Murray (1988) 
found only 1.6 percent (4 of 247) of asthmatics aged 6 to 17 years who admitted to 
smoking. However, underreporting by children of their smoking habits is probable 
and some degree of positive confounding (increasing with age) cannot be excluded. 
3.5.3.2. Parental symptoms 
A number of the studies reviewed have found that parents with chronic respiratory 
symptoms such as wheeze report more symptoms in their children than parents 
without such symptoms (Leeder 1976, Lebowitz 1935, Schilling 1977, Schenker 
1983, Ware 1984). Controlling for parental symptoms has attenuated the ETS 
exposure - wheeze relationship to different degrees. Lebowitz (1976) found that an 
association between parental smoking and children's wheezing all but disappeared 
once parental symptoms were taken into account. In the study by Ware (1984), the 
odds ratio relating maternal smoking to wheeze fell only modestly from 1.31 to 1.23 
after adjusting for parental illness. Other studies have found that the effects of ETS 
exposure were still detectable after controlling for parental symptoms (Weiss 1980, 
Burchfiel 1986, Martinez 1992). 
The link between parental and children's symptoms is a complex one and may be the 
product of a number of associations (Colley 1974). It may be due to a direct effect of 
tobacco smoke on both the parents and children. Alternatively, it may be due to 
cross-infection within the family (Colley 1974). To the extent that parental respiratory 
infections are due to their smoking habit, cross-infection would an indirect 
mechanism for the impact of parental smoking on children. Common symptoms may 
derive also from hereditary tendencies in asthma (Leeder 1976, Hopp 1984). 
However, parents with asthma would, if anything, be less likely to smoke than non-
asthmatics; this would reduce the likelihood of observing an association between 
parental smoking and childhood asthma. Finally, parents with symptoms may simply 
overreport symptoms in their children, creating a spurious association between their 
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smoking and wheezing in their children. 
Adjusting for parental symptoms is needed where factors other than ETS exposure 
underlie the association between symptoms in parent and child. If however, this 
association is due to a common impact of ETS exposure, either directly, or indirectly 
through cross-infection, some degree of overadjustment will occur if parental 
symptoms are controlled for in the analysis (National Research Council 1986). As 
these effects are difficult to disentangle, analysis with and without parental symptoms 
is advisable. 
3.5.3.3. Socioeconomic status (SES) 
In developed countries, smoking prevalences are typically highest among people of 
lower SES as measured by occupation (Cuvey 1992) and education (Pierce 1989). 
On the other hand, the relation between SES as conventionally measured and 
childhood asthma is unclear. Although asthma has been found by some 
investigators to be more common among children of higher SES (Leeder 1976), 
other studies have failed to confirm this (Horwood 1985, Gortmaker 1982) or have 
found the converse (Schwartz 1990). Wheezing, in contrast, appears to be 
consistently correlated with lower SES (Leeder 1976, Neuspiel 1989, Schwartz 1990, 
Arshad 1992b) and with less parental education (Ware 1984, Dekker 1991). 
Most studies which have adjusted for confounding have included some measure of 
SES as a potential confounder without removing the association between ETS 
exposure and wheezing or asthma. Conventional measures of social class such as 
parental occupation or educational status may not, however, fully capture important 
influences on respiratory health (Pullan 1980, Schwartz 1990). These influences 
include housing quality such as presence of dampness (Strachan 1988, Andrae 
1988), family size (Colley 1974), maternal care factors (Pullan 1980) and other risk 
factors for respiratory infection (Graham 1990). Even after adjustment for parental 
education or occupation, ETS exposed and unexposed children may differ in other 
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potentially important respects. Residual confounding by SES may th_us remain. 
3.5.3.4. Home fuel (gas) use 
Gas stove or heater use as a cause of respiratory illness in children in developed 
countries has been included as a potential confounder in a number of studies. It has 
not been found to be related to asthma nor wheezing (Weiss 1980, Schenker 1983, 
Dodge 1982, Ekwo 1983, Ware 1984}, and is thus unlikely to confound an observed 
relationship with ETS exposure. 
Finally, even if individual confounders are controlled, combinations of potential 
confounders may have unpredictable effects. A number of studies have adjusted the 
risk due to maternal smoking for multiple covariates such as demographic factors, 
home characteristics and family history of allergy. In these studies there was in most 
cases little or no reduction in the odds ratio relating ETS exposure to wheeze or 
asthma (Neuspeil 1989, Gortmaker 1982, Ware 1984, Weitzman 1990), a result 
confirmed by Strachan and Cook in their review (Cook 1997. Strachan 1998b). In 
their meta-analysis of prevalence studies, those authors found a marked reduction in 
heterogeneity if studies which had not adjusted for any confounders were excluded. 
In addition, the pooled odds ratio for asthma, although not for wheeze, was 
somewhat reduced by exclusion of such studies. 
3.5.4. Effect modification 
Variables that have been identified as potential effect modifiers of the relation 
between ETS exposure and asthma include age, sex, maternal education and use of 
day care. Differences in these factors between study populations may explain some 
of the conflicting findings. Alternatively, failure to stratify within a study by the effect 
modifier may result in masking of a real association in the relevant stratum. 
Discussion of effect modification is complicated by the probable association of all of 
the above variables with exposure. Variation in effect with a given factor may be due 
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to a correlation of that factor with the child's dose of tobacco smoke undetectable by 
questionnaire. This is probable in the case of age. maternal education and day care 
use, and somewhat less probable in the case of sex. 
In their examination of the age-dependence of the assocation between ETS and 
asthma/wheeze, Strachan and Cook concluded that the evidence supports an age-
related effect of ETS on wheezing, with stronger associations seen in younger 
children under about 7 years of age than in older schoolgoing children (Cook 1998, 
Strachan 1998b). The evidence is not entirely consistent, however. Some 
longitudinal studies have found associations with maternal smoking in older children 
and not in younger children (Strachan 1996), while Murray (1989) found that older 
asthmatic children were more severely affected by parental smoking than were 
younger children. 
Some of the decline in risk with age is probably due to lower ETS exposure with age 
(Irvine 1997). If there is real effect modification, it suggests that ETS exposure may 
have a greater impact in producing the early wheezers rather than the persistent or 
late onset wheezers as defined by Martinez (Godfrey 1985, Martinez 1995). 
With respect to sex, a number of studies have suggested that boys may be more 
susceptible to the effects of ETS exposure (Burchfiel 1986, McConnochie 1986, 
McConnochie 1989, Martinez 1988, Murray 1989). Others have failed to confirm this 
(Ware 1984) or found girls to be at greater risk (Somerville 1988). Although some 
studies have found greater ETS exposure of boys than girls, the increased suscepti-
bility among boys is unlikely to be fully explained by greater exposure. Rather, 
sensitivity to ETS exposure may be conditioned or mediated by the same factors that 
make boys more susceptible to childhood asthma in general (Evans 1987). For 
example, in the population studied by Martinez (1988) and Ronchetti (1990), parental 
smoking was related to increased skin test reactivity, serum lgE and eosinophilia 
only among boys. McConnochie (1989) reported a strong interaction between 
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maternal smoking, male sex and a fam
ily history of asthma in their effect on
 
wheezing. A child with all three factors w
as 21 times more likely to wheeze at age
 
thirteen years than a child with none. 
Martinez (1992) found an effect of matern
al smoking on the cumulative incidence o
f 
asthma only among children of mothers
 with twelve or fewer years of education
 
(while maternal education had no indep
endent association with asthma). Lowe
r 
maternal educational levels may entail a
 number of modifying factors ( other than
 
ETS exposure) affecting the child, includ
ing poorer nutrition, less health consciou
-
sness and greater exposure to other antig
ens, all of which may potentiate the impac
t 
of ETS exposure. 
Effect modification by use of day care wa
s reported Wright (1991), with an effect o
f 
heavy maternal smoking (more than 20 c
igarettes daily) d_emonstrable only among
 
children who did not use day care. The 
simplest explanation is that children who
 
more spend more time at home with sm
oking mothers have greater exposure to
 
tobacco smoke. However, among children
 in day care, a strong positive interaction
 
between maternal smoking and smoking b
y the caregiver on lower respiratory illness
 
has been found (Holberg 1993). 
3.6 Conclusions 
The question of causality can be approa
ched through the time honoured Bradfor
d 
Hill criteria (Hill 1965). In particular, d
oes the evidence meets the criteria o
f 
consistency, temporality, dose-response,
 strength of association and biologica
l 
plausibility (Rothman 1986)? 
There is strong consistency across many s
tudies using different study designs, in 
the association between maternal smoking
 and wheezing in childhood. Where such 
studies have sought to quantitate ma
ternal smoking, an exposure-response
 
association has generally been found. 
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There are a number of possible explanations for the maternal predominance. 
Children spend more time in closer proximity to their mothers than to their fathers
 
and correspondingly inhale more smoke from this source. Mothers are also likely to
 
smoke more cigarettes in the house than smoking fathers. Maternal smoking in
 
pregnancy may also play an important aetiologic role, although the close correlation 
of postnatal smoking with smoking in pregnancy makes it difficult to separate the
 
effects of the two periods of exposure. This is discussed further below. 
While there is strong evidence of the importance of exposure to ETS in early life, the
 
evidence suggests at least some ongoing or contemporaneous effect of materna
l 
smoking on wheezing occurrence and asthma severity. This is suggested by those
 
studies (section 2.5.4. above) demonstrating equal or increased susceptibility o
f 
older children to ETS, including those showing an association of ETS with new
 
wheezing in older cohorts of children (McConnochie (1989) or variation in the
 
severity of the ETS-asthma association by season (Murray 1988, 1989). 
Also, while an association with paternal smoking alone is generally less evident, an
 
exposure response association with cumulative number of household smokers is
 
apparent. While number of smokers might be confounded with intensity of materna
l 
smoking, it is plausible that the effect of number of smokers is due to an increase in
 
the total dose of ETS received by the child. 
The relationship of maternal smoking to diagnosed asthma is weaker. This discrep
-
ancy may reflect the limitations of epidemiologic measurement of asthma rather than
 
absence of an effect. Widespread underdiagnosis of asthma mayl reduce the power
 
of questionnaire studies to detect a relationship with parental smoking. Two othe
r 
explanations suggest themselves, however. ETS exposure may exert its effec
t 
mainly by increasing the frequency of respiratory infections. In such cases,
 
physicians may be less inclined to diagnose the wheezing associated with these
 
episodes of infection as asthma. Alternatively, parents of children diagnosed as 
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asthmatic may quit (or red
uce) their smoking. Mein
ert (1994) has shown that
 
parents of children with BHR
 are more likely to quit smo
king during the child's early
 
childhood - a "healthy passi
ve smoker" effect. 
For demonstration of tempor
ality, i.e. that ETS exposure 
clearly precedes (and is not 
influenced by) the onset o
f asthma, one looks to co
hort studies. Although the 
evidence here is supportiv
e of an association betwe
en maternal smoking and 
wheezing in childhood, certa
in negative studies remain t
o be explained, in particular
 
the cohort studies of Horwoo
d (1985) and Strachan (199
6). The Horwood study is of
 
New Zealand children whos
e environment may be diffe
rent from those in the UK o
r 
USA. It is noteworthy that
 only eight percent of the
 children in that study had
 
received the diagnosis of w
heezy bronchitis, the rest be
ing diagnosed with asthma. 
In contrast, in the 1970 birth
 cohort study of British child
ren by Neuspiel (1989) more
 
than twice as many wheezin
g children had been diagno
sed with wheezy bronchitis 
as with asthma (as recalled 
by the mother). This reflects
 local diagnostic practice an
d 
perhaps maternal recall, bu
t may also reflect different 
distributions of risk factors, 
such as allergens and infecti
on, in different populations. 
Strachan's (1996) study of t
he 1958 national British coh
ort found a consistent effec
t 
of maternal smoking (inclu
ding reported smoking in 
pregnancy) on asthma or 
wheezing bronchitis only a
fter age 16 years. This is 
in apparent contrast to the
 
findings of the 1970 British C
ohort Study (Neuspiel 1989, 
Lewis 1995), which showed 
an effect of maternal smok
ing on any wheezing by 5 
years of age. An intriguing
 
speculation is that the 1970
 cohort had an greater sus
ceptibility to ETS at young 
ages than the 1958 cohort. 
The strength of the associa
tion may be assessed from
 the pooled odds ratios as
 
calculated by Strachan and 
Cook. These vary somewha
t by study design and age 
but are of the order of 1.3, 
which indicates a weak ass
ociation. It has been argued
 
that measures of effect of th
is order are below the resolv
ing power of epidemiology 
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to exclude confounding (Shapiro 1994, Taubes 1995, Witorsch 1991 ). Although 
many studies have attempted to adjust for potential confounders, this is likely to be 
imperfect (Witorsch 1991 ). In addition, unknown confounding is always a possibility. 
However, the consistency of the findings in different populations across a large 
number of studies which have adjusted for a variety of confounders, shifts the onus 
to demonstrate such confounding onto the sceptics. 
Biological plausibility was considered in section 3.2. above. However, the 
mechanism of the effect of maternal smoking in producing wheezing in children 
remains elusive. It may induce the asthmatic state, it may maintain or aggravate the 
asthmatic state once established, it may trigger acute attacks, or act at all these 
levels. Pre- and postnatal influences may be involved. 
Population studies of BHR in older children have failed to establish a consistent 
association with ETS exposure. Respiratory infection may play an important 
mechanistic role. There is strong evidence that ETS exposure increases the risk of 
acute respiratory infection among children under two years of age, including infection 
with respiratory syncytial virus (Pullan 1980). To the extent that such illness, 
particularly bronchiolitis, is a risk factor for later asthma, wheezing and increased 
BHR (Pullan 1982, McConnochie 1984, Weiss 1985, Peat 1987), it may provide one 
(indirect) pathway for the effect of early ETS exposure on subsequent wheezing 
among a subgroup of children. In older children, on the other hand, there are few if 
any data on the association between ETS exposure and viral respiratory infections. 
Distinguishing the contribution to later wheezing of smoking in pregnancy from that of 
postnatal smoking requires populations in which maternal smoking habits can be 
separated according to the periods of interest. Taylor (1987) was able to show that 
prenatal rather than postnatal smoking by the mother was a risk factor for respiratory 
infection among British children. However, when data from the same cohort were 
analysed for an effect on wheezy bronchitis up to age ten years, no difference was 
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apparent between children of mothers who smoked 
only in pregnancy and those who 
smoked only after the child's birth (Neuspiel 1989). 
Recent studies have examined the role of prena
tal smoking on lung function in 
infants. Hanrahan (1992) was able to demonstrate 
that children born of smoking 
mothers had reduced forced expiratory flow r
ates compared to children of 
nonsmoking mothers, an effect independent of pos
tnatal smoking. This finding was 
confirmed by Stick (1996) who showed reduced re
spiratory function in neonates a 
few days old associated with in utero smoke exposu
re. Young (1991) were unable to 
show such an effect, although their measurement o
f smoking was cruder than in the 
study by Hanrahan, and pre- and postnatal influen
ces were not separable in their 
study. They did, however, find elevated levels of BH
R among infants whose parents 
smoked, apparent only among those with no family 
history of asthma. 
The significance of the above finding by Hanrah
an (1992) and Stick (1996) is 
considerable if taken with the reports of Martine
z (1988a, 1992, 1995), linking 
decrement in early airway function to increased ri
sk of wheezing lower respiratory 
illnesses in early childhood. Maternal smoking durin
g pregnancy may thus influence 
the development of airways (Wang 1984) or lu
ng parenchyma (Collins 1985, 
Lieberman 1992) to produce irreversible structural c
hanges at birth which predispose 
to future wheezing illness. The exact mechanis
m and anatomic location of the 
lesion and its relationship to airflow limitation and BH
R remain to be elucidated. 
Separating prenatal from postnatal smoking epidem
iologically may become easier in 
the future as women quit smoking for the duratio
n of pregnancy in response to 
publicity about adverse effects. A problem is that
 mothers who quit in pregnancy 
may diff on a number of factors from those that pe
rsist. For example, mothers who 
smoke in pregnancy may smoke more intensely pr
e- and postnatally than mothers 
who quit in pregnancy and resume after the child 
is born. Without quantitation of 
smoking, therefore, merely comparing the effects of
 maternal smoking status by 
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period of interest would be misleading. One strategy would be to randomise mothers 
to anti-smoking interventions in pregnancy and follow the children after birth. This 
would control for some of the confounding associated with quitting and allow more 
careful quantitation of maternal smoking. This design has been used in studies of 
pre-term smoking mothers in which positive effects of quitting on birthweight have 
been shown (Sexton 1984, Haddow 1991 ). 
It is this author's opinion that the results of the studies described, coupled with the 
methodological considerations discussed, support the hypothesis that maternal 
smoking causes wheezing episodes in children of all ages. This conclusion is based 
on the strong consistency among a number of large studies of different designs 
which have examined maternal smoking specifically, reasonable evidence of 
temporality, some demonstration of exposure-response relationships, exclusion of 
the influence of known confounders, and reasonable bio_logical plausibility. The 
pooled effect size is relatively weak, but in the absence of empirical demonstration of 
confounding, one can accept the evidence as sufficient for public health purposes, 
even in the face of residual uncertainty. 
There are relatively few studies among children already indentified as asthmatic. In 
this regard, the evidence is suggestive (and coherent with our conception of the 
triggering of asthma by respiratory irritants) that maternal smoking is associated with 
aggravated clinical expression of the disease. 
Further epidemiological research is likely to refine measures of exposure and 
contribute towards understanding mechanisms of effect, including during intrauterine 
and early neonatal life. Clarification is needed also of the association of maternal 
smoking with atopy and BHR and the relationship of such smoking to viral respiratory 
infection in older children. 
Most of the research comes from developed countries. Studies are also needed in 
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developing countries where living conditions associated with poverty, the burden of 
other disease, and in certain populations very high smoking rates, may modify or 
aggravate an association between ETS and asthma. Local studies are also 
invaluable as a means of influencing indigenous public health action by providing an 
estimate of the burden of disease attributable to ETS. 
3.6.1. Burden of disease in the USA 
Although the measure of effect is relatively weak, the public health implications of the 
association between ETS and wheezing and asthma are impressive. Various authors 
have estimated the burden of illness attributable to ETS for the United States by 
calculating the excess prevalence or number of cases or episodes and the 
associated cost. Stoddard (1995) using age specific odds ratios declining with age 
(overall 1.36) estimated that 380 000 excess cases of childhood wheezing or asthma 
(7.5 percent of all such cases) were attributable to maternal smoking for 1987. Of 
these, 136 000 were under 2 years of age. Aligne (1997) using a relative risk of 1.4, 
estimated 1.8 million annual excess outpatient visits and 28 000 excess 
hospitalisations attributable to parental smoking, implying $180 million in additional 
direct expenditures. 
3. 7 References 
Aligne CA, Stoddard JJ. Tobacco and children. An economic evaluation of the medical effects of 
parental smoking. Arch Pediatr Adolesc Med 1997; 151 :648-653. 
Anderson HR, Bland JM, Peckham CS. Risk factors for asthma up to 16 years of age. Chest 1987; 
91 (Suppl): 127S-130S. 
Andrae S, Axelson 0, Bjorksten B, Fredriksson M, Kjellman N-1 M. Symptoms of bronchial 
hyperreactivity and asthma in relation to environmental factors. Arch Dis Child 1988; 63:473-478. 
Arshad SH, Matthews S, Gant C, Hide OW. Effect of allergen avoidance on development of allergic 
disorders in infancy. Lancet 1992a; 339:1493-97. 
69 
Literature review: ETS and asthma 
Arshad SH, Hide OW. Effect of environmental factors on the development of allergic disorders in 
infancy. J Allergy Clin lmmunol 1992b; 90:235-241. 
Bauman A, Young L, Peat JK, Hunt J, Larkin P. Asthma under-recognition and under-treatment in an 
Australian community. Aust NZ Med J 1992; 22:36-43. 
Buist AS, Vollmer WM. Reflections on the rise in asthma morbidity and mortality. JAMA 1990; 
264:1719-1720. 
Burchfiel CM, Higgins MW, Keller JB, Howatt WF, Butler WJ, Higgins ITT. Respiratory conditions and 
pulmonary function in Tecumseh, Michigan. Am Rev Resp Dis 1986; 133:966-973. 
Burney PGJ, Britton JR, Chinn S, Tattersfield AE, Papacosta AO, Kelson MC, Anderson F, Corfield 
DR. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community 
study. Thorax 1987; 42:38-44. 
Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from 
the national study of health and growth 1973-86. BMJ 1990; 300:1306-1310. 
Burrows B, Halonen M, Barbee RA, Lebowitz MD. The relationship of serum immunoglobulin E to 
cigarette smoking. Am Rev Resp Dis 1981; 124: 523-525. 
Chilmonczyk BA, Knight GJ, Palomaki GE, Pulkinnen AJ, Williams J, Haddow JE. Environmental 
tobacco smoke exposure during infancy. Am J Public Health 1990; 80:1205-1208. 
Chinn S, Rona RJ. Quantifying health aspects of passive smoking in British children aged 5-11 years. J 
Epidemiol and Comm Health 1991; 43:188-194. 
Cnattingius S, Haglund B, Meirik 0. Cigarette smoking as a risk factor for late foetal and early neonatal 
death. Brit Med J 1988: 297:258-261. 
Cogswell JJ, Mitchell EB, Alexander J. Parental smoking, breast feeding, and respiratory infection in 
development of allergic diseases. Arch Dis Child 1987; 62:338-344. 
Colley JRT. Respiratory symptoms in children and parental smoking and phlegm production. Br Med J 
1974; 2: 201-204. 
70 
Literature review: ETS and ast
hma 
Collins MH, Moessinger AC, K
leinerman J et al. Fetal lung 
hypoplasia associated with ma
ternal 
smoking: a morphometric analys
is. Pediatric Res 1985; 19:408-4
12. 
Committee on Environmental H
azards, American Academy of
 Pediatrics. Involuntary smokin
g - a 
hazard to children. Pediatrics 19
86; 77:755-757. 
Cook DG, Strachan DP. Health 
effects of passive smoking: 3 -
Parental smoking and prevalenc
e of 
respiratory symptoms and asthm
a in school age children. Thorax
 1997; 52:1081-1094. 
Cook DG, Strachan DP. Health 
effects of passive smoking: 7 -
Parental smoking, bronchial rea
ctivity 
and peak flow variability in childr
en. Thorax 1998; 53:295-301. 
Coultas DB, Howard CA, Peak
e GT, Skipper BJ, Samet JM. 
Salivary cotinine levels and inv
oluntary 
tobacco smoke exposure in chi
ldren and adults in New Mexico
. Am Rev Respir Dis 1987; 136
: 305-
309. 
Coultas DB, Samet JM, McC
arthy JF, Spengler JD. Varia
bility of measures of exposu
re to 
environmental tobacco smoke in
 the home. Am Rev Respir Dis 1
990; 142: 602-606. 
Coultas DB. Passive smoking 
and the risk of adult asthma a
nd COPD: an update. Thorax 
1998; 
53:381-387. 
Davis RA, Stiles MF, deBethizy
 JD, Reynolds JH. Dietary nico
tine: A source of urinary cotinin
e. Fd 
Chem Toxic 1991; 29:821-827. 
Dekker C, Dales R, Bartlett S
, Brunekreef B, Zwanenburg 
H. Childhood asthma and the
 indoor 
environment. Chest 1991; 100:9
22-926. 
Dijkstra L, Houthuijs, Brunekree
f B, Akkerman I, Boleij JSM. R
espiratory health effects of the 
indoor 
environment in a population of D
utch children. Am Rev Respir D
is 1990; 142: 1172-1178. 
Dodge R. The effects of indoor p
ollution on Arizona children. Arch
 Environ Health 1982; 37: 151-1
55. 
Ehrlich RI, Kattan M, Godbold J
, Saltzberg OS, Grimm KT, La
ndrigan PJ, Lilienfeld DE. Chi
ldhood 
asthma and passive smoking: 
urinary cotinine as a biomarke




Literature review: ETS and asthma 
Ehrlich R, Kattan M, Lilienfeld DE. Is passive smoking a cause of asthma in chi
ldhood? J Smoking-
Related Dis 1993; 4:91-99. 
Ekwo EE, Weinberger MM, Lachenbruch PA, Huntley WH. Relationship of paren
tal smoking and gas 
cooking to respiratory disease in children. Chest 1983; 84: 662-668. 
Emerson JA, Hovell MF, Meltzer SB, Zakarian JM, Hofstetter CR, Wahlgren DR, L
eaderer BP, Meltzer 
EO. The accuracy of environmental tobacco smoke exposure measures among 
asthmatic children. J 
Clin Epidemiol 1995; 48:1251-1259. 
Evans D, Levison MJ, Feldman CH, Clark NM, Wasilewski Y, Levin B. The impac
t of passive smoking 
on emergency room visits of urban children with asthma. Am Rev Respir Dis 1987
; 135:567-572. 
Evans R, Mullally DI, Wilson RW, Gergen PJ, Rosenberg HM, Grauman JS, Chev
arly FM, Feinleib M. 
National trends in morbidity and mortality of asthma in the US. Chest 1987; 91(Sup
pl):65S-74S. 
Fergusson OM, Horwood LJ. Parental smoking and respiratory illness during childhood:
 a six-year 
longitudinal study. Pediatr Pulmonol 1985; 1:99-106. 
Ferris Jr, BG. Epidemiology standardisation project. Am Rev Respir Dis 1978; 11
8(Suppl):7-53. 
Fielding JE, Phenow KJ. Health effects of involuntary smoking. N Eng J Med 1988
; 319:1452-1460. 
Forastiere F, Corbo GM, Michelozzi P, Pistelli R, Agabiti N, Brancato G, Ciapp
i G, Perucci CA. 
Effects of environment and passive smoking on the respiratory health of children. I
nt J Epidemiol 1992; 
21:66-73. 
Frischer T, Kuehr J, Meinert R, Karmaus W, Barth R, Hermann-Kunz E, Urbanek 
R. Maternal smoking 
in early childhood: a risk factor for bronchial responsiveness to exercise in prima
ry-school children. J 
Pediatr 1992;121:17-22. 
Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among chil
dren: 1979 to 1987. 
JAMA 1990; 264: 1688-1692. 
Gergen PJ, Weiss KB. The increasing problem of asthma in the United States. 
Am Rev Respir Dis 
1992; 146:823-824. 
72 
Literature review: ETS and asthma 
Gerrard JW, Douglas CH, Mink J, Meyers A, Dosman JA. lmmunoglobulin levels in smokers a
nd non-
smokers. Ann Allergy 1980a;44:261-262. 
Gerrard JW, Cockroft OW, Mink JT, Cotton DJ, Poonwala R. Dosman JA. Increased nonspecific 
bronchial reactivity in cigarette smokers with normal lung function. Am Rev Respir Dis 1980
b; 122: 
577-581. 
Godfrey S. What is asthma? Arch Dis Child 1985; 60:997-1000. 
Goren Al, Hellman S. Passive smoking among schoolchildren in Israel. Environ Health Pers
p 1991; 
96:203-211. 
Gortmaker SL, Walker DK, Jacobs FH, Ruch-Ross H. Parental smoking and the risk of ch
ildhood 
asthma. Am J Pub Health 1982; 72: 57 4-579. 
Graham NMH. The epidemiology of acute respiratory infections in children and adults: a
 global 
perspective. Epidemiol Rev 1990; 12:149-176. 
Greenberg RA, Haley NJ, Etzel RA, Loda FA. Measuring the exposure of infants to tobacco
 smoke: 
nicotine and cotinine in urine and saliva. New Engl J Med 1984; 310:1075-1078. 
Greenberg RA, Bauman KE, Glover LH, Strecher VJ, Kleinbaum DG, Haley NJ, Stedman HC
, Fowler 
MG, Lodan FA. Ecology of passive smoking by young infants. J Pediatr 1989; 114:774-780. 
Greenland S. Quantitative methods in the review of the epidemiologic literature. Epidemiol Re
v 1987; 
:1-30. 
Greenland S. Can meta-analysis be salvaged? Am J Epidemiol 1994; 140: 783-787. 
Guyatt GH, Newhouse MT. Are active and passive smoking harmful? Determining causation
. Chest 
1985; 88:445-451. 
Hanrahan JP, Tager 18, Segal MR, Tosteson TD, Castile RG, Van Vunakis H, Weiss ST, Speiz
er FE. 




Literature review: ETS and asthma 
Harlap S, Davies AM. Infant admissions to hospital and maternal smoking. Lancet 1974; 529-532. 
Henderson FW, Reid HF, Morris R, Wang 0-L, Hu PC, Helms RW, Forehand L, Mumford J, Lewtas J, 
Haleu NJ, Hammond SD. Home air nicotine levels and urinary cotinine excretion in preschool children. 
Am Rev Respir Dis 1989; 140: 197-201. 
Henderson FW, Henry MH, Ivins SS, Morris R, Neebe EC, Leu S-Y, Stewart PW, and Physicians of 
Raleigh Pediatric Associates, PA. Correlates of recurrent wheezing in school-age children. Am J 
Respir Crit Care Med 1995; 151:1786-1793. 
Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965: 58: 295-300. 
Holberg CJ, Wright AL, Martinez FD, Morgan WJ, Taussig Land the Group Medical Associates. Child 
day care, smoking by caregivers, and lower respiratory tract illness in the first 3 years of life. Pediatrics 
1993; 91: 885-892. 
Holt PG, Turner KJ. Respiratory symptoms in the children of smokers: ~n overview. Eur J Respir Dis 
1984; 133(Suppl):109-120. 
Hopp RJ, Bewtra AK, Watt GD, Nair NM, Townley RG. Genetic analysis of allergic disease in twins. J 
Allergy Clin lmmunol 1984; 74: 265-270. 
Horwood L, Fergusson DM, Shannon FT. Social and familial factors in the development of early 
childhood asthma. Pediatrics 1985; 75: 859-868. 
Hulbert WC, Walker DC, Jackson A, Hogg JC. Airway permeability to horseradish peroxidase in guinea 
pigs: the repair phase after injury by cigarette smoke. Am Rev Respir Dis 1981; 123:320-326. 
Jarvis D, Luczynska C, Chinn S, Burney P. The association of age, gender and smoking with total lgE 
and specific lgE. Clin Exp Allergy 1995; 25:1083-1091. 
Idle JR. Titrating exposure to tobacco smoke using cotinine - a minefield of misunderstandings. J Clin 
Epidemiol 1990; 43:313-317. 
Irvine L, Crombie IK, Clark RA, Slane PW, Goodman KE, Feyerabend C, Cater JI. What determines 
levels of passive smoking in children with asthma? Thorax 1997; 52:766-769. 
74 
Literature review: ETS and asthma 
Jackson R, Sears MR, Beaglehole R, Rea HH. International trends in asthma m
ortality; 1970-1985. 
Chest 1988; 94:914-919. 
Jarvis MJ, Russell MAH, Feyerabend C, Eiser JR, Morgan M, Gammage P, G
ray EM. Passive 
exposure to tobacco smoke: saliva cotinine concentrations in a representative p
opulation sample of 
non-smoking schoolchildren. Br Med J 1985; 291 :927-929. 
Jarvis MJ, McNeil! AD, Russell MAH, West RJ, Bryant A, Feyerabend C. P
assive smoking in 
adolescents: one-year stability of exposure in the home (letter). Lancet 1987; 8545: 
1324-1325. 
Jarvis MJ, Strachan DP, Feyerabend C. Determinants of passive smoking in ch
ildren in Edinburgh, 
Scotland. Am J Public Health 1992; 82:1225-1229. 
Kershaw CR. Passive smoking, potential atopy and asthma in the first five years
. J Royal Soc Med 
1987; 80:683-688. 
Kjellman N-IM, Effect of paternal smoking on lgE levels in children. (Letter). Lancet 1980; 
1 :66. 
Kleinman JC, Pierre, Jr MB, Madans JH, Land GH, Schramm WF. The effects of m
aternal smoking on 
fetal and infant mortality. Am J Epidemiol 1988; 127:274-282. 
Konig P. Asthma: a pediatric pulmonary disease and a changing concept. Ped
iatr Pulmonol 1987; 
3:264-275. 
Lebowitz MD, Burrows B, Respiratory symptoms related to smoking habits of f
amily adults. Chest 
1976: 69:48-50. 
Lieberman E, Torday J, Barbieri R, Cohen A, Van Vunakis H, Weiss ST. Associ
ation of intrauterine 
cigarette smoke exposure with indices of fetal lung maturation. Obstet and Gynecol
 1992;79:564-570. 
Lee DA, Winslow NR, Speight ANP, Hey EN. Prevalence and spectrum of asthma i
n childhood. Br Med 
J 1983; 286: 1256-1258. 
Leeder SR, Corkhill RT, lrwig LM, Holland WW. Influence of family factors on as
thma and wheezing 
during the first five years of life. Br J Prev Soc Med 1976; 30:213-218. 
75 
Literature review: ETS and asthma 
Lehrer SB, Barbandi F, Taylor JP, Salvaggio JE. Tobacco smoke "sensitivity" - Is there an imm
unologic 
basis? J Allergy Clin lmmunol 1984; 73:240-245. 
Lewis S, Richards D, Bynner J, Butler N, Britton J. Prospective study of risk factors for e
arly and 
persistent wheezing in childhood. Eur Respir J 1995;8;349-356. 
Magnusson CGM. Maternal smoking influences cord serum lgE and lgD levels and increases 
the risk 
for subsequent infant allergy. J Allergy Clin lmmunol 1986; 78:898-904. 
Marcus AC, Crane LA. Current estimates of adult cigarette smoking by race/ethnicity. Paper p
resented 
at the lnteragency Committee on Smoking and Health, March, Washington, DC, March 
31, 1987 
(obtainable from the Office of Smoking and Health, Rockville, Maryland). 
Martinez FD. Antognoni G, Macri F, Bonci E, Midulla F, De Castro G, Ronchetti R. Parental smok
ing 
enhances bronchial responsiveness in nine-year-old children. Am Rev Respir Dis 1988a; 138:
518-523. 
Martinez FD, Morgan WJ, Wright AL. Diminished lung function as a predisposing factor for 
wheezing 
respiratory illness in infants. N Engl J Med 1988b; 319:1112-1117. 
Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM, Group Health Medical Associat
es. Initial 
airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three
 years of 
life. Am Rev Respir Dis 1991; 143:312-316. 
Martinez FD, Cline M, Burrows B. Increased incidence of asthma in children of smoking 
mothers. 
Pediatrics 1992; 89:21-26. 
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ and the Grou
p Health 
Medical Associates. Asthma and wheezing in the first six years of life. N Engl Med J 1995; 3
32: 133-
138. 
McConnochie KM, Roghmann KJ. Bronchiolitis as a possible cause of wheezing in childho
od: new 
evidence. Pediatrics 1984; 74:1-10. 
McConnochie KM, Roghmann KJ. Breast feeding and maternal smoking as predictors of wh
eezing in 
children age 6 to 1 O years. Pediatr Pulmonol 1986; 2:260-268. 
76 
Literature review: ETS and asthma 
McConnochie KM, Roghmann KJ. Wheezing at 8 and 13 years: changing importance of bronchiolitis 
and passive smoking. Pediatr Pulmonol 1989; 6:138-146. 
McWhorter WP, Polis MA, Kaslow RA. Occurrence, predictors and consequences of adult asthma in 
NHANES1 and follow-up survey. Am Rev Respir Dis 1989; 139:721-724. 
Meinert R, Frischer T, Kuehr J. The "healthy passive smoker": relationship between bronchial hyper-
reactivity in school children and maternal smoking. J Epidemiol Community Health 1994; 48:325-326. 
Murray AB, Morrison BJ. The effect of cigarette smoke from the mother on bronchial responsiveness 
and severity of symptoms in children with asthma. J Allergy Clin lmmunol 1986; 77:575-581. 
Murray AB, Morrison BJ. Passive smoking and the seasonal difference of severity of asthma in 
children. Chest 1988; 94:701-708. 
Murray AB, Morrison BJ. Passive smoking by asthmatics: its greater effect on boys than on girls and 
on older than on younger children. Pediatrics 1989;84: 451-459. 
National Research Council, Committee on Passive Smoking. Environmental tobacco smoke: 
measuring exposures and assessing health effects. Washington D.C.: National Academy Press. 1986. 
Neuspiel DR, Rush D, Butler NR, Golding J, Bijur PE, Kurzon M. Parental smoking and post-infancy 
wheezing in children: a prospective cohort study. Am J Public Health 1989; 79: 168-171. 
Nilsen ST, Sagen N, Kim HC, Bergsjo P. Smoking, hemoglobin levels, and birth weights in normal 
pregancies. Am J Obstet Gynecol 1984; 148: 752-763. 
O'Connell EJ, Logan GB. Parental smoking in childhood asthma. Ann Allergy 1974; 32:142-145. 
O'Connor GO, Weiss ST, Tager I, Speizer FE. The effect of passive smoking on pulmonary function 
and nonspecific bronchial responsiveness in a population-based sample of children and young adults. 
Am Rev Respir Dis 1987; 135:800-804. 
O'Connor GT, Sparrow D, Segal MR, Weiss ST. Smoking, atopy, and methacholine airway 
responsiveness among middle-aged and elderly men. Am Rev Respir Dis 1989; 140:1520-1526. 
77 
Literature review: ETS and asthma 
Oldigs M, Jorres R, Magnusson H. Acute effect of passive smoking on lung function and airway 
responsiveness in asthmatic children. Pediatric Pulmonol 1991; 1 O: 123-131. 
Ownby DR, McCullough J. Passive exposure to cigarette smoke does not increase allergic 
sensitization in children. J Allergy Clin lmmunol 1988; 82:634-637. 
Patishall EN, Strope GL, Etzel RA, Helms RW, Haley NJ, Denny FW. Serum cotinine as a measure of 
tobacco smoke exposure in children. Am J Dis Child 1985; 139:1101-1104. 
Peat JK, Britton WJ, Salome CM, Woolcock AJ. Bronchial hyperresponsiveness in two populations of 
Australian schoolchildren: II. relative importance of associated factors. Clin Allergy 1987; 17:283-290. 
Pedreira FA, Guandolo VL, Feroli EJ, Mella GW, Weiss IP. Involuntary smoking and incidence of 
respiratory illness during the first year of life. Pediatrics 1985; 75:594-597. 
Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the 
United States. JAMA 1989a; 261 :56-60. 
Pierce JP. International comparisons of trends in cigarette smoking prevalence. Am J Public Health 
1989b; 79:152-157. 
Pullan CR, Toms GL, Martin AJ, Gardner PS, Webb JKG, Appleton DR. Breast-feeding and respiratory 
syncytial virus infection. Br Med J 1980; 281 :1034-1036. 
Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with 
respiratory syncytial virus in infancy. Br Med J 1982; 284:1665-1669. 
Reddy P, Meyer-Weitz A, Yach D. Smoking status, knowledge of health effects and attitudes towards 
tobacco control in South Africa. S Afr Med J 1996; 86:1389-1393. 
Reese AC, James IR, Landau LI, Lesouef PN. Relationship between urinary cotinine level and 
diagnosis in children admitted to hospital. Am Rev Respir Dis 1992; 146:66-70. 
Ronchetti R, Macri F, Ciofetta G, lndinnimeo L, Cutera R, Bonci E, Antognoni G, Martinez FD. 
Increased serum lgE and increased prevalence of eosinophilia in 9 year-old children of smoking 
parents. J Allergy Clin lmmunol 1990; 86:400-407. 
78 
Literature review: ETS and asthma 
Rothman KJ. Modem Epidemiology. Boston/Toronto: Little Brown, 1986. 
Rylander E, Pershagen G, Curvall M, Kazemi-Vala E. Exposure to environmental tobacco smoke and 
urinary excretion of cotinine and nicotine in children. Acta Paediatr Scand 1989; 78:449-450. 
Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part 1. Am 
Rev Respir Dis 1987a; 136:1486-1508. 
Samet JM. Epidemiologic approaches for the identification of asthma. Chest 1987b; 91 (Suppl.):75S-
78S. 
Schenker MB, Samet JM, Speizer FE. Risk factors for childhood respiratory disease: the effect of host 
factors and home environmental exposure. Am Rev Respir Dis 1983; 128: 1038-1043. 
Schilling RSF, Letai AD, Hui SL, Beck GJ, Schoenberg JB, Bouhuys A. Lung function, respiratory 
disease and smoking in families. Am J Epidemiol 1977; 106:274-283. 
Schmeltz I, Hoffmann D, Wynder EL. The influence of tobacco smoke on indoor atmospheres. Prev 
Med 1975; 4:66-82. 
Schwartz J, Gold D, Dockery DW, Weiss ST, Speizer FE. Predictors of asthma and persistent wheeze 
in a national sample of children in the United States. Am Rev Respir Dis 1990; 142:555-562. 
Sexton M, Hebel RJ. A clinical trial of change in maternal smoking and its effect on birth weight. 
JAMA 1984; 251:911-915. 
Shapiro S. Meta-analysis/shmeta-analysis. Am J Epidemiol 1994; 140:771-778. 
Sherman CB, Tosteson TD, Tager 18, Speizer FE, Weiss ST. Early childhood predictors of asthma. 
Am J Epidemiol 1990;132:83-95. 
Sherrill DL, Martinez FD, Lebowitz MD, Holdaway D, Flannery EM, Herbison GP. Longitudinal effects of 
passive smoking on pulmonary function in New Zealand children. Am Rev Respir Dis 1992; 145: 1136-
1141. 
Somerville SM, Rona RJ, Chinn S. Passive smoking and respiratory conditions in primary children. J 
79 
Literature review: ETS and asthma 
Epidemiol Comm Health 1988; 42:105-110. 
Speight ANP, Lee DA, Hey EN. Underdiagnosis and undertreatment of asthma in childhood. 
Br Med J 
1983; 286: 1253-1255. 
Spitzer WO, Lawrence V, Dales R, Hill G, Archer MC, Clark P, Abenhaim L, Hardy J, Sa
mpalis J, 
Pinfold SP, Morgan PP. Links between passive smoking and disease: a best evidence synth
esis. Clin 
Inv Med 1990; 13:17-42. 
Steyn K. Jooste PL, Langenhoven M, Roussouw JE, Steyn M, Jordaan PC, Joubert G. Smok
ing 
patterns in the coloured population of the Cape Peninsula (CRISIC study). S Afr Med J 1987
; 71:145-
148. 
Steyn K, Yach D, Stander I, Fourie JM. Smoking in urban pregnant women in South Africa. S A
fr Med J 
1997; 87:460-463. 
Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN. Effects of mater~al smoking during p
regnancy 
and a family history of asthma on respiratory function in newborn infants. Lancet 1996; 348:10
60-1064. 
Stoddard JJ, Miller T. Impact of parental smoking on the prevalence of wheezing respiratory illne
ss in 
children. Am J Epidemiol 1995; 141:96-102. 
Strachan DP. Damp housing and childhood asthma: validation of reporting of symptoms. B
r Med J 
1988; 297: 1223-1226. 
Strachan DP, Jarvis MJ, Feyerabend C. The relationship of salivary cotinine to respiratory sy
mptoms, 
spirometry, and exercise-induced bronchospasm in seven-year-old children. Am Rev Respir D
is 1990; 
142:147-151. 
Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezin
g illness 
from early childhood to age 33 in a national British cohort. Br Med J 1996; 312:1195-1199. 
Strachan DP, Cook DG. Health effects of passive smoking: 1 -Parental smoking and lower re
spiratory 
illness in infancy and early childhood. Thorax 1997a; 52:905-914. 
Strachan DP, Cook DG. Health effects of passive smoking: 5 -Parental smoking and allergic 
80 
Literature review: ETS and asthma 
sensitisation in children. Thorax 1998a; 53:117-123. 
Strachan DP, Cook DG. Health effects of passive smoking: 6 - Parental smoking and childhood 
asthma: longitudinal and case-control studies. Thorax 1998b; 53:204-212. 
Tager 18. Passive smoking - bronchial responsiveness and atopy. Am Rev Respir Dis 1988; 138:507-
509. 
Tager 18. Smoking and childhood asthma -where do we stand? Am J Respir Crit Care Med 1998; 
158:349-351. 
Taubes G. Epidemiology faces its limits. Science 1995; 269:164-169. 
Taylor 8, Wadsworth J. Maternal smoking during pregnancy and lower respiratory tract illness in early 
life. Arch Dis Child 1987; 62:786-791. 
United States Department of Health, Education and Welfare. Smoking and health: a report of the 
Surgeon-General. Washington, DC: U.S. PHS, Government Printing Office, 1979. (DHEW Publication 
Number PHS 79-50066). 
United States Department of Health and Human Services. The health consequences of involuntary 
smoking. Washington D.C.: Government Printing Office, 1986 (Publication no. DHSS (CDC) 87-8398). 
Vesterinen E, Kaprio J, Koskenvuo M. Prospective study of asthma in relation to smoking habits 
among 14729 adults. Thorax 1988;43:534-539. 
Wang NS, Chen MF, Schraufnagel DE. The cumulative scanning electron microscopic changes in 
baby mouse lungs following prenatal and postnatal exposures to nicotine. J Pathol 1984; 144:89-100. 
Ware JH, Dockery DW, Spiro Ill, A, Speizer FE, Ferris Jr, BG. Passive smoking, gas cooking, and 
respiratory health of children living in six cities. Am Rev Respir Dis 1984; 129:366-374. 
Weiss ST, Tager 18, Speizer FE, Rosner 8. Persistent wheeze: its relation to respiratory illness, 
cigarette smoking, and level of pulmonary function in a population sample of children. Am Rev Respir 
Dis 1980; 122:697-707. 
81 
Literature review: ETS and asthma 
Weiss ST, Tager IA, Schenker M, Speizer FE. The health effects of involuntary smoking. Am J Respir 
Dis 1983; 128:933-942. 
Weiss ST, Tager 18, Munoz A, Speizer FE. The relationship of respiratory infections in early childhood 
to the occurrence of increased levels of bronchial responsiveness and atopy. Am Rev Respir Dis 1985; 
131 :573-578. 
Weiss KB, Wagener DK. Changing patterns of asthma mortality. Identifying target populations at high 
risk. JAMA 1990; 264:1683-1687. 
Weitzman M, Gortmaker S, Sobol A Racial, social, and environmental risks for childhood asthma. Am 
J Dis Child 1990a; 144:1189-1194. 
Weitzman M, Gortmaker S, Walker DK, Sobol MA Maternal smoking and childhood asthma. 
Pediatrics 1990b; 85: 505-511. 
Welty C, Weiss ST, Tager 18, Munoz A, Becker C, Speizer FE, Ingram RH Jr. The relationship of 
airways responsiveness to cold air, cigarette smoking, and atopy to respiratory symptoms and 
pulmonary function in adults. Am Rev Respir Dis 1984; 130: 198-203. 
Willers S, Svenonius E, Skarping G. Passive smoking and childhood asthma. Allergy 1991; 46:330-
334. 
Williams H, McNicol KN. Prevalence, natural history, and relationship of wheezy bronchitis and asthma 
in children. An epidemiological study. Br Med J 1969; 4:321-325. 
Wilson NM. Wheezy bronchitis revisited. Arch Dis Child 1989; 64: 1194-1199. 
Wissow LS, Gittelsohn AM, Szklo M, Starfield, B, Mussman M. Poverty, race and hospitalization for 
childhood asthma. Am J Public Health 1988; 78:777-782. 
Withers NJ, Low L, Holgate ST, Clough JB. The natural history of respiratory symptoms in a cohort of 
adolescents. Am J Respir Crit Care Med 1998; 158:352-357. 
Witorsch RJ, Wu JM, Hood RD, Witorsch P. Further analyses of the role of confounding variables in 
epidemiologic studies of environmental tobacco smoke and the respiratory system in school-age 
82 
Literature review: ETS and asthma 
children. Proceedings: Indoor Air Quality in Asia confierence, Thailand, 28-29 Nov. 1991. 
Wright AL, Holberg C, Martinez FD, Taussig LM, Group Health Medical Associates. Relationship of 
parental smoking to wheezing and nonwheezing lower respiratory tract illness in infancy. J Pediatr 
1991; 118:207-214. 
Yach D, Joubert G. Deaths related to smoking in South Africa in 1984 and projected deaths among 
coloureds and blacks in the year 2000. S Afr Med J 1988; 73:400-402. 
Yach D, McIntyre D, Saloojee Y. Smoking in South Africa: the health and economic impact. Tobacco 
Control 1992; 1 :272-280. 
Young S, Le Souef PN, Geelhoed GC. The influence of a family history of asthma and parental 
smoking on airway responsiveness in early infancy. New Engl J Med 1991; 324: 1168-73. 
Zetterstrom 0, Osterman K, Machado L, Johannson SGO. Another smoking hazard: raised serum lgE 
concentrations and increased risk of occupational allergy. Brit Med J 1981; 283:1215-1217. 
83 

Population and sampling 
CHAPTER4 
POPULATION, SAMPLING AND ETHICAL CONSIDERATIONS 
4.1 . Study area 
4.2. Study population 
4.3. Sample size considerations 
4.4. Sampling methods 
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4.1. Study area 
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Cape Town lies on the southwestern tip of the African continent at 34 degrees latitude 
south of the equator and 17 degrees longitude east of Greenwich (Fig. 4.1 ). The climate 
is Mediterranean, with hot dry summers and cool wet winters. Mean monthly relative 
humidity was 75.3 percent in 1993, ranging from 66 percent in November to 87 percent in 
May. Temperature ranges are moderated by the coastal situation and warm Mozambique 
oceanic current (1993: daily minimum 12.0°C., daily mean 16.6°C., daily maximum 
23.6°C.) Strong south easterly winds are a feature of the spring and summer months. 
Autumn is associated with still warm days and temperature inversions. 
Mitchell's Plain is situated at the southeast rim of the Cape Peninsula on the high water 
table sandy plain known as the Cape Flats, bounded by the coastal dunes of False Bay to 
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the southwest (Fig. 4.1 ). Vegetation is sparse shrub, with Acacia being prominent. The 
area is dusty owing to coastal dune sandblasting by the southeasterly winds, and damp 
owing to the coastal location and high water table of the Cape Flats. 
Although there is a small industrial area to the west, Mitchell's Plain is at some distance 
from heavier smokestack industry. Ambient air pollution in Cape Town in recent years has 
tended to be of the photochemical smog variety (Bailie 1994), concentrated in the central 
metropolitan business area and along traffic routes into the city, which lies approximately 
50 km from Mitchell's Plain. Relatively high levels of secondary pollutants such as ozone 
have, however, been measured at some distance from traffic sources (Loewenheim 
1988), and may be contribute to ambient air pollution in Mitchell's Plain. No local 
monitoring is done in the area. 
4.2. Study population 
Mitchell's Plain consists of a number of municipally defined suburbs. For purposes of this 
study, the area covered included Beacon Valley, Eastridge, Lentegeur, Parklands, 
Rocklands, Tafelsig, Westridge and Woodlands. 
Mitchell's Plain was initiated by the municipal housing authority as a large scale 
development in the 1970s to house people classified as coloured by apartheid legislation, 
including many who had been moved from other parts of the Cape Peninsula by 
apartheid segregation policy. In the two decades since, the area has grown rapidly, with 
its population increasing from approximately 8 000 in 1976 to over 200 000 by 1990. 
Housing ranges from mainly single storey free standing homes with gardens to poorer 
terraces of two storey flats. 
In the 1990 census the population of Mitchell's Plain was approximately 210 000 people, 
of whom 30 000 were aged 5 to 9 years (RSA 1991 ). About two thirds were Afrikaans 
speaking, almost all of the remainder speaking English. There were approximately 
40 000 homes. The average family size was 5.2 (City of Cape Town Municipality, Urban 
Policy Unit - personal communication). 
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Mean annual household income was R19 6001 at the 1990 census (range across suburbs 
R15 012 to R25 537), compared to R31 340 for the City of Cape Town municipal area as 
a whole (RSA 1991). Only 40 percent of the population were classified as economically 
active, of whom 6.9 percent were categorised as "unemployed (not looking for work)". 
The true proportion of chronically unemployed is likely to be much higher, however. 
The relative socioeconomic status of Mitchell's Plain can by gauged by the position of its 
suburbs on a scale ranking the 73 suburbs within the municipal boundaries of the City of 
Cape Town according to a "levels of living index" (comprising indicators of income, 
education, overcrowding, welfare and unemployment) (City of Cape Town Municipality -
ibid.). None of the Mitchell's Plain suburbs fall into the upper third of this ranking (middle 
to high income areas: index range 1 to 7.7). Only one suburb, Westridge, falls into the 
middle third (middle to low income areas: index range 8 to 17.5). All of the remaining 
suburbs fall into lower third (public housing estates/township category: index range 17 to 
51), although none are in the poorest end of this category (7 areas: index range 39 to 51). 
Medical services are provided in the area by a number of private general practitioners and 
by public health services in the form of one community health centre (general outpatients) 
and 5 polyclinics (providing antenatal services, immunisation, and treatment of sexually 
transmitted diseases and tuberculosis). There is good road access to private and public 
hospital facilities between 10 and 15 km away. Immunisation coverage in 1991/92 was 
94.2 percent for Diphtheria/Whooping cough/Pertussis, 95.3 percent for Polio and 87. 7 
percent for Measles (City of Cape Town Municipality, Health Department - personal 
communication). A coverage figure is not available for BCG immunisation, which is 
carried out by perinatal services, but is assumed to be very high. 
Mitchell's Plain is believed by residents and clinicians to be a high allergy and high 
asthma area. There is only indirect evidence for its status in this regard compared to 
other areas. First, using race as a socioeconomic and geographic marker, between 
1 Approximately R3.50 = $US1.00 in 1990. 
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1984 and 1990 coloured children in general contributed 83 percent of asthma 
admissions to the Red Cross War Memorial Children's hospital (Ehrlich 1994) 
compared to only 51 percent of pneumonia and 61 percent of bronchiolitis admissions, 
suggesting overrepresentation in asthma admissions. Underrepresentation of black 
children in admissions for asthma could produce the same effect, however (see section 
2.4.2.). 
Second, a large number of asthma admissions to the Red Cross War Memorial Children's 
hospital come from the Mitchell's Plain area (Lachman 1990). However, it is not possible 
to determine whether the proportion of asthma admissions exceeds the proportion of all 
cause admissions represented by children from Mitchell's Plain. 
4.3 Sample size considerations 
4.3.1 Prevalence study 
The precision goal in the part of the study directed at establishing prevalence of asthma 
and defining a case group was a confidence interval of no more than 3 percent on either 
side of the sample proportion. Previous studies in the United Kingdom, Australia and 
New Zealand of similarly aged children had recorded a prevalence of one year wheezing 
of between approximately 10 and 25 percent (Strachan 1988, Clifford 1989, Robertson 
1991 ). Assuming a prevalence of asthma in this population on the case definition used 
(four or more different asthma symptoms within the past 12 months, or reported asthma 
plus one symptom - see section 6.2.1.) of 15 percent, a population of a little under 2000 
Sub-8 children would give a confidence interval of 13 to 17 percent. The target sample 
size was thus 2000 primary schoolchildren. From this group, it was expected that 300 
cases would be identified. 
4.3.2. Risk factor study 
The calculation for this purpose was based on the hypothesis that maternal smoking is 
associated with the occurrence of asthma/wheeze, and further that maternal smoking 
occurs in 40% of the population (Steyn 1987). Given 300 cases, and an equal number of 
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controls assumed to reflect the population or background rate of maternal smoking of 
40%, the study would have an 80% power to detect an odds ratio of 1.60 at the 95% level 
of significance. This odds ratio estimate was within the range of reported elsewhere (see 
Chapter 3). 
4.3.3. Bronchial hyperresponsiveness (BHR) and underrecognition studies 
These hypotheses were subsidiary to the above, and accordingly no independent sample 
size calculations were performed. Power considerations are raised in the relevant 
chapters (7 and 8). 
4.4. Sampling and response rates 
Children in the second year of primary school (sub-B or grade 2), typically aged 7 or 8 
years, were the target population. This age group was chosen for a number of reasons. 
First, although asthma may begin at a young age (arguably in infancy), the diagnosis is 
difficult in young children, many of whom have transient wheezing (Martinez 1995). By 
schoolgoing age, the diagnosis of asthma becomes more specific. 
Second, schoolchildren are an accessible population for study and cooperation is 
generally high. Seven years was considered the youngest age at which children are able 
to carry out the forced expiratory manoeuvre required for the histamine challenge test. 
Analysis of age distributions of asthma admissions to the regional children's hospital 
between 1979 and 1990 revealed a second peak at approximately school going age, the 
first being at three years of age (author - unpublished data). Finally, compared to older 
ages where school dropout becomes a factor, schoolgoing at this age is likely to be 
reasonably complete. 
The cluster sampling frame consisted of all 35 primary schools in Mitchell's Plain. Given 
approximately three sub-B classes per school and 35 children per class, this provided a 
sampling frame of 3 675 children. A simple random sample of 18 schools was selected 
from the 35 primary schools. Two of these schools were chosen for an initial pilot study, 
and a third for a subsequent pilot study, leaving 15 schools for participation in the first 
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phase of the study. 
What follows is an overall description of the sampling procedure. Each phase is described 
in more detail in the relevant chapter. The sampling is illustrated in Fig. 4.2. 
4.4.1 Prevalence study (Chapter 5) 
Self-administered questionnaires were distributed to the parents of all 2 172 sub-8 
children on the class lists of the sample schools. Questionnaires were returned by 1 955 
parents, a response rate of 90%. 
4.4.2 Risk factor study (Chapter 6) 
Of the 1 955 who responded to the self-administered questionnaire, 83 subsequently 
participated in a second pilot study, 114 did not give consent to be interviewed further, 
and 22 failed to provide enough questionnaire information. From the remaining sample of 
1 736 children, a "current asthma/wheeze" case group of 368 was defined (see section 
6.2.1.), and a control group of 294 selected from the remainder of the sampling frame. Of 
these 662 cases plus controls, the parents of 620 (348 cases, 272 controls) were 
successfully interviewed in the second phase of the study, a response rate of 97.9%. 
4.4.3. Bronchial hyperresponsiveness study (Chapter 7) 
For BHR testing, the group of 368 case children were randomly ordered in lists by school, 
and a sample chosen with the aim of achieving a minimum of a 70% sample per school. It 
was necessary to sample because of resource constraints. A total of 263 cases 
attempted the BHR test (a 72.5% sample from the total case group of 368). Of those, 249 
subjects had usable BHR test results, a response rate among those tested of 93.2%. 
4.4.4. Underrecognition study (Chapter 8) 
For purposes of evaluating recognition and treatment of asthma, those children who met 
the criteria for case status on both the self-administered and home interview 
questionnaire were defined as having asthma. A total of 242 had full information. 
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Fig. 4.2 Overall sampling pathways 
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4.5. Pilot studies 
Two pilot studies were undertaken. The first, carried out at two schools, was designed to 
train the study team, test the self-administered and interview questionnaires and 
procedures, the procedure for collecting urine specimens and the assay for urine cotinine. 
Non-specific BHR was tested initially by means of a standard exercise running test (Van 
Niekerk 1979). 
As a result of the pilot, the questionnaires were modified to improve comprehensibility 
and ease of response. The exercise test was abandoned in favour of a histamine 
challenge test. Of concern was that of the 40 children identified in the pilot questionnaire 
with asthma/wheeze, only 2 had positive exercise tests (5%, 95% C.I. 0.16 - 16.9). This 
insensitivity may be have been due to the difficulty in standardising the running effort 
made by the participants. Histamine challenge may be more sensitive for asthma than 
exercise testing, although less specific. However, the relationship between either test and 
asthma is complex and probably reflects different physiological responses (Clough 1991 ). 
The possible impact on the study of the unpredictable Cape Town spring with regard to 
rain was a further factor in the decision to switch from exercise to histamine. 
Histamine was chosen for the bronchoconstrictor challenge rather than methacholine 
because experience in its use existed in Cape Town (Vermeulen 1991) and because 
histamine phosphate was readily available. The histamine challenge test was itself piloted 
in a third school, and a satisfactory procedure established. 
4.6. Timing 
The self-administered questionnaires were completed in July 1993, winter months. Home 
interviews, urine collection for cotinine assays and BHR testing were conducted between 
September and November 1993, spring months. 
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4.7. Ethical considerations 
4. 7.1 Approval and consent 
The study was approved by the Ethics and Research Committee of the Medical Faculty 
of the University of Cape Town. 
Permission to conduct the study was obtained from the Department of Education. At each 
school the permission of the school principal and sub-8 teachers was sought in face-to-
face discussion. 
As part of the self-administered questionnaire sent to parents, the study was described, 
the voluntary nature of participation indicated and confidentiality assured. Returned 
signed consent was requested. The sample of children for the home interview, histamine 
challenge test and urine test was drawn from those whose parents gave signed consent. 
The home interviews were conducted by trained interviewers after contacting the parents 
in advance by telephone, or by leaving a note or via neighbours if there was no 
telephone. Confidentiality and voluntary participation were again explained. 
The parents of the children to be histamine tested were re-informed by letter the week 
before the test, including a request to withhold medication on the morning of the test if the 
child was otherwise well. The parents of each child undergoing histamine challenge 
received another letter after the test containing the test result and appropriate advice 
concerning their child's symptoms and treatment. 
The histamine challenge test was performed by trained pulmonary technologists under 
supervision of a medical practitioner according to an internationally accepted protocol. 
Further detail about the test is given in Chapter 7. 
4. 7.2. Interested parties 
Parties with a potential interest in the results were identified as academic Departments of 
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Paediatrics and Child Health in the Western Cape and elsewhere in South Africa, 
researchers internationally, public sector clinical facilities, private and public sector 
medical practitioners and other clinical professionals, community agencies and personnel 
such as schools and school nurses, and parents and residents of Mitchell's Plain and 
similar areas to which the results could be generalised. Associations and agencies such 
as the National Asthma Education Programme and the Council for Tobacco and Health 
have a natural interest in the results. 
4. 7.3. Dissemination of results 
Publication of the results has been sought in peer reviewed journals. Results have also 
been presented at annual meetings of the Allergy Society of South Africa and the 
Epidemiologic Society of Southern Africa. The Medical Research Council of South Africa 
has publicised some of the results in press releases, in radio interviews and in its Annual 
Report. The National Asthma Education Programme has made use of some of the 
results in campaign activities. 
A pamphlet, mainly for use by teachers, was developed based on the findings and sent to 
every primary school in the Western Cape. The author has also addressed the Mitchell' s 
Plain Community Health Forum , a joint network of residents and health care providers, 
on the study findings. 
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5.1 Background and objectives 
Measurement of the prevalence of childhood asthma in different populations has become 
an important international research programme. There are a number of reasons of this. 
Prevalence surveys measure the size of a problem in a population, which, if substantial, 
attracts public health interest, effort and resources. Serial prevalence surveys are also 
needed to test the hypothesis that asthma is becoming more common. 
Since asthma is a common chronic condition, prevalence surveys offer possibilities for 
examining associations between asthma and putative risk factors at the individual level. 
At the ecologic level, differences in prevalence between populations may also suggest 
aetiologic factors (Lewis 1998). 
Finally, prevalence surveys provide a means to examine the usage of health care and the 
quality of care at the population level rather than in selected clinic populations. 
Identification of barriers to and determinants of good asthma care in turn enable the 
design of interventions which may reach all sectors of a population. 
This prevalence research programme has stimulated the search for a standard method to 
study differences in childhood asthma occurence between populations and, in the longer 
term, to examine secular trends in the disease. Although an objective test of bronchial 
hyperresponsiveness may be desirable in a survey of asthma prevalence (Toell 1992), 
questionnaire studies remain the mainstay of population based asthma epidemiology 
(Burr 1992). Recent efforts have thus been devoted to the development of standard 
questions to measure the prevalence and severity of childhood asthma (ISAAC 
Coordinating Committee 1992, Pearce 1993, Burr 1994) and to the measurement of the 
reliability and validity of these survey instruments (Shaw 1992a, 1992b, 1995). 
The primary objective of the study reported in this chapter was to determine the 
prevalence of asthma and asthma-like symptoms in a population of Cape Town primary 
school children. The study design enabled also the examination of the of repeatability 
("reliability") of parental reports of asthma symptoms between a self-administered and 
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interviewer administered questionnaire a few weeks apart. The questionnaire used in this 
study was based closely on one being developed at the time for use in the International 
Study of Asthma and Allergy in Childhood (ISAAC) (ISAAC Coordinating Committee 
1992). However, the study was not itself part of the ISAAC project. 
5.2. Methods 
5.2.1. Self administered questionnaire 
The overall sampling strategy has been described in section 4.4. The final study group 
consisted of a random sample of 15 schools chosen from the 35 primary schools in 
Mitchell's Plain, Cape Town. Questionnaires, in English or Afrikaans depending on the 
medium of instruction of the child, were distributed in July 1993 (winter) to teachers and 
sent via the children to the parents of all 2 265 sub-B children (second grade, typically 
aged 7 to 8 years) on the class lists of the sample schools. 
The project was advertised as a survey of breathing problems in children. The Afrikaans 
translation was refined by discussing the questions with Afrikaans-speaking health care 
professionals working in this community, and by asking parents of asthmatic children 
attending an allergy clinic to describe their children's symptoms. 
Over 8 schooldays, the children were encouraged to have their parents return the 
questionnaires. The English version of the questionnaire is presented in Appendix 1. 
Symptom questions referred either to the previous 12 months, or to occurrence ever. 
Asthma refers to asthma ever, with no reference to a doctor's diagnosis. 
5.2.2. Home interviews 
A subsample of 662 children was chosen whose parents answered the self-administered 
questionnaire and gave consent for further participation. Selection of the subsample was 
determined by the design of risk factor phase of the project (see section 6.2.), and 
included children with multiple symptoms of asthma, or with the diagnosis of asthma (n = 
368) and a random 21.5 percent sample of children with few or no symptoms (n = 294). 
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The parents of children in the subsample who lived within the study area were visited by 
five bilingual interviewers between six weeks and three months after the self-completed 
questionnaires were returned. These visits took place in the spring months September to 
November, 1993. 
In the longer questionnaire used in the home interview, all of the asthma and symptom 
questions in the self-administered questionnaire were repeated in the same order. The 
English version of the questionnaire is included as Appendix 2. 
The interviewers were trained by group demonstration, and by conducting interviews in a 
one week pilot study with report-back sessions. In addition, a sample of six households 
per interviewer were telephoned by the field manager four to twelve weeks after the 
interview and six selected questions (from all sections of the interview questionnaire) 
repeated. There was high concordance (93.8%; 95% confidence interval 90%-97%) 
between the interview and telephone responses. 
5.2.3. Statistical methods 
Symptom prevalences on the self-completed questionnaire were analysed by respondent, 
age, sex and language. Prevalences based on the interview data were calculated taking 
into account sampling fractions. The effect of cluster sampling by school was found to be 
minor, and no adjustment was made. The responses to the questions on asthma and 
asthma treatment were compared to responses to the wheeze questions. Differences 
were evaluated statistically by chi-squared tests. Agreement between responses to the 
two questionnaires was expressed as percent concordance or observed agreement (Po: 
concordant responses/total responses), and by the kappa statistic (chance corrected 
agreement)(Landis 1977). 
5.3. Results 
5.3.1. Self-administered questionnaire 
Of 2 265 children on the February class lists, 2 172 were still registered at the school at 
the start of the study in July. Seven children were absent during the entire week in which 
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the questionnaire was handed out. A total of 1 955 questionnaires were returned, a 
response rate of 90.0%. 
The sample was equally distributed by sex. Of the 90% of children for whom ages were 
given, 46.5% were 7 years of age, 33.5% were 8 years, 8% 9 years of age, the remainder 
being outside this range (Table 5.1 ). Afrikaans was the medium of instruction for 55% of 
children, and English for 45%. The mother alone was marked as the respondent in most 
cases (71 %), followed by the father alone (14%), mother and father together (7%), 
grandmother (5%) and other (3%). 
Table 5.1 Characteristics of prevalence study sample (n = 1955)* 












* Based on self-administered questionnaire 
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Symptom prevalences based on the self-administered questionnaire are listed in Table 
5.2. Of note was that 26.8% of respondents reported recent wheeze in the child, and 
6.4% reported four or more attacks of wheeze in the previous 12 months. Asthma (ever) 
was reported by 10.8% of the sample. 
Table 5.2 Prevalence of asthma symptoms by type of questionnaire 
Self-administered Interviewer-administered 
guestionnaire guestionnaire 
Total Prevalence 95 % C.I. Total Prevalence 95%C.I. 
respondents ( % ) respondents ( % ) 
Past 12 months 
Wheeze 1899 26.8 (24.8-28.8) 619 34.4 (30.5-38.3) 
Wheeze frequency 1825 6.4 (5.3-7.6) 618 10.2 (8.0-12.4) 
(~4 episodes) 
Sleep disturbance 1856 20.4 (19.0-22.8) 614 22.9 (19.8-26.0) 
by wheeze (any) 
Speech disturbance 1881 9.3 (8.0-10.7) 614 10.4 (8.4-12.4) 
by wheeze 
Wheeze after 1884 20.0 (18.2-21.9) 620 16.7 (14.2-19.2) 
Exercise 
Night cough 1883 25.4 (23.5-27.5) 619 26.9 (23.2-30.6) 
Tight chest 1885 23.9 (22.0-25.9) 618 21.9 (18.8-25.0) 
Wheeze ever 1896 30.3 (28.2-32.4) 620 41.7 (37.2-46.2) 
Asthma ever 1905 10.8 (9.5-7.8) 619 10.6 (8.8-12.4) 
On regular asthma 1895 6.6 (5.5-7.8) 
Treatment 
C.I. : Confidence interval 
Prevalence and reliability 101 
Boys had a slightly higher prevalence than girls of most symptoms, but only the excess in 
wheeze ever (32.6% vs. 28.2%, p = 0.03) and asthma (12.2% vs. 9.5%, p = 0.06) 
attained or approached statistical significance. 
There was no difference in asthma or recent wheezing by language group. There was a 
small excess of some recent symptoms in the Afrikaans group compared to the English 
group: sleep disturbance (22.7% vs. 17.5%, p = 0.04), speech disturbance (10.6% vs. 
7.5%, p=0.03) and night cough (27.4% vs. 23.0%, p=0.03). 
There were consistent and significant differences in symptom prevalences reported by 
different respondents (Table 5.3). A joint response by mother and father gave the highest 
prevalences, with mother and grandmother separately reporting somewhat lower preva-
lences, and father alone the lowest. 
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Table 5.3 Prevalence of asthma symptoms as reported by different 
respondents (n=1955) 
Mother and Mother Grandmother Father 
father 
(n=130) (n=1363) (n=97) (n=271) 
Past 12 months 
Wheeze 28.6 27.3 27.4 
Wheeze frequency (~4 episodes) 7.1 6.6 5.5 
Sleep disturbance by wheeze 24.4 21.5 18.7 
(any) 
Speech disturbance by wheeze 17.2 9.4 10.8 
Wheeze after exercise 24.2 20.7 20.2 
Night cough 31.3 26.6 22.8 
Tight chest 26.4 24.9 21.1 
Wheeze ever 28.9 32.4 25.3 
Asthma ever 15.5 10.8 10.3 
On regular asthma treatment 11.8 6.7 4.1 
5.3.2. Relationship of reported asthma to wheeze and treatment 
The proportion reporting asthma rose with the number of episodes of wheezing in the 
previous 12 months (Table 5.4). However, even among children with more than twelve 
attacks of wheeze in the previous 12 months, only 18 of 30 (60%) were reported as 
having asthma, and only 16 of 29 (55%) as being on regular treatment. Similarly, among 
children reported as having recently had all six of the separate symptoms described in the 
questionnaire, only 47% were reported as asthmatic and 39% as being on regular 
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Table 5.4 Reported asthma by wheeze frequency (n=1955) 
Episodes of wheeze ( past 
12 months) 
0 
1 - 3 
4 - 12 
> 12 
*P< 0.0001 for trend 
n Reported asthma (%) 
1354 53 (3.9) 
347 87 (25.0) 
86 36 (41.8) 
30 18 (60.0)* 
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The likelihood of regular treatment for a given wheeze frequency was strongly influenced 
by whether asthma was reported by the respondent (Table 5.5). Among those children 
with more than twelve wheezing episodes, the proportion on regular treatment rose to 
72% if asthma was also reported, compared to 27% if it was not. 
5.3.3. Interviewer administered questionnaire 
Of the total of 1 955 returned self-administered questionnaires, 22 lacked usable 
information, 83 were used in a pilot study of the interviews, and 114 parents did not give 
consent to be interviewed. Of the remaining total of 1 736, a subsample of 662 was 
chosen as described above. Of these, 29 lived outside the study area, leaving 633 
eligible subjects. Six of these subjects changed their consent, 6 could not be interviewed 
and one interview was incomplete. A total of 620 interviews (97.9% of eligible) were thus 
successfully completed. 
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Table 5.5 Regular asthma treatment by wheeze frequency and 
reported asthma (n=1955) 
On regular treatment 
Episodes of wheezing in past 12 Asthma ever 
months 
No Yes 
0 1.1 % 26.4 %* 
1-3 4.2% 37.2 %* 
4-12 10.4 % 74.2 %* 
> 12 27.2 % 72.2 %* 
*P<0.05 for difference between yes and no groups 
5.3.3. Interviewer administered questionnaire 
Of the total of 1 955 returned self-administered questionnaires, 22 lacked usable 
information, 83 were used in a pilot study of the interviews, and 114 parents did not give 
consent to be interviewed. Of the remaining total of 1 736, a subsample of 662 was 
chosen as described above. Of these, 29 lived outside the study area, leaving 633 
eligible subjects. Six of these subjects changed their consent, 6 could not be interviewed 
and one interview was incomplete. A total of 620 interviews (97.9% of eligible) were thus 
successfully completed. 
5.3.4. Reliability 
The repeatability of responses between the self-administered and interviewer 
administered questionnaires is shown in Table 5.6. Observed agreement ranged 
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between about 70 and 80 percent, except for the question on asthma for which observed 
agreement was closer to 90 percent. Chance corrected repeatability (kappa) showed 
greater variation, however, ranging from "fair" (Landis 1997) (0.21 to 0.40) to "substantial" 
(0.61 to 0.80). The questions about asthma, recent wheeze and recent sleep 
disturbance were the most reliable, while those inquiring about recent wheeze frequency, 
speech disturbance and night cough, and about wheeze ever, were less reliable. 
Table 5.6 Reliability of responses* between of self-administered 
versus interviewer-administered questionnaire (by all respondents 
and by mother) 
All (n=620) Mother respondent on both 
occasions (n=394) 
Proportion 
observed kappa Po kappa 
agreement (Po) 
Asthma ever 0.89 0.70 0.90 0.72 
(0.86-0.91) (0.64-0. 76) (0.87-0.93) (0.64-0.80) 
Wheeze 0.80 0.59 0.83 0.65 
(0.77-0.83) (0.53-0.65) (0. 79-0.86) (0.57-0. 73) 
Sleep disturbance by 0.78 0.56 0.81 0.62 
wheeze (0. 74-0.81) (0.50-0.62) (0. 77-0.85) (0.54-0.70) 
Tight chest 0.73 0.46 0.77 0.55 
(0.69-0. 76) (0.40-0.50) (0. 73-0.82) (0.47-0.63) 
Wheeze after exercise 0.72 0.44 0.76 0.51 
(0.80-0.86) (0.36-0.52) (0. 71-0.80) (0.43-0.59) 
Wheeze frequency 0.83 0.44 0.82 0.44 
(2'.4 episodes) (0.80-0.86) (0.34-0.54) (0. 78-0.86) (0.32-0.56) 
Wheeze ever 0.71 0.42 0.71 0.42 
(0.68-0. 75) (0.34-0.50) (0.67-0. 76) (0.32-0.52) 
Night cough 0.68 0.37 0.70 0.41 
(0.65-0. 72) (0.29-0.45) (0.66-0. 75) (0.31-0.51) 
Speech disturbance by 0.76 0.33 0.76 0.37 
wheeze (any) (0. 73-0. 79) (0.25-0.41) (0. 72-0.80) (0.27-0.47) 
* Previous 12 months unless otherwise seecified 
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Reliability was only slightly greater when the mother was the respondent on both 
occasions than for the whole group (Table 5.6). Numbers were too small to calculate the 
kappa statistic separately for classes of respondent other than the mother. 
Calculated symptom prevalences (i.e. weighted by sampling fractions) based on the 
interview responses are shown in Table 5.2. For some of the questions, viz. sleep 
disturbance, speech disturbance, night cough, tight chest, and asthma, the prevalences 
found by the two questionnaires were close. For recent wheeze, wheeze frequency ~ 4 
episodes) and wheeze ever, the interviewer administered questionnaire produced 
significantly higher prevalences. 
5.3.5 Selection bias 
Possible selection effects, in choosing the subsample for home interviews from a smaller 
group of parents (n = 1 736) than the group who returned the self-administered 
questionnaire (n = 1 955), were examined (see section 5.3.3.). After correction for the 
sampling fractions, there was no significant difference in responses to the self-
administered questionnaire between the subsample (n = 662) and the original respondent 
group (n = 1 955). 
5.4. Discussion 
Information based on parental recall of symptoms or diagnoses in children is subject to 
inaccuracy or error resulting in misclassification. Ideally, the extent of such 
misclassification would be measured against a "gold standard" . However, there is no 
gold standard for asthma in epidemiologic studies, nor any easy way of independently 
verifying parental reports in such studies. 
An alternative way of evaluating measurement error is to assess repeatability or reliability, 
which was estimated in this study by comparing responses in approximately one third of 
the self-administered questionnaires to those of an interviewer administered question-
naire. Kelsey (1986) has argued that reliability is easiest to interpret when low - in such 
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cases it can be inferred that accuracy is poor as well. By contrast, high reliability does not 
necessarily imply high accuracy if there are similar errors (e.g. underreporting) in both 
sets of measurements. Nevertheless, it is reasonable to have more confidence in those 
questions (e.g. asthma or recent wheeze) with relatively good reliability than those (e.g 
night cough) that showed poor reliability. This is especially so as the two instruments were 
somewhat different and applied with a time interval between them of a few weeks to 
months. 
The impact of misclassification resulting from measurement error on the estimates of 
prevalence obtained (i.e. a binary outcome measure) is difficult to predict. Assuming the 
error is random (i.e. misclassification is as likely in either direction), the prevalence 
estimate will remain unbiased although the confidence interval may be widened. In this 
study, the symptom prevalences derived from the two questionnaires were close. Notably, 
the prevalence of asthma remained the same. Although wheeze prevalences (recent, 
frequent recent and ever) were significantly higher in the interview, the interpretation for 
public health purposes is the same on either questionnaire. 
Other studies have examined the repeatability of asthma symptom reports by parents. 
Peat (1992) in a study of children aged 8 to 10 years of age in Sydney, also followed a 
self-administered questionnaire with a home interview. Findings regarding recent 
symptoms were similar to those found in this study: "substantial" repeatability for wheeze 
(kappa 0.65), and "fair'' for post-exercise wheeze (kappa 0.41) and night cough (kappa 
0.41 ). Their question about wheeze ever (kappa 0.67) showed somewhat greater 
repeatability than in this study, as did asthma referring to a doctor or hospital diagnosis 
(kappa 0. 78). 
Studies which have compared responses to repeated self-administered questionnaires 
(Salome 1987, Clifford 1989, Luyt 1993) have found questions concerning wheeze (ever 
or recent) to be rnore repeatable than in this study. 
There are a number of possible reasons for the incomplete agreement between 
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responses to the first and second questionnaire, even with the same respondent. First, 
the mode of administration was different. In particular, a personal interview may elicit 
different responses from a self-administered questionnaire, perhaps because of more 
considered answers by the respondent or interviewer pressure. Second, parental recall is 
likely to fade with the passage of time so that recent experience is more vivid. Where 
there is seasonality in symptoms, prevalences will vary through the year. In this 
population, asthma hospital admissions peak in May (autumn) and November (early 
summer) (Ehrlich 1994). The interviews thus overlapped with a seasonal rise in asthma 
severity, and this may have contributed to higher wheezing prevalences in the second 
round of questioning. 
A third possibility is that responses to the second questionnaire were influenced by having 
completed the first questionnaire, which could have increased awareness of these 
symptoms. Finally, some parents whose home language was different from the language 
of school instruction of their child may have switched languages between the self-
administered questionnaire and the interview. Different connotations of terms such as 
asthma and wheeze in the two languages might have caused a change in response in 
some cases. 
Reported prevalence was influenced also by the respondent's relationship to the child. 
Lower rates of reporting of symptoms in children by fathers have been found elsewhere -
(Clifford 1989, Schenker 1983). Mothers are likely to spend more time with the children 
and to be more involved with any ill-health, during the day or night. Theirs may thus be 
the more accurate perception. The higher rates reported when both parents are marked 
as respondents confirm a similar finding elsewhere (Clifford 1989) and may represent a 
pooling of the recall of the two parents. 
There are a few comparable South African studies, all from Cape Town. In a 1989 study 
of higher socioeconomic status (white) school pupils (aged 12 years) in Cape Town, 17.8 
percent were reported by parents with recent wheeze, considerably less than in this study 
(Burr 1994). A similar figure to this (16.1%) was found in the Cape Town ISAAC study of 
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school pupils aged 13 to 14 years, covering the whole socioeconomic spectrum and 
reporting on their own symptoms (ISAAC Steering Committee 1998). The children in 
those studies were older than in the current study; however, studies elsewhere have 
shown relatively little difference in recent wheeze between children aged 7 and 11 years 
(Robertson 1991, 1993). 
In contrast to the wheeze discrepancy, reported asthma in the above studies, viz. 11.5 
percent (Burr 1994) and 13.1 percent (ISAAC Steering Committee 1998) were closer to 
the prevalence found in the current study. These findings regarding asthma prevalence 
are higher than those from a 1987/8 Cape Town study of schoolchildren of mean age 13 
years (range 6 to 20 years), in which a history of doctor diagnosed asthma was reported 
in only 4 percent of coloured schoolchildren compared to 9 percent in white 
schoolchildren (Terblanche 1990). One explanation for the discrepant findings in the latter 
study might be that reference to a doctor's diagnosis in the question about asthma lowers 
the reported prevalence, the more so in a lower socioeconomic status population. 
For international comparison, recent surveys of similarly aged school children (particularly 
6 to 10 years) which used equivalently worded questions were examined (Table 5.7). 
The question regarding wheeze in the past 12 months was common to a number of 
studies. Asthma was linked to a doctor's diagnosis in some of the studies. Both asthma 
ever (independently of a doctor's diagnosis) and doctor diagnosed asthma are presented 
for comparison. 
The prevalence of recent wheeze in Cape Town (26.8 percent on the self-administered 
questionnaire) is at the high end of the range, comparable to that reported in Australia 
and Chile (Robertson 1991, 1993). The prevalence of reported asthma (doctor 
diagnosed or not) shows less variation, with this study towards the lower end of the range. 
The larger discrepancy in our study between wheeze and asthma than in most other 
studies (including Burr's Cape Town study [1994]) could be explained by overreporting of 
wheeze, underreporting of asthma or underdiagnosis of asthma in this study. 
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Table 5.7 International comparison of prevalence of reported wheeze 
and asthma in young schoolchildren (aged approx. 6 to 1 O years) 
Year Reference Location Ages Wheeze Asthma of (years) (previous 12 ever* study months)% % 
Cape Town, South Africa 
1993 This study • Self-administered 7-9 26.8 10.8 
• Interviewer 34.4 10.6 
1992 Peat • Belmont, Australia 8-10 27.6 (37.7) 
1994 • Wagga-wagga, 8-10 23.1 (29.7) 
Australia 
1990 Robertson Melbourne, Australia 7 23.1 24.1 
1991, 1993 La Serena, Chile 7 26.2 9.4 
1992 Strachan Great Britain 5-7 16.7 (12.8) 
1994 8-10 15.9 (12.6) 
1985 Asher Auckland, New Zealand 8-10 14.8 (14.2) 
1988 
? Nystad Norway, 4 cities 6-8 11.0-15.3 
1997 (ranqe) 
1996 Ronmark Northern Sweden 7-8 11.7 (5.7) 
1998 
1995 Ones Istanbul, Turkey 6-12 8.2 (9.8) 
1997 
1994 Sekuk Edirne, Turkey 7 7.7 (18.3) 
1997 
1994- SIDRIA Northern, central Italy 6-7 7.7 9.0 
1995 1997 
1990 Robertson St Gallen, Switzerland 7 7.3 4.3 
1993 
? Veale Rural Australia 8-12 1.9 
1996 (Aboriginal communities) 
*Doctor diagnosed asthma in parentheses 
Overreporting of wheeze is a possibility. A higher proportion of recent wheezing (75.2 
percent) in this study fell into the "infrequent" category (1 to 3 episodes, as opposed to 4 
or more episodes) than in recent studies in Melbourne (Robertson 1993) or Great Britain 
(Strachan 1994). Parents in our population might thus be more inclined to report 
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occasional wheezing than elsewhere. 
Underreporting of diagnosed asthma is unlikely as an important cause of low asthma 
prevalence. This is confirmed by the close association in this study between the reporting 
of asthma and regular asthma treatment (Table 5.4). 
A more likely explanation for the wide wheeze-asthma discrepancy is that access to 
accurate medical diagnosis is relatively poor in this population. Among children with four 
or more episodes of recent wheeze, only 46.5% were reported by their parents as having 
asthma. This is similar to the findings of Bauman (1992) in south-western Sydney, where 
61 percent of children with at least three episodes of cough and wheeze in the previous 
12 months had been labelled as asthmatic. Another marker of severity in this population 
was wheeze severe enough to interfere with speech (9.3 percent). Even among these 
children, asthma was reported in only 38.5 percent. 
Underdiagnosis renders accepted treatment regimens and education of parents about 
allergen reduction and avoidance less likely, and in turn may contribute to high symptom 
prevalences (Anderson 1983). In this study, children with the combination of the label 
asthma and frequent wheezing were much more likely to be on regular asthma treatment, 
than frequent wheezers not reported as having asthma (Table 5.4). This theme is 
examined in more detail in Chapter 8. 
There are, however, plausible environmental causes of a high underlying prevalence of 
wheeze in this group. These factors include close proximity to the coast and climatic 
conditions conducive to housedust mite proliferation (Ordman 1971, Manjra 1994). 
Housedust mite has been shown to be the most prevalent type of immediate skin prick 
reactivity among asthmatic children in Cape Town (Van Niekerk 1977, Potter 1991). 
Smoking prevalence among women is as high as 41 percent in the population of which 
this area is a part, with a quarter of women smoking more than 10 cigarettes daily (Steyn 
1987). In view of the association between maternal smoking and childhood wheezing and 
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asthma (reviewed in Chapter 3 and investigated in Chapter 6), such smoking may be a 
further cause of the high prevalence of asthma symptoms. The popularity of softdrinks 
and foodstuffs preserved with sulphites, which may be potent triggers of bronchospasm, 
may play some role in increasing symptoms in susceptible individuals (Steinman 1993). It 
has also been suggested that infestation with Ascaris lumbricoides, an intestinal parasite 
common in this population, may contribute to the induction or severity of asthma by 
enhancing immune reactivity to a range of aeroallergens (Joubert 1980). 
In conclusion, the findings of this study support the recent advice (Peat 1992) that some 
caution is needed in the interpretation of a single prevalence survey of childhood 
respiratory symptoms. This applies particularly to questions designed to assess wheeze 
severity, situational wheeze and nocturnal cough. Variation of reported symptoms by 
mode of administration and the respondent's relationship to child could add to the impre-
cision of prevalences. However, the high wheeze prevalences reported in both 
questionnaires in this study, and the relatively low frequency of recognition of asthma, 
confirm that asthma and underdiagnosis are public health problems in this population of 
some magnitude. 
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6.1. Background and study objectives 
Among the environmental causes of childhood asthma and wheezing, household factors 
contributing to their occurence or severity merit particular attention, since their 
identification might allow focused preventive strategies. Such household factors include 
indoor allergens (Sporik 1990, Jones 1998) and environmental tobacco smoke (ETS) 
(see Chapter 3) and less consistently, damp and mould (Verhoeff 1995, Brunekreef 1989, 
Dijkstra 1990, Williamson 1997) and oxides of nitrogen (Dijkstra 1990, Infante-Rivard 
1993). An association between salt intake, another potentially modifiable risk factor at the 
household level, and asthma or bronchial hyperresponsiveness (BHR) has also been 
suggested (Burney 1986, 1987, 1989, Pistelli 1993). 
The findings in Chapter 5 established that sub-B schoolchildren in Mitchell's Plain, Cape 
Town, have a high prevalence of wheezing with probable underdiagnosis of asthma. 
Features which may contribute to the risk of asthma or wheezing in this population 
include a climate conducive to house dust mite proliferation (Van Niekerk 1977), and a 
high prevalence of cigarette smoking among men and women (Steyn 1987, 1997, Reddy 
1996) including a high prevalence of maternal smoking in pregnancy (Steyn 1997). Of 
these, ETS is the factor more amenable to public health intervention given current 
knowledge. 
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The objective of this phase of the study was to measure the association between 
household risk factors, particularly ETS exposure, and current asthma or wheezing. For 
this purpose a prevalence case control design embedded in the previously described 
prevalence survey was used. Because of the problem of underdiagnosis, the case 
definition included children with wheezing and related symptoms with or without a 
reported diagnosis of asthma. 
To strengthen the study, urinary cotinine, an objective measure of current ETS exposure, 
was measured in the children. 
6.2. Method 
6.2.1. Selection of cases and controls on self-administered questionnaire 
Cases and controls were selected from the prevalence survey described in chapter 5 (see 
also section 4.4.2. and Fig. 4.2). In summary, two groups were chosen from the 1 736 
children available after the pilot study subjects and non-responding subjects had been 
withdrawn from the sampling frame. The "current asthma/wheeze" case group (n = 368) 
was defined as those children with (1) parent reported asthma, plus at least one symptom 
in the past 12 months (n = 162), or, (2) in the absence of reported asthma, affirmative 
responses to four or more symptom questions referring to the past 12 months (n = 206). 
This resulted in a score on a scale of O to 10 (Table 6.1 ). Case status was based on a 
score of 4 or more. 
The control group consisted of a random sample of children with few or no symptoms 
drawn from the remaining children (n = 294, 21.5% of potential controls). 
6.2.2. Definition of risk factors and covariates on interview administered questionnaire 
The parents of cases and controls were interviewed between six weeks and three months 
after the self-completed questionnaires were returned. In the longer questionnaire used in 
the home interview, the asthma symptom questions were repeated, and further 
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information sought on: sociodemographic features; the child's medical history; household 
smoking; breastfeeding; household factors such as pets, energy/fuel use, visible damp 
and mould; dietary salt preference; family history of asthma; and the respondent's history 
of recent chest illness (Table 6.2). 
Table 6.1 Questions and scores (in parentheses) used in 
questionnaires as basis of case definition (maximum score = 10) 
1. Has your child had wheezing or whistling in the chest in the last 12 months? 
If yes: 1. 1. How many attacks of wheezing or whistling has your child had 
in the last 12 months? 
1-3 (1) 4-12 (2) more than 12 (2) 
2. In the last 12 months, how often, on average, has your child woken up due to chest 
wheezing or whistling? 
never (0) not every week (1) every week (1) 
3. In the last 12 months, has wheezing or whistling in the chest ever been so bad that 
your child couldn't talk properly or had to whisper? (1) 
4. In the last 12 months, has your child's chest every sounded wheezy or whistly, during 
or after running or playing hard? (1) 
5. In the last 12 months, has the child had a troublesome dry cough in the night that was 
not from a cold or chest infection? (1) 
6 In the last 12 months, has the child had a tight chest ? (1) 
7. Has your child ever had asthma? (3) 
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Number of persons/children in child's bedroom. 
Number of rooms in house. 
Mother's education/occupational status. 
Male parent's education/occupational status/presence. 
Male parent contributes to family income. 











*Damp and mould 
*Dietary salt preference, 
Cooking/heating energy source. 
Pets (cat or dog). 
*Smoking exposures 
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Mother's smoking: ever; pregnancy; current; first year of child's life; current daily 
consumption. 
Male parent's smoking: ever; first year of child's life; current; current daily 
consumption. 
Number of other people smoking in house. 
Smoking in child's bedroom. 
Urinary cotinine concentration. 
Respondent 
Mother as respondent. 
Recent chest illness or symptoms (wheeze, tight chest, coughing up phlegm or 
chest illness in past 12 months). 
Time spent at home during week. 
* Of a priori interest. 
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The questions used to define dietary salt preference and household damp are 
reproduced in Table 6.3. Based on analysis of results from the pilot study, positive "salt 
preference" was defined as a positive response to the highest category in any of the salt 
questions, and entered as a single variable into the analysis. Answers to the damp/mould 
questions (with each room represented in a separate question) were analysed as 
separate variables. 
Table 6.3 Questions on which variables household damp and salt 
preference were defined 
Damp 
1. Within the past year has there ever been wet or damp spots on surfaces inside the 
child's present home (e.g. walls, ceiling, carpets)? (Yes/no/don't know). 
2. Have you ever noticed mould or mildew growing on any surface (walls, ceiling, 
carpets)? (In the child's bedroom/in the living room/in the kitchen/in the bathroom/in any 
other inside area of the child's home: Yes/No). 
3. Has there been a leak, flooding or water damage in the child's home in the past year? 
(Yes/no/don't know) 
Salt preference 
1. When food is cooked for the family, how much salt (Aromat/Fondor) is added? (2 or 
more teaspoons/1 teaspoon/just a pinch or one shake/none/don't know). 
2. Does the child (or anyone else) add extra salt or Aromat/Fondor to the food the child 
eats? (No, no extra salt or AromaUFondor is added/yes, but the child's food is tasted first before adding/yes, 
even before the food is tasted/don't know). 
3. How often did the child eat salty snacks during the last week (i.e. chips, niknaks, salted 
peanuts, salty biscuits, biltong, dried sausage)? (Never/1-2 times/3 or more times/don't know). 
4. How often did the child eat cold meats (polony, viennas) during the last week? 
(Never/1-2 times/3 or more times/don't know). 
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6.2.3. Urinary cotinine 
Urinary cotinine is a specific metabolite of nicotine with a half life of approximately 20 to 
40 hours, and is a validated marker of exposure to environmental tobacco smoke (U.S. 
Environmental Protection Agency 1992; see also section 3.5.1.1.). 
In parallel with the home visits, a specimen of urine was collected from the children at 
school. These were frozen on the day of collection to minus 20°C. and later analysed by 
radioimmunoassay, adapted from a method by Knight (1985). This method uses 
polyclonal rabbit antiserum, 1125 labelled cotinine, with cotinine added to horse serum as a 
standard. The method has a detection sensitivity of 5 ng/ml, and an inter-assay precision 
of < 10%. Quality control was exercised by measuring known standards from the 
supplying laboratory. To allow standardisation for varying diuresis, urinary creatinine was 
measured by the Jaffe reaction on a Beckman CX5 discrete analyser. 
6.2.4. Statistical analysis 
As the design effect of sampling schools rather than individuals was found to be small, no 
adjustment for this effect was made. Bivariate analysis was carried out to identify 
potentially significant risk factors or confounders of asthma/ wheeze. Odds ratios and 
confidence intervals were estimated for categorical variables using one of the levels of 
that variable as the reference group. For continuous variables, the odds ratio is used as a 
"summary" measure of effect referring to a unit increment in that variable. 
The use of prevalence odds ratios rather than prevalence ratios to estimate the "relative 
risk" in aetiologic studies based on prevalent cases has been the subject of debate (Lee 
1993, Stromberg 1995, Thompson 1998). Thompson (1998) has recently examined how 
the relationships between the prevalence odds ratio (POR), prevalence ratio (PR) and 
incidence rate ratio (IRR) vary for a hypothetical dynamic cohort under varying parametric 
assumptions. 
Examination of the outcomes using values from Thompson's model (Thompson 1998) 
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closest to those likely in the cohort under study here reveals minimal difference between 
the various measures of effect. For example, assume an underlying IRR of asthma of 1.5 
(incidence rates in exposed and unexposed respectively= 0.03 and 0.02) and "recovery" 
rates = 0.01 and 0.005 respectively). Given either a 5 year follow up (resulting 
prevalence 5%) or 10 year follow up (resulting prevalence 21%), the prevalence odds 
ratio would be 1.5, equal to the IRR and little different from the prevalence ratio of 1.4. 
Only with a much higher assumed incidence rate ratio [e.g. IRR= 5], would the prevalence 
odds ratio produces an overestimate (5.4) of the IRR. 
Variables entered into the multivariate logistic model included all those of a priori interest, 
plus those identified as significant in bivariate analysis. The final model was refined with 
the help of stepwise regression with an entry p-value of 0. 1, with the requirement that it 
contain at least one variable (each) reflecting smoking, damp and salt preference. Effect 
modification was examined by inclusion of interaction terms in the final model on the 
basis of a priori hypotheses, and effects were reported separately where significant. 
The urinary cotinine creatinine ratio (CCR) was used (1) to examine the association 
between cotinine and covariates such as age, sex and number of household smokers, 
and (2) to define strata of cotinine for use as a categorical variable, including a cut-off 
above which CCR might reflect active as well as passive smoking. In multivariate 
regression analysis, log cotinine and creatinine were entered separately as continuous 
variables. 
6.3. Results 
6.3.1. Features of study group 
Of the 662 children chosen for home interviews, 29 did not live in the study area and were 
excluded. Of the remaining 633 children, 620 home interviews were successfully 
concluded (348 cases and 272 controls), a response rate of 97.9%. Urine specimens 
were available for' analysis in 576 of the interviewed sample. 
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In this phase of the study, boys comprised 51.2% of the sample. Of the children, 50.4% 
were 7 years of age, 37.6% 8 years, 8.1% 9 years, and the remaining 3.9% outside this 
range. The mother was identified as the respondent in most cases (79.7%), followed by 
grandmother (9.3%), father (6.0%) and other (5.0%). 
There was no difference in age between cases and controls (both 7.6 years), nor in sex 
distribution (cases: 52.6% male, controls 50.2% male). Table 6.4. illustrates the symptom 
prevalences among cases, controls, and potential controls not sampled. The control 
group selected was representative of all potential controls. 
Table 6.4 Symptoms and asthma prevalence* in cases, controls and 
remainder of potential sample (n=1736) 
Cases Controls Remainder of potential 
(n=348)** (n=272) sample (n=1093) 
% % % 
Wheeze 94.5 10.5 10.9 
Wheeze frequency ~ 4 30.2 0.4 0.0 
Sleep disturbed by wheeze 86.1 2.8 5.0 
Speech disturbed by wheeze 42.4 1.5 0.7 
Wheeze on exercise 80.2 6.7 5.5 
Tight chest 86.7 9.0 8.4 
Cough at night 81.4 12.5 12.4 
Asthma ever 44.1 2.2 2.0 
On regular asthma treatment 26.1. 1.5 1.5 
*Past 12 months unless otherwise specified 
**Excludes 20 cases not successful!}'.'. interviewed 
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6.3.2 Bivariate associations 
Tables 6.5 and 6.6 compare cases and controls with respect to a range of 
sociodemographic, medical history and environmental exposure variables. Household 
occupancy of more than 6 persons (against 6 or fewer) and lack of paternal contribution 
to income were the socioeconomic indicators associated with current asthma/wheeze. Of 
the medical history variables, eczema, hayfever, a paternal, maternal or sibling history of 
asthma, and recent chest illness in the respondent were significantly associated with 
current asthma/wheeze. 
Among the environmental exposure factors, visible mould in the child's bedroom, all the 
maternal smoking measures, the number of current household smokers, and CCR were 
associated with current asthma/wheeze. Paternal smoking, pet ownership (cat or dog), 
energy/fuel source (i.e. paraffin or gas against electricity), and salt preference showed no 
significant association. 
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Table 6.5 Association of sociodemographic and medical history 
variables with current asthma/wheeze (n=620) * 
Variable Cases Controls Odds 95% confidence 
(n=348) (n=272) ratio interval 
% % 
Socioeconomic 
Maternal education < 8 years 59.7 58.1 1.07 0.77-1.17 
Father not formally employed 61.7 56.5 1.25 0.80-1.72 
Paternal education < 8 years 60.5 57.8 1.12 0.81 -1.55 
No paternal contribution to income ** 38.9 30.6 1.44 1.03 - 2.03 
>6 people in house 46.7 38.4 1.41 1.02 - 1.94 
>3 children in house 33.3 30.9 1.12 0.80 - 1.57 
>2 people share child's bedroom 52.0 48.2 1.17 0.85 - 1.60 
<4 rooms in house 19.8 22.4 0.86 0.58 - 1.26 
Child's history 
Eczema 25.6 12.6 2.40 1.55 - 3.69 
Hayfever 33.5 8.2 5.69 3.48 - 9.28 
Never breast-fed 12.6 15.7 0.78 0.49 - 1.22 
Famill'. historv asthma 
Father 10.8 5.4 2.11 1.11-3.99 
Mother 16.4 8.7 2.07 1.24 - 3.46 
Sibling 20.9 12.2 1.90 1.22 - 2.97 
Respondent 
Mother respondent 80.0 79.3 1.04 0.70-1.55 
Recent chest illness 54.5 45.2 1.45 1.05 - 2.00 
*See Table 6.2 for full list of variables tested 
**Includes absence of male parent 
Risk factors for asthma 128 
Table 6.6 Association of enviromental exposure variables* with 
current asthma/wheeze (n=620) * 
Variable N Cases Controls Odds 95% confidence 
(n=348) (n=272) ratio interval 
% % 
Mould in child's bedroom 33.1 25.0 1.48 1.04 - 2.11 
Pets ( cat or dog) 55.5 55.5 1.00 0.73-1.37 
Salt preferenence 68.4 64.7 1.18 0.84- 1.65 
Maternal smoking 1.29 - 2.50 
Ever 68.2 54.4 1.80 1.42 - 2.73 
In pregnancy 53.2 36.6 1.97 1.20 - 2.35 
First year of child's life 55.8 42.5 1.70 1.23 - 2.34 
Current 58.6 45.4 1.70 1.23 - 2.34 
Cigarettes daily 0 291 41.4 54.6 
1 - 5 108 19.4 15.1 
6 - 10 122 20.6 18.8 
> 11 99 18.8 11.5 1.19** 1.05 - 1.55 
Parental smoking 
First year of child's life 70.0 164.0 1.31 0.93 - 1.85 
Current 54.5 49.3 1.23 0.90-1.70 
Other smokers in child's bedroom 23.3 18.0 1.38 0.93 - 2.05 
Total household smokers 0 125 17.1 24.3 
1 144 20.0 27.6 
2 100 27.8 23.5 
>3 188 35.0 24.6 1.21 *** 1.10 - 1.34 
*See Table 6.2 for full list of variables tested 
**Odds ratio for an increment of 5 cigarettes in logistic model 
***Odds ratio for an increment of one household smoker in logistic model 
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6.3.3. Urinary cotinine 
Overall (n = 576), the median CCR was 63.5 ng/mg (interquartile range 30.6 - 130.1 ). Of 
this total. 4 values exceeded 1 000 ng/mg and 72 fell between 200 ng/mg and 1000 
ng/mg. The median CCR among cases [73.2 ng/mg (interquartile range 34.4 - 137.7)] 
was significantly greater than among controls [55.2 ng/mg (interquartile range 22.5-
124.30)] (Wilcoxon test, p = 0.02). The CCR increased with the number of smokers at 
home (Spearman's r = 0.57; p = 0.0001) (Fig. 6.1). 
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The median CCR (and unadjusted cotinine) was higher among children over seven years 
of age than among those six or seven years of age, but the trend by age was not 
significant. 
To assess an exposure response relationship, the CCR was divided into quartiles, and 
the lowest quartile used as a reference group in a categorical analysis (Table 6. 7). The 
data are consistent with an exposure response relationship with saturation of the effect in 
the highest quartile. One can allow for the possibility that high values of CCR included 
some active smokers, by assuming that all children in the stratum with a CCR above 130 
ng/mg were active smokers. Exclusion of this stratum strengthens the exposure-
response trend. 
Table 6. 7 Association between current asthma/wheeze and CCR by 
quartile, with lowest quartile as reference group (n=576) 
CCR N Odds ratio 95% Confidence 
(ng/mg) 
<30.6 144 1.00 
30.6 - 63.5 144 1.21 0.76-1.93 
63.5 - 130.1 144 1.66* 1.04 - 2.66 
>130.1 144 1.61* 1.01 - 2.58 
* Chi-square test for linear trend over first three strata= 62.9; p = 0.0001 
** Chi-square test for linear trend over whole range = 5.4; p = 0.02 
6.3.4. Multivariate logistic model 
interval 
The associations between variables of interest and current asthma/wheeze after 
adjustment for potential confounders are displayed in Table 6.8 (first column). The 
strongest predictors were hayfever and eczema. Parental asthma history (mother or 
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Table 6.8 Final model of predictors of current asthma or wheezing in 
multivariate analysis, using different case definitions* 
Asthma or Asthma reported No asthma More severe 
wheezing (n=396) reported wheezing 
(n=575) 146 cases (n=429) (n=429) 
325 cases 178 cases 179 cases 
Hayfever 5.30 7.37 4.28 7.26 
(3.16 - 8.89) (4.04 - 13.44) (2.40 - 7.61) (4.14-12.76) 
Eczema 2.19 3.26 1.51 2.29 
(1.33 - 3.62) (1. 79 - 5.92) (0.84 - 2. 73) (1.28 - 4.08) 
Parental history 1.77 3.07 1.07 1.43 
of asthma ( 1.11 - 2. 84) (1.76 - 5.38) (0.60 - 1.91) (0.80 - 2.53) 
Sibling history of 1.54 1.33 1.71 1.55 
asthma (0.93 - 2.56) (0. 70 - 2.54) (0.97 - 3.05) (0.85 - 2.80) 
No parental 1.72 1.85 1.68 1.85 
contribution to (1.17 - 2.54) (1.11-3.08) (1.08 - 2.63) (1.16-2.95) 
income** 
Maternal 1.87 2.20 1.79 2.04 
smoking in (1.25-2.81) (1.28 - 2.85) (1.14 - 2.85) (1.25 - 3.34) 
pregnancy 
Number of 1.15 1.07 1.20 1.17 
household (1.01 - 1.30) (0.91 - 1.25) (1.04 - 1.38) (1.003 - 1.35) 
smokers*** 
Bedroom mould 1.19 1.35 1.07 1.11 
(0.79-1.79) (0.80 - 2.28) (0.66 - 1. 72) (0.68 - 1.83) 
Salt preference 1.03 0.92 1.20 1.08 
(0. 70 - 1.52) (0.56 - 1.51) (0. 76 - 1.88) (0.68-1.71) 
*See text for definitions 
**Includes absence of male parent 
***Odds ratio for an increment of one household smoker 
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father) was also positively associated with asthma/wheeze, with sibling history being 
marginally significant. Of the socioeconomic variables, only the absence of paternal 
contribution to family income remained a significant predictor. Among the environmental 
risk factors, maternal smoking in pregnancy and number of smokers at home were 
independently associated with asthma/ wheeze. Log cotinine adjusted for creatinine (OR 
= 1.23; 95% C.I.= 0.82-1.84) was not significant when substituted for number of 
household smokers in the final model. 
As a number of the smoking measures were closely related to one another, the final 
model was re-examined by entering, separately, these smoking variables (or 
combinations of variables) into the model. Of 288 currently non-smoking mothers, 253 
had also not smoked in pregnancy. Of 321 currently smoking mothers, 243 had also 
smoked in pregnancy. Smoking in pregnancy and current smoking were thus highly 
correlated (concordance = 81.4%). When various maternal smoking variables were 
entered separately into the model predicting current asthma/wheeze, only those variables 
which included pregnancy smoking remained significant (Table 6.9). 
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Table 6.9 Effect of using different definitions of maternal smoking on 
its contribution to final model of predictors of current asthma/wheeze 
(n=575) 
Variable Reference Improvement p Odds 95% 
Level Chi square ratio Confidence 
interval 
Smoked in Did not smoke in 9.27 0.002 1.87 1.25 - 2.81 
pregnancy pregnancy 
Smoked first year Did not smoke 2.72 0.09 1.40 0.94 - 2.10 
of life first year of life 
Smoking currently Not smoking 1.53 0.21 1.33 0.85 - 2.00 
currently 
Smoked but not in Never smoked 9.88* 0.007 0.79 0.43 - 1.44 
pregnancy* 
Smoked in Never smoked 1.72 1.09 - 2.72 
pregnancy* 
*Entered together into model 
6.3.5. Interactions 
Interactions of environmental factors with sex, hayfever, eczema and maternal education 
in their association with current asthma/wheeze were examined. An interaction was 
found between reported bedroom mould and hayfever, i.e. while no association between 
bedroom mould and asthma/wheeze was detectable in the absence of hayfever (OR = 
1.01, 95% C.I. 0.65-1.59), this association was strong when hayfever was reported (OR= 
2.91, 95% C.I. 1.98-4.29). 
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A further interaction was demonstrable between current maternal smoking (but not 
smoking in pregnancy) and maternal education. Current maternal smoking was a 
predictor of asthma/wheeze among children whose mothers had eight years of education 
or less (OR= 1.76, 95% C.I.= 1.01-3.05), but not among children whose mothers had 
more than eight years of education (OR = 0.92, 95% C.I.= 0.50-1.70). Maternal 
education was itself inversely related to the child's nicotine absorption, in that the median 
urinary CCR among children of mothers with eight years of education or less (73.1 ng/mg) 
was significantly greater than that among children of mothers with more than eight years 
of education (55.3 ng/mg; p = 0.02). 
Finally, the interaction term between salt preference and sex was significant when 
entered into the model, with boys tending to show a greater association between salt 
preference and asthma/wheeze (OR= 1.50; 95% C.I.= 0.87-2.59) than girls (OR= 0.71, 
95% C.I. = 0.41-1.24). 
6.3.6. Alternative case and control definitions 
The effect on the final model of using three alternative case definitions was examined 
(Table 6.8): column 2: cases whose parents reported asthma, column 3: cases whose 
parents did not report asthma, and column 4: cases with more severe symptoms, viz. 
children reported as having had either four or more wheezing episodes or an episode of 
wheezing which interfered with speech, in the past year. There was some variation in 
the odds ratios: in particular, the reported asthma group tended to show stronger 
associations with hayfever, eczema, parental asthma history, and maternal smoking in 
pregnancy, but weaker associations with sibling asthma history and number of houshold 
smokers. 
Since the control group contained some subjects (n = 73) with a few current symptoms, 
the final model was also re-examined by limiting the controls to currently asymptomatic 
children (n = 199). Such restriction did not materially alter the findings. 
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6.4. Discussion 
The case definition in this study of children aged predominantly 7 to 9 years was based 
on parental reporting of asthma or of symptoms, mainly wheezing, typical of asthma. In 
the ISAAC based questionnaire used in this study, the asthma question does not refer to 
a doctor's diagnosis. However, since asthma is more likely to be underdiagnosed than 
overdiagnosed in this population (see Chapters 5 and 8) parental reporting of asthma is 
probably specific. To overcome the problem of underascertainment, children not labelled 
asthmatic by the parent but with multiple manifestations of wheeze, tight chest, or night 
cough (without a cold) were also included in the case group in the initial analysis. 
Wheezing children with a label of asthma may; however, differ from other wheezing 
children in a number of respects. These include a greater likelihood of severe symptoms, 
a parental history of asthma, presence of other atopic disease such as hayfever, actions 
taken to avoid environmental triggers, and less likelihood of wheezing only with viral 
respiratory infections. Restriction of the case definition in the final model to children 
labelled as asthma by their ·parents increased the strength of most but not all of the 
associations. 
The factors associated with current asthma/wheeze in this study can be grouped into 
three types. The first category reflects the atopic and familial components of childhood 
asthma, i.e. hayfever and eczema in the child, a history of asthma in either parent and to 
a lesser degree in siblings. With the exception of sibling history, these variables were 
stronger predictors among children with reported asthma than among wheezing children 
without asthma. Children labelled asthma are thus more likely to have a cluster of atopic 
or allergic manifestations than wheezing children not so labelled. Also, asthmatic parents 
are presumably more likely to identify wheezing in their children as asthma. 
The second category includes variables indicative of socioeconomic status. The risk of 
diagnosed asthma as inferred from cohort studies has not been clearly related to 
socioeconomic status (Horwood 1985, Martinez 1992). In contrast, wheezing symptoms 
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(Leeder 1976), severe asthma (Mielck 1996) and asthma complications tend to be more 
common among children of lower socioeconomic status, reflecting the lesser access to 
diagnosis and good quality asthma care among poorer children (Halton 1993, Mielck 
1996). In this study, the only predictive socioeconomic variable (of a list including medical 
insurance, maternal and paternal education and occupation, family size, numbers of 
household and bedroom occupants), was the lack of paternal contribution to family 
income. This held whatever the case definition. Female headed households may thus 
reflect some characteristic of poverty not captured by the categories of occupation or 
education used. 
· Low maternal education did, however, enhance the association between current maternal 
smoking and asthma/wheeze, as has been found elsewhere (Martinez 1992). This 
implies that one of the routes by which low maternal education contributes to asthma or 
wheezing is through its association with increased smoking activity in the household, 
confirmed in this study by the inverse association between cotinine in the child's urine and 
maternal education. 
The third category of risk factor is exposure to environmental agents. Sensitisation to 
specific antigens was not measured directly in this study, which relied on reporting of 
exposures. Pet ownership (whether of a cat or dog) was very similar among the two 
groups, and was thus unrelated to current asthma/wheeze. Damp and/or mould, one of 
the household factors of interest in this study, has elsewhere been linked to respiratory 
symptoms and reported asthma or wheezing (Verhoeff 1995, Brunekreef 1989, Dijkstra 
1990) probably via sensitisation to moulds or house dust mite (Verhoeff 1995). Although 
the association of asthma/wheeze with visible mould in the child's bedroom in this sample 
was not significant after adjusting for covariates, bedroom mould was a risk factor among 
the subgroup of children with hayfever. These children with both hayfever and asthma 
symptoms are presumably more likely to be the group sensitised to the allergens 
associated with damp. 
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There was too little use of energy sources other than electricity, such as gas or paraffin 
(household kerosene), to be able to examine their association with asthma/wheeze. Salt 
preference, another factor of a priori interest, did not differ overall between the case and 
control groups. However, there did appear to be some difference between the sexes, in 
that salt preference showed a stronger association with current asthma/wheeze among 
boys than among girls. Despite the crude questionnaire definition of salt intake used, this 
sex-specificity accords with findings in adult studies of asthma or BHR (Burney 1986, 
1987, 1989, Pistelli 1993), and remains intriguing even if difficult to explain. 
In multivariate analysis, two environmental exposure variables remained independently 
associated with current asthma/wheeze under most of the case definitions: maternal 
smoking in pregnancy, and number of household smokers. 
Potential confounders of the association between maternal and household smoking and 
asthma or wheezing include active smoking by the child, socioeconomic status, 
household fuels other than electricity, and possibly the respondent's own symptoms (see 
Chapter 3). All of these potential confounders, other than active smoking by the child, 
could be controlled to some degree in the analysis. 
The urinary cotinine levels may be of some interest in evaluating the role of active 
smoking. Cotinine levels were high in this population, even among children with no 
reported smokers at home. The most likely explanation is the high background exposure 
of these children in the homes of friends and relatives and perhaps in other enclosed 
spaces such as on transport and in shops. There was no direct way to identify actively 
smoking children, as the questioning of young schoolchildren at school is likely to be 
ineffectual in obtaining such information. However, if active smoking in the sample of 
children were important enough to influence mean cotinine levels, it would be expected 
that cotinine levels would rise with age, and that the active smokers would tend to be 
clustered in the children with the highest cotinine levels. There was a tendency for CCR 
to be higher in older children, but exclusion of children with urinary CCR > 130 ng/mg 
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strengthened rather than weakened the association between CCR and asthma/wheeze. 
The mechanism for the association between ETS and asthma or wheezing in this age 
group remains unknown. It is difficult in cross-sectional studies of schoolchildren to 
distinguish an effect of in utero exposure which lays the anatomic or physiologic basis for 
later wheezing illness from a postnatal effect which induces or aggravates its clinical 
appearance. In this study, maternal smoking in pregnancy was closely correlated with 
postnatal maternal smoking, whether in the first year of life or at the time of the study. 
However, it was possible to distinguish statistically mothers who smoked both in 
pregnancy and postnatally from those who smoked postnatally only, while controlling for 
smoking by other household members and for nicotine absorption by the child. The 
results imply that maternal smoking in pregnancy may be necessary to the association 
between maternal smoking and current asthma/wheeze, either alone or in combination 
with postnatal smoking. 
However, the finding in this study that independently of maternal smoking, the number of 
current household smokers was associated with asthma/wheeze, is consistent with a 
postnatal effect of ETS exposure. Validation of the questionnaire measure of household 
smoking was obtained by measurement of urinary cotinine, which was correlated most 
closely with the number of smokers in the household. Cotinine was associated also with 
current asthma/wheeze in bivariate analysis, showing an exposure-response relationship. 
Limitation of the case group to children with an asthma label, while strengthening the 
association with maternal smoking, resulted in disappearance of the association with 
number of household smokers. A possible explanation for this is that an asthma 
diagnosis leads to smoking restriction in such households. 
In conclusion, this phase of the study has demonstrated that both maternal smoking and 
number of household smokers are independently significant risk factors for current 
wheezing illness, with some variation depending on whether asthma is reported or not. 
The findings are thus consistent with the hypothesis that there may be at least two 
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mechanisms at work in the association between household or familial smoking and 
wheezing illness in young schoolchildren, one operating in utero and the other 
postnatally. 
The prevalence of wheezing was shown in Chapter 5 to be high in this population, with 
probable underdiagnosis of asthma. Crude smoking rates in the population of which the 
study community is a part are the highest in South Africa, with 58% of men and 59% of 
women in surveys admitting to smoking (Reddy 1996). This includes a smoking rate in 
pregnancy of 44% (Steyn 1997). The high cotinine levels recorded in this study confirm 
the considerable exposure of these children to ETS from all sources. Based on estimates 
of attributable fraction (see section 3.1.6.), a substantial proportion of childhood 
wheezing illness in this population could thus be prevented by targeting smoking by 
mothers and other household members as a public health priority. 
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7 .1 Background and objectives 
The study described in Chapter 6 found an association between maternal and household 
smoking and the occurrence of asthma and wheeze in a population of primary school 
children. This is in accordance with the body of population studies reviewed in Chapter 3 
which supports the hypothesis that maternal tobacco smoking is associated with an 
increased frequency o asthma and wheezing illness in young children. In addition, some 
but not all general population studies of children have shown a positive association 
between ETS exposure and bronchial hyperresponsiveness (O'Connor 1987, Martinez 
1988, Strachan 1990, Frischer 1992, Soyseth 1995, Cook 1998). 
In contrast to studies of general populations of children, investigations or analyses of 
samples of asthmatic or wheezing children address the question of exacerbation of the 
condition by ETS rather its initiation or induction. Studies of asthmatic children have shown 
positive associations between ETS and symptoms (Murray 1986, 1988, 1989) daily peak 
flow variability (Meijer 1996) and frequency of emergency room visits (Evans 1987), and a 
negative association between ETS and lung function (Murray 1986, 1988, 1989, Sherrill 
1992, Chilmonczyk 1993). Some of these studies have also found an association between 
ETS exposure and BHR, a possible mechanism underlying the aggravation of asthma by 
ETS in susceptible children (O'Connor 1987, Martinez 1988, Murray 1986, 1988, 1989). 
The objective of the study described below was to test the aggravation hypothesis, viz. that 
exposure to household ETS is associated with increased bronchial hyperresponsiveness in 
children identified as having asthma/wheeze. 
7 .2. Methods 
7.2.1. Selection of study subjects 
The current study drew for its sampling frame on the case group defined in section 6.2. 1. in 
the previous chapter. In summary, cases with "current asthma/wheeze" (n = 368) were 
defined as those children with (1) parent reported asthma, plus at least one symptom in 
the past 12 months (n = 162), or, (2) in the absence of reported asthma, affirmative 
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responses to four or more symptom questions referring to the past 12 months (n = 206). 
This resulted in a score with a scale of Oto 10 (see Table 6.1). Case status was based on 
a score of 4 or more. 
Resources available to the study did not permit BHR testing of every child meeting the 
case definition. Accordingly, for BHR testing, the 368 case children were randomly 
ordered in lists by school, and selected with the aim of achieving as large a sample as 
practicable, in this case a minimum of a 70% sample per school (n = approximately 258). 
Any unavailable subject was replaced by the child next on the random list for that school. 
7.2.2. Smoking and other covariates 
Information on household smoking and other covariates was obtained from the home 
interviews. Items in the home interview questionnaire of interest in this phase of the study 
included information on: sociodemographic features; the child's medical history; household 
smoking; visible damp and mould; dietary salt preference and family history of asthma. 
"Atopic history" was defined as a history of hayfever or eczema in the child. "Asthma 
recognition" was defined by a yes answer to the question: "Has your child ever had 
asthma?". Symptom score was treated as a binary variable (7-10 vs 4-6). Urinary cotinine 
was measured as described in section 6.2.3. in the previous chapter. 
7.2.3. Bronchial hyperresponsiveness testing 
Histamine challenge tests were carried out using the long challenge protocol of Yan 
(1983). A Vitalograph S wedge-bellows spirometer was used, calibrated daily with a 3 litre 
syringe. Any child judged clinically by the medical practitioner present to have a significant 
respiratory infection on the day was not tested. Parents were requested to withhold routine 
asthma medication on the morning of the test unless the child was ill, but it was not 
possible to evaluate compliance with this request. Each child was also asked privately at 
the time of the test 
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whether he or she had ever tried cigarettes; none admitted to having done so. 
Temperature and humidity readings were obtained for each day of the study from the 
metropolitan weather station. 
Each child carried out a standing forced expiratory manoeuvre without a noseclip until 2 
reproducible tracings, i.e. within 100 ml of each other, were obtained. The baseline 
measurement was repeated after an inhalation of normal saline. Any child found to have a 
pre or post-saline forced expiratory volume in one second (FEV1) of less than 75 percent 
of predicted for sex, age and height was not challenged with histamine. Instead, the child 
inhaled 200 ug salbutamol from a metered dose inhaler and repeated the expiratory 
manoeuvre after 10 minutes. A positive bronchodilator test was defined as one in which the 
FEV1 increased by 15 percent or more post bronchodilator. 
In the children whose baseline FEV1 was 75 percent or more of predicted, the test 
consisted of inhaling doubling doses of histamine solution delivered with a series of De 
Vilbiss No. 40 handheld nebulisers which dispense an average of 0.003 ml solution with 
each squeeze. The exact amount per squeeze delivered by each of the nebulisers used in 
the study was measured at the beginning and again in the middle of the study to calculate 
the delivered dose for the coming phase of testing. The test was ended when a fall in 
FEV1 of 20 percent or greater from the post-saline value was recorded (a positive test), or 
when a cumulative dose of approximately 7.8 umol histamine been reached without such a 
fall (a negative test). 
Any child who experienced a fall of 10 percent or more in the course of the challenge was 
given 200 ug salbutamol at the end of the testing and observed until the FEV1 had 
returned to its baseline value. 
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7.2.3. Statistical analysis 
The principle of bronchorovocation tests such as histamine challenge is to start with a very 
low inhaled dose, measure any fall in FEV1 from baseline, and increase the dose until a 20 
percent or greater fall in FEV1 occurs or until the limit dose is reached. There are different 
methods available to analyse information obtained from such bronchoprovocation tests 
(O'Connor 1987b, de Marco 1998). The most commonly used method has been to treat 
BHR as a binary variable, with positive responders defined by a 20 percent or greater fall 
in their FEV1 ("hyperresponsiveness") within the dose range of the test. 
A more quantitative scale can be obtained from estimation of the actual dose of histamine 
required to provoke a 20 percent fall in FEV1 among positive responders. This is done by 
interpolating between the last dose at which the FEV1 decline is less than 20 percent and 
the first dose at which the fall in FEV1 exceeds 20 percent. 
Another way of examining the effect of ETS exposure and other variables on BHR while 
making maximal use of histamine dose-response data is by means of survival analysis 
(Sunyer 1996, Sunyer 1997, de Marco 1998). The principle of this method is to treat the 
"effective concentration" of histamine at which a positive response is attained as the 
chronological time to failure, i.e. as a hazard function (with the covariates of interest at their 
baseline values). Censored observations are those from negative or incomplete tests. 
In the above methods, there is censoring of the information of negative responders, i.e. of 
subjects whose FEV1 does not fall by 20 percent by the time the highest test dose is 
reached. An alternative is to estimate the slope of the dose-response curve drawn through 
the points defined by successive FEV1 measurements (O'Connor 1987b). This can be 
estimated by either the slope of the linear regression line through all data points of the 
individual's dose-response curve, or by the percentage fall in FEV1 divided by the total 
dose administered (Peat 1991 ). An advantage of this method is that an estimate of BHR 
can be obtained for every subject, including the minimal responders. This method has 
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been criticised, however, for assuming a linear relationship between FEV1 fall and the 
bronchoprovocation dose (de Marco 1998). 
In modelling BHR to methacholine against a variety of covariates, the method based on 
survival analysis has been shown to perform better than either logistic regression based on 
a binary definition of response or linear regression making use of the dose response slope 
(de Marco 1998). 
For purposes of this study both logistic regression using a binary definition of BHR and 
survival analysis were used to model the data. The results of the two analyses were 
essentially the same. Since the output of survival analysis is somewhat unfamiliar, for 
ease of exposition only the analysis based on a binary definition of BHR is presented, viz. 
a 20 percent or greater fall in FEV1 within the test dose range. Subjects who underwent a 
bronchodilator test because their baseline FEV1 was less than 75 percent were included 
in the BHR group in the reported analysis. However, the analysis was repeated after 
excluding them. As the design effect of sampling schools rather than individuals was found 
to be small, no adjustment for this effect was made. 
The association between BHR and a range of covariates was first examined in bivariate 
analysis, expressed as the prevalence ratio (of a positive BHR test using one of the levels 
of exposure as the reference). These covariates included socioeconomic, medical history, 
and ETS exposure variables, as well as baseline FEV1 , asthma recognition and symptom 
score (see section 7.2.2. above for definitions). 
The association between BHR and covariates of interest was then modelled in multivariate 
analysis using logistic regression, with the prevalence odds ratio as the measure of effect. 
The variables entered into multivariate analysis included ETS exposure variables of 
interest, covariates that were statistically significant in bivariate analysis, and potential 
confounders. 
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Effect modification, i.e. variation of the ETS-BHR association across subgroups in the 
population, was tested by examining interaction terms in the model. Effect modifiers of 
interest were sex, atopic history, asthma recognition and symptom score. 
Besides BHR, the other association of interest was that between baseline FEV1 and ETS. 
FEV1 was analysed as a continuous variable, after adjusting for age, sex and height, and 
mean adjusted FEV1 compared across different levels of the exposure variables. 
7 .3. Results 
7.3.1. Final sample 
A total of 263 children attempted the BHR test. Of another 33 children invited to the testing 
but replaced by the child next on the list, 14 were absent on the day, 14 were judged at the 
test site to have a respiratory tract infection, and 5 were no longer at the school. Of those 
who attempted the test, 8 were unable to perform an adequate test and 2 tests were 
curtailed because of time. There was insufficient or no questionnaire information on 4 of 
the children who completed the test, leaving 249 subjects for analysis. Of these, 240 
successfully completed the histamine challenge test (115 positive, 125 negative). Of the 
positives, 23 responded by the fifth histamine dose of 0.49 umol, 61 by the seventh dose of 
1.95 umol and 115 by the last dose of 7.8 umol. A further nine children had bronchodilator 
tests only (6 with positive, 3 with negative tests). 
CCR results were available for 248 children of these children. The median cotinine 
creatinine ratio (CCR) was 74.2 ng/mg (interquartile range 33.9 to 137.7 ng/mg). The CCR 
increased with the number of smokers at home (Spearman's r-0.5, p=0.0001 ). 
Median daily temperature on the testing days was 18 degrees C. (range 12 - 22), and 
median daily humidity 69 percent (range 46 - 95). 
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7.3.2. Predictors of BHR 
The symptom and maternal smoking profiles of the children who underwent BHR testing 
are listed in Table 7.1 and compared to those children with asthma/wheeze who were not 
tested (n=99). There were no significant differences between the tested and untested 
group in symptoms, asthma recognition, hayfever or maternal smoking prevalence. There 
was also no difference between the groups in a range of other demographic, 
socioeconomic and domestic exposure variables (not shown). 
Table 7.1 Group that completed bronchial hyperresponsiveness testing 
compared to untested group (n=348) 
Symptoms*/ diagnosis 
Wheeze 
Wheeze frequency ::4 
Sleep disturbance 
Speech disturbance 





Selected exposure characteristics 
Mother smokes currently 
Mother smoked in pregnancy 















*Past 12 months unless otherwise indicated. 














**Includes 9 children who underwent bronchodilator rather than histamine test. 
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Table 7.2 compares BHR with respect to a number of sociodemographic and medical 
history variables. There was no association between age or sex and BHR. There was a 
positive association between medical insurance and BHR (prevalence ratio [PR] = 1.30, 
95% confidence interval [C.I.] 1.03 - 1.66). 
Of the medical history variables, children with an atopic history also showed greater 
BHR (PR= 1.46, 95% C.I. 1.14 -1.81 ). This was also the case for a history of hayfever 
or eczema separately. Symptom score was positively associated with BHR (PR= 1.45, 
95% C.I. 1.01 - 2.09), while asthma recognition was somewhat less so. Higher baseline 
FEV1 was inversely associated with BHR (PR= 0.57, 95% C.I. = 0.39-0.81). 
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Table 7.2 Bronchial hyperresponsiveness by demographic, 
socioeconomic, medical history and lung function variables {n=249) 
Variable Category N Positive BHR Prevalence ratio 
test% {95% CQ 
Age (yrs) 6-7 109 50,5 0. 98 (0. 76 - 1.26) 
8-11 124 51.6 
Sex Female 119 52.9 0.94 (0. 74 - 1.2) 
Male 130 50.0 
Medical insurance No 172 47.1 1.30 (1.03 - 1.66) 
Yes 75 61.3 
Mother's education 0-8 152 53.3 0.91 (0.71 -1.18) 
(yrs) >8 96 49.0 
Mother contributes No 153 49.7 1.11 (0.88 - 1.40) 
to income Yes 94 55.3 
Father's education 0-8 151 55.0 0.85 (0.66 - 1.10) 
(yrs) >8 94 46.8 
Father contributes No 95 53.7 0.94 (0.74-1.19) 
to income Yes 153 50.3 
Hayfever No 169 45.6 1.44 ( 1. 14 - 1,81) 
Yes 78 65.4 
Eczema No 186 48.4 1.25 (0.97 - 1.60) 
Yes 63 60.3 
Atopic history No 135 43.0 1.46 (1.14-1.85) 
Yes 112 62.5 
Parental asthma No 170 50.6 1.08 (0.83 - 1.40) 
Yes 68 54.4 
Sibling asthma No 191 51.8 1.04 (0. 78 - 1.38) 
Yes 54 53.7 
Asthma recognition No 142 45.8 1.28 (0.90-1.81) 
Yes 106 58.5 
Symptom score * 4-7 183 45.9 1.45 (1.01 - 2.09) 
8 - 10 66 66.7 
Baseline FEV1 650- 125 65.6 0.57 (0.44-0.74) 
1420 
(ml) 1420- 124 37.1 
2150 
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Table 7.3 compares BHR at different levels of a number of ETS exposure measures as 
well as reported household damp or mould. In general, exposure to maternal smoking was 
associated with less BHR in the children, although not reaching statistical significance, (i.e. 
the confidence interval included one). 
The most suggestive effect was among children of mothers who smoked 15 or more 
cigarettes a day, who showed considerably less BHR compared to children whose mothers 
smoked none (PR = 0.60, 95% C.I. 0.34 - 1.08). A similar pattern was evident for the 
number of smokers in the household, where the highest stratum (> 3 smokers) showed 
somewhat less BHR than the intermediate or unexposed stratum. 
There was no association between paternal smoking and BHR. Although the higher 
quartiles of urinary CCR were associated with less BHR than the lowest stratum, there was 
no exposure response trend. There was no association between reported household damp 
and BHR. There was also no association between BHR and temperature or humidity on 
the test day ( not shown). 
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Table 7 .3 Bronchial hyperresponsiveness by household smoking and 
other environmental variables {n=249} 
Variable Category N Positive Prevalence ratio 
BHR test{%) {95% CQ 
Mother's smoking 
Current Never 76 61.8 1.00 
Ex 27 44.4 0. 72 (0.38 - 1.36) 
Current 144 47.9 0. 78 (0.54 - 1.12) 
Daily cigarettes 0 104 56.7 1.00 
1 - 14 102 53.9 0.95 (0.66 - 1.37) 
15- 35 41 34.2 0.60 (0.34 - 1.08) 
In pregnancy No 114 53.5 0. 93 (0. 73 - 1. 18) 
Yes 133 49.6 
First year of child's No 109 54.1 0.91 (0.72-1.16) 
life 
Yes 140 49.3 
Father's smoking 
Current No 115 51.3 0.99 (0. 78 - 1.27) 
Yes 131 51.2 
First year of child's No 71 46.5 1.12 (0.84 - 1.50) 
Life 
Yes 167 52.1 
Number of 0 41 53.7 1.00 
Smokers in house 1 - 3 154 55.8 1.04 (0. 76 - 1.43) 
>3 52 36.5 0.68 (0.43 - 1.08) 
CCR (ng/mg) 0-33.8 60 56.7 
33.9- 74.2 64 48.4 0.86 (0.61 - 1.20) 
74.3-137.7 62 53.2 0.94 (0.68 - 1.30) 
>137.7 61 45.9 0.81 {0.57 - 1.15} 
Household damp or No 161 49.1 1.14 (0.89 - 1.45) 
Mould Yes 88 55.7 
BHR: Bronchial hyperresponsiveness. Cl: Confidence interval. CCR cotinine creatinine 
ratio. 
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To explore whether the child's symptoms or perception of the child's cond_ition by parents 
might cause them to reduce the child's exposure to ETS, the relationships between urinary 
CCR and atopic history, asthma recognition and asthma score were examined. This is 
shown in Table 7.4. Urinary cotinine was in fact lower among children with an atopic 
history and with asthma recognition than those without. Children with a higher symptom 
score showed a slightly lower level of urinary CCR. 
Table 7.4 Association of urinary cotinine with various features of asthma or 
atopic status in children with asthma/wheeze (n=249) 
Variable Category N Cotinine creatinine p-value 
ratio/(ng/mg) 
Atopic history No 134 84.4 (2.70) 
Yes 110 56.1 (2.91) 0.002 
Asthma recognition No 140 81.5 (2.64) 
Yes 105 58.9 (3.00) 0.015 
Symptom score 4-7 181 72.8 (2.58) 
8-10 65 64.1 (2.58) 0.4 
Table 7.5 shows the results of multivariate analysis. Among the ETS variables current 
smoking by the mother in the form of number of cigarettes smoked daily was entered into 
the model. This was adjusted for medical insurance, atopic history, baseline FEV1, 
asthma recognition, and symptom score (treated as confounders) in multivariate analysis. 
There was no change in the negative association between maternal daily cigarette 
consumption and BHR compared to the bivariate analysis. 
No significant effect modification was found. In particular, the associations (or lack of 
them) between BHR and maternal smoking, paternal smoking, number of household 
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smokers or CCR did not vary significantly by atopic history, asthma recognition, higher 
symptom score, or parental or sibling history of asthma. 
Table 7.5 Predictors of bronchial hyperresponsiveness in multivariate 

























(95% confidence interval) 
1.00 
0.97 (0.67 - 1.41) 
0.62 (0.34 - 1.11) 
1.27 (0.88 - 1.83) 
0.60 (0.42 - 0.86) 
1.06 (0.72-1.58) 
1.34 (0.89 - 2.01) 
1.32 (0.87 - 2.00) 
The analysis was repeated excluding the children who underwent the bronchodilator test 
only, with no change in the results. 
ETS exposure and FEV1 
Table 7.6 shows mean baseline FEV1 adjusted for age, sex and height in relation to 
smoking exposure variables. The significant associations were a lower mean FEV1 among 
children whose mothers currently smoked compared to children whose mothers did not, 
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and similarly for children whose parents both smoked. Children whose fat
hers smoked had 
a higher mean FEV1 than those of nonsmoking fathers, but this di
fference was not 
statistically significant. There was no association between FEV1 and CCR
. 
Table 7.6 FEV1* by household smoking variables and CCR (n=247) 
Mean FEV1 Mean difference 
Variable (SE) (ml) 
(ml) 









First year of child's 
life 
Mother and father 
smoke 




0 - 33.8 
33.9 - 74.2 
74.3- 137.7 
>137.7 
1409 (19) 1641 (115) 
1526 (69) 1467 (48) 
1464 (60) 1557 (83) 
1463 (57) 1560 (88) 
1561 (91) 1449 (32) 
1518 (72) 1502 (47) 
1385 (32) 1591 (62) 
1455 (53) 1591 (102) 





*Adjusted for age, sex and height 
FEV1: Forced expiratory volume in one second. SE: Standard error. 
Cl: Confidence interval. CCR: Cotinine creatinine ratio. 
-232 (-461, -2) 
59 (107, 225) 
-93 (-296, 110) 
-97 (-305, 110) 
112 (-78, 302) 
16 (-154, 186) 
-150 (-286, -131) 
-137 (-366, 92) 
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7 .4. Discussion 
Bronchial hyperresponsiveness can be interpreted as a marker of current asthma severity, 
or alternatively, susceptibility to acute asthmatic episodes, in children identified on 
questionnaire as having asthma or wheeze. BHR is not a fixed nor a defining 
characteristic of asthma, however. It may vary over time in the same child or vary 
considerably between asthmatic children, i.e. it shows intra- and inter-individual variability 
(Phelan 1991 ). In clinical settings a single measurement of BHR must be interpreted with 
caution. However, as long as this variability is distributed equally across the groups of 
interest, BHR remains useful as an objective outcome in epidemiologic analysis of 
exposure factors contributing to asthma or its severity. 
This study has failed to show that household ETS exposure is associated with increased 
BHR in a population based sample of children with a recent history of wheeze or diagnosis 
of asthma. This was so whether ETS exposure was defined in terms of urinary cotinine, 
reported parental smoking or number of smokers in the house. Unexpectedly, BHR was 
lowest in the highest stratum of each of three ETS variables, viz. more than 15 cigarettes 
smoked daily by the mother (compared to fewer or none), four or more smokers in the 
house (compared to fewer or none) and CCR > 137.7 ng/mg (compared to any of the 
lower strata of CCR). 
The only expected association (Murray 1988, Sherill 1992, Chilmonczyk 1993) 
demonstrated in this group of schoolchildren with asthma/wheeze was an FEV1 deficit 
among children whose mothers currently smoked, or whose parents both smoked, 
compared to children whose mothers (or parents) were current nonsmokers. 
The findings were also surprising in view of the findings in Chapter 6, namely a robust 
association ( odds ratio of the order of 1. 7 to 2. 0) between maternal and other household 
smoking and asthma/wheeze when the whole population, i.e. including the controls (scores 
O to 3), was analysed. The results of the two studies suggest a model in which maternal · 
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smoking contributes to the induction of asthma, and to its chronicity as measured by FEV1, 
but not to the worsening of BHR in children already identified with asthma/wheeze. 
Of other covariates examined, the known association between atopy and BHR from 
population studies (Martinez 1988, Peat 1987) was confirmed. However, no significant 
variation in BHR by age, sex, reported household damp or mould, or socioeconomic 
markers (other than medical insurance) could be demonstrated. The increased BHR 
among children with medical insurance is interesting but ambiguous, as medical insurance 
is both an indicator of better socioeconomic circumstances and greater access to private 
sector medical care. 
Possible explanations for the unexpected findings include lack of power, bias, negative 
confounding or effect modification. Lack of power is evident from the wide confidence 
intervals. However, the measures of effect estimates for the smoking variables were 
consistently either close to one or smaller than one. While a larger study would have 
reduced the size of the confidence intervals, it is unlikely to have resulted in substantial 
reversal of the direction of the estimates. 
Bias (due to the cross-sectional study design) away from finding an effect of current ETS 
exposure on BHR would occur if parents of children with correlates of BHR (such as more 
active or severe asthma or multiple manifestations of atopy such as rhinitis and eczema) 
avoided smoking around the children or reduced their smoking altogether. This was 
suggested by Frischer (1992) who found an association between ETS and peak expiratory 
flow rate variability (assumed to reflect BHR) in non-atopic asthmatic children but not in 
atopic asthmatic children, and by Chen (1996) who found an association between ETS and 
diagnosed asthma in non-allergic but not in allergic children. 
A seemingly protective effect of current smoking on current BHR among 8 year old 
asthmatics was also found by Meinert (1994), in contrast to positive associations between 
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smoking by the mother in pregnancy and during the child's first year of life and current 
BHR. This suggested that mothers reduced their smoking over time (or did not take it up) in 
response to having a child with BHR. The authors called this the "healthy passive smoker'' 
effect. 
In this study asthma recognition, atopic history and symptom score were associated with 
increased BHR. In addition, urinary CCR was significantly lower in children with asthma 
recognition and atopic history than those without, and slightly lower in those with a higher 
asthma/wheeze score. These covariates thus qualify as potential confounders. A strong 
selection effect based on these correlates of BHR could possibly produce a spurious 
inverse association between ETS and BHR, with the more bronchially responsive children 
having less ETS exposure. 
However, when these potential confounders were entered into multivariate analysis 
together with current maternal smoking activity, there was no change in the inverse 
association between maternal smoking and BHR. 
Other forms of negative confounding were considered. Meijer (1996) measuring circadian 
peak flow variation in allergic asthmatic children, found an association of ETS with peak 
flow variation among children with mild to moderate BHR as measured by histamine 
challenge, but not among those with severe BHR. Those authors postulated that the effect 
of ETS in the group of children with severe BHR was masked by the impact of other 
exogenous stimuli. The only marker of environmental allergen exposure measured in the 
current study was household mould or damp, which was not associated with BHR. While 
house dust mite sensitisation is the most common form of atopy in this population (Van 
Niekerk 1977, Potter 1991) it is implausible that house dust mite exposure would be 
inversely related to ETS exposure. 
Effect modification may result in an effect that occurs in a subgroup of the population being 
diluted if the whole population is studied. In this study there was no effect modification by 
ETS and BHR 162 
atopy, in contrast to the findings of Chen (1996) and Frischer (1992). Effect modification 
of the association between ETS and BHR among asthmatics by age, sex ·and season has 
been noted in some studies. Murray (1988, 1989) found in their series that a positive 
association was demonstrable mainly in boys, among adolescents compared to the age 
group 7 to 11 years (the age range of this study), and during testing in the cold, wet season 
rather than in the warm, dry season. In the current study, there was no sex difference in 
the findings. All the testing was done in spring and early summer when the child's 
household ETS exposure would conceivably be lower than in the wet winter months. It has 
also been suggested by some authors that there may be a susceptibility factor, as yet 
uncharacterised, making some asthmatics more sensitive to ETS than others (O'Connell 
1974, Lehrer 1984, Menon 1992). 
The findings regarding ETS and BHR are in conflict with a number of other studies of 
children with asthma/wheeze, in which BHR was greater in the children of smokers 
(O'Connor 1987, Martinez 1988, Murray 1986, 1988, 1989). One of these study 
populations, (Murray 1986, 1988, 1989)] in which histamine challenge was also used, 
consisted of diagnosed asthmatics attending a clinic and may have represented a selected 
group with more severe asthma. The sample in the current study was a group of children 
described as having symptomatic asthma or multiple symptoms of asthma in the previous 
12 months. In this study, the spectrum of disease would be different from studies of clinic 
asthmatics, in that the sample included both children with current active asthma, and those 
whose asthma might have been episodic, seasonal or mild. However, the findings also 
contradict those studies in which children the asthma group were identified from population 
based samples in a similar way (O'Connor 1987, Martinez 1988), although the methods of 
BHR testing were different. 
Chamber studies, in which asthmatic subjects are subjected to ETS under controlled 
conditions, have reproduced acute symptoms of upper and lower respiratory tract irritation, 
but have produced conflicting results with regard to changes in BHR. Oldigs (1991) 
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studied asthmatic children, and found no consistent change in lung function or BHR after 
one hour of exposure to ETS. Some chamber studies of adult asthmatics have shown lung 
function decline and increased BHR on ETS challenge (Knight 1985, Menon 1992), 
although in the latter study subjects were pre-selected for previous "sensitivity" to ETS. 
Other chamber studies of asthmatic adults failed to show these responses to ETS 
(Shephard 1979, Weidemann 1986, Jorres 1992). In general, these studies are able to 
reproduce only acute ETS exposures in small samples of mainly adult volunteers, and the 
relevance to chronic exposure of children in home environments is limited. 
In conclusion, this study does not support the hypothesis that ETS aggravates asthma by 
increasing BHR. If anything, an inverse association between heavier maternal smoking 
and BHR was found. It is difficult to conceive of a biological basis for an inverse 
association. An attempt was made to adjust for factors which might induce parents to 
modify their smoking in response to manifestations of asthma in their child, but the 
effectiveness of such adjustment is difficult to judge in a cross-sectional study. Further 
cross-sectional studies cannot solve this problem. Only prospective studies with 
measurement over appropriate time periods of both the child's ETS exposure and BHR are 
likely to answer the question. 
The findings of this study should be considered in the light of the conclusion of a recent 
systematic literature review by Cook and Strachan (1998). Reviewing studies of passive 
smoking and BHR both in general populations and in asthmatic populations or subgroups, 
the authors concluded that there was insufficient evidence for an effect of ETS on BHR at 
the general population level. They cited selective reporting of results in published studies 
and publication bias in favour of positive studies as having produced a spurious a positive 
association in the literature. In addition, the relatively few studies of asthmatic children 
were contradictory or inconclusive. 
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In contrast to the findings regarding BHR, the results of this study are consistent with an 
effect of maternal smoking, and combined maternal and paternal smoking, on lung function 
deficit (as reflected in FEV1) among symptomatic children. ETS exposure may thus be an 
added risk factor for long term lung function loss in wheezy or asthmatic children (Sherrill 
1992). 
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8.1 Background and study objectives 
Although asthma is not curable, the quality of life of asthmatic children can be greatly 
improved by appropriate management. Elements of such management include 
appropriate anti-inflammatory and bronchodilator medication, education of caregivers 
about the disease, home monitoring and a self-management plan, allergen control, and 
attention to psychosocial obstacles to treatment (British Thoracic Society and Others 
1993, Bosley 1996). Guidelines for the treatment of childhood asthma have been 
published in South Africa in recent years (South African Childhood Asthma Working 
Group 1992, 1993a, 1993b, 1994). Doubt has been expressed, however, about the extent 
of their application in practice (Morris 1994, Green 1998). 
Appropriate management of childhood asthma requires acceptance of the diagnosis by 
parents or caregivers, which in turn requires recognition by medical practitioners. 
Underrecognition and/or undertreatment of childhood and adolescent asthma have been 
studied and identified as problems in the United Kingdom (Speight 1983, Duran-Tauleria 
1996), Australia (Bauman 1992), the Netherlands (Kolnaar 1994), the USA (Davidson 
1994) and Denmark (Siersted 1998). Differences between socioeconomic and ethnic 
groups in the recognition and treatment of childhood asthma have also been noted 
(Duran-Tauleria 1996, Bauman 1992, Davidson 1994, Evans 1992). The common finding 
is that poorer, inner city or minority status children, depending on the society, tend to 
suffer more from their asthma and receive worse care than better off children. 
It was shown in Chapter 5 that primary school children in Mitchell's Plain have a relatively 
high prevalence of wheezing by published international standards. The aim of the current 
study was to determine, based on parental reporting, the degree to which asthma is 
recognised and appropriately managed in this population. The influence of 
socioeconomic and other factors on the recognition and treatment of asthma was also 
examined. 
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8.2. Method 
8.2.1. Selection of group for study 
Because the focus of this phase of the study was on diagnosis and treatment, in order to 
increase the validity (Kelsey 1986) of the case definition of asthma, responses to both 
questionnaires were used in the case definition. Thus only children who met the criteria 
for asthma (see section 6.2.1. and Table 6.1) on both the self-administered and interview 
questionnaire were regarded as having asthma. 
Fig. 8.1 illustrates how the groups for analysis in this part of the study were obtained. A 
total of 243 children qualified as asthmatic by meeting the criteria for case status on both 
the initial and repeat questionnaires, of whom 242 had sufficient information for analysis. 
Because of the sampling for BHR testing (see 7.2.1.), among the group that completed 
BHR tests, only 178 also met the criteria for case status on both questionnaires. As a 
result, for 64 of the asthma cases in this phase of the study, BHR status was unknown. 
(See Fig. 8.1 ). Of the 178 children who had undergone the test, 100 showed positive 
BHR. 
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Fig. 8.1 Sampling pathway to case group in study of underrecognition 
and undertreatment of asthma 
Completed first 
uestionnaire: 1955 
2nd sam le: 1736 




Met case definition on 
both uestionnaires: 242 
non-response 




Also had bronchial 
responsiveness test: 178 h 
No bronchial 
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8.2.2. Measurement of descriptive and predictive variables of interest 
Items on the home interview of particular relevance to this phase of the study
 were 
sociodemographic characteristics, the child's respiratory medical history, histo
ry of 
treatment for chest symptoms, knowledge of asthma management, and terms us
ed by 
the parent and medical practitioner to describe the child's condition (Table 8.1 ). If 
the 
child was on current treatment, the respondent indicated the medication used by the
 child 
with the aid of a chart with photographs of the most common oral and inhaled medi
cation 
in local use. The name and mode of delivery of the medication were recorded b
y the 
interviewer if the information could be obtained. 
· The primary division of interest in this study sample was into those children for wh
om the 
respondent answered yes to the question "has your child ever had asthma" (recog
nised 
asthma) on the interview questionnaire, and those for whom the respondent answer
ed no 
(unrecognised asthma). 
Current treatment was defined as affirmative response to the question "is your
 child 
currently on treatment from a doctor for any of the following symp
toms: 
wheezing/whistling in the chest, tight chest, night cough or asthma?" Appropriaten
ess of 
treatment was inferred qualitatively by comparing patterns of reported treatment a
gainst 
the recommended South African 1991 consenus guideline published in 1992 (
South 
African Childhood Asthma Working Group 1992). Of particular interest was conf
ormity 
with recommendations that short acting beta-2 agonist therapy is preferab
le to 
theophylline as front line medication, and that children with moderate or severe a
sthma 
should be on daily anti-inflammatory treatment. (Later guidelines emphasised the be
nefits 
of inhaled over oral therapy). 
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Table 8.1 Questions used in interview questionnaire on asthma 
recognition and treatment 
1. Has the child ever had asthma? 
1.1 Does s/he still have asthma? 
173 
2. In talking about these symptoms (wheeze, tight chest, night cough) with your doctor, 
family or friends, what name do you use to describe the problem? (record) 
3. During the past 12 months, has the child received any treatment from a doctor for 
any of the following symptoms? (wheezing/whistling in the chest, tight chest, 
difficulty sleeping because of cough) 
3.1 What name(s) did the doctor use to describe the child's chest problem? (record) 
3.2 Where did the child go for treatment for this chest problem? [private doctor, day 
hospital, Red Cross Hospital, other hospital or clinic, other (specify)] 
4. Is the child currently on any treatment for any of the following: wheezing/whistling in 
the chest, tight chest, night cough or asthma? 
4.1 If yes what treatment? [tablets, syrup, inhaler, nebuliser (oxygen), injection, 
other (specify)] 
5. Do you know of anything you can do inside the child's bedroom to prevent allergy or 
breathing problems? (specify) 
6. Do you know of anything your child can avoid eating or drinking so as to prevent 
allergy or breathing problems? (specify) 
7. Has the child ever been asked by a doctor or nurse to blow into a peak flow meter? 
(show picture of meter) 
Socioeconomic status was measured by a number of variables including highest 
educational standard reached by mother and/or father, employment and occupational 
status of mother and/or father, number of people in the household in relation to number of 
rooms, number of other children in the household and, less directly, membership of a 
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medical aid (insurance) scheme and use of a private doctor. In addition, the school was 
rated by a Department of Education official on a relative scale of "high, medium or low 
socioeconomic status". 
8.2.3. Statistical analysis 
Symptom proportions in the two "recognition" subgroups as well as the proportions of the 
two groups reporting various aspects of management and knowledge of asthma were 
compared using the likelihood ratio chi-squared statistic. 
The associations of sociodemographic, medical and family history factors and symptom 
severity with asthma recognition, current treatment and use of an inhaler were tested in 
bivariate analysis. (As the objective was exploratory, multivariate analysis was not carried 
out). The measure of effect presented in this analysis is the prevalence ratio. The Cox 
proportional hazards model was used obtain the point estimates and the corresponding 
95% confidence intervals (Lee 1994) of the prevalence ratios. 
8.3. Results 
8.3.1. Features of recognised versus unrecognised asthma 
Of the 242 children identified as asthmatic using the case definition, only 129 (53%) had 
recognised asthma. Even in this group, only 88 (37% of total) were acknowledged as 
"still" having asthma (Table 8.1: question 1.1 ). Even on a stricter criterion requiring case 
status on both questionnaires plus BHR (n=100), recognition of asthma occurred in only 
62 percent, with only 45 percent acknowledged as current. 
The majority of children in the sample in this phase of the study were aged 6 to 8 years. 
Boys made up just over half of both the recognised and unrecognised asthma groups. 
The mother was identified as the respondent in 85 percent of both groups. 
The unrecognised group had significantly higher prevalences of wheeze, sleep 
disturbance and night cough compared to the recognised group (Table 8.2). By contrast, 
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a higher proportion of the recognised asthma group had a positive BHR test (62% vs 
48.1%, p = 0.07). 
Table 8.2 Reported symptoms and bronchial hyperresponsiveness by 
asthma recognition (n=242) 
Symptoms 
(past 12 months) 
Wheeze 
Wheeze ~4 episodes 
Sleep disturbance by wheeze 



































Table 8.3 describes the terms offered by the respondent to describe the child's 
respiratory problem, as well as the terms attributed to the child's doctor (Table 8.1: 
questions 2 and 3). The term "asthma" was offered by only 31.0 percent of the 
recognised group, and 2. 7 percent of the unrecognised group (the latter thus 
contradicting the response to the direct question about asthma). The largest proportion in 
both groups preferred "tight chest" ("toebors" in Afrikaans). "Wheeze/wheezing chest" 
was rarely used. In describing what term the doctor used, "asthma" was reported by the 
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majority (71.9%) of the recognised group. In the unrecognised group, "bronchitis" (49%) 
and "cold" ("verkoue op die bars" in Afrikaans) (20%) were the majority responses. 
Table 8.3 Terms to describe child's symptoms* used by respondent 
or attributed to doctor, by asthma recognition (n=242) 

















*See Table 8.1, questions 2 and 3.1 
Asthma recognised Asthma not recognised 
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Almost all of the children in both groups had received some treatment for asthma 
symptoms in the previous 12 months (Table 8.4). However, while 23.2 percent of the 
recognised group were on daily treatment, and a further 42.9 percent on treatment as 
needed, only 3 percent in the unrecognised group were on daily treatment, with a large 
proportion (63%) on no current treatment. Children in the recognised group were more 
likely to have been treated privately and/or at Red Cross Children's Hospital, the regional 
paediatric teaching hospital. By contrast, day hospitals (public sector community 
outpatient clinics) were a more common site of treatment of children in the unrecognised 
group. 
With regard to types of medication currently used, syrups (sweetened liquid preparations) 
were mentioned by a large majority of the respondents to this question (90.5% and 88.9% 
respectively), with pills the next most common mode of treatment reported. Inhalers were 
used by 44.6 percent of the recognised group and only 8.3 percent of the unrecognised 
group. Nebulisers were as commonly used as inhalers (the question did not distinguish 
between nebuliser use in a clinic or doctor's surgery and at home). Only 46.8 percent of 
the recognised group and 13.2 percent of the unrecognised group reported that the child 
had ever used a peak flow meter. 
Response rates to the questions about home preventive measures were low (Table 8.4). 
Of the 114 who answered the question about preventive bedroom measures, a minority 
(16.4% in the recognised asthma group, 8.7% in the unrecognised group) mentioned 
avoidance of smoking in the child's bedroom. Even fewer respondents (60) answered the 
question about dietary avoidance. Among these, the most common reference was to 
cooldrinks (synthetic or fruit based sweet drinks). There were no significant differences 
between the two groups in these responses. 
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Table 8.4 Treatment and parential knowledge of home management, 
by asthma recognition (0/o) (n=242) 
Treatment in past 12 months (yes = 215) 
Source of treatment (n=215)* 
Private doctor 
Day hospital 
Red Cross Hospital 
Other hospital 
Other 









Inhaler or nebuliser 
Injection 
Other 
Peak flow meter (ever used) (n=242) 




Sleep with fresh air 
No soft furniture/carpets 
Other 
Did not specify 






































































aO.OOS<P <0.01 for difference between two groups; 6P<0.005 for difference between two 
groups; cP<0.000 for difference between two groups across all 3 categories 
*Respondent could choose one or more 
**See Table 8.1, questions 5 and 6. Numbers are those who answered yes. 
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A total of 101 of the 242 respondents provided more detail about the treatment the child 
used currently, either daily or as needed (see Table 8.1: question 4.1.). (Non-response 
implies either that the child was not on current treatment or no response to that question). 
Based on these responses, the number of times a specific medication/mode of delivery 
was mentioned is listed in Table 8.5. (A given respondent could mention more than one 
medication). Salbutamol was most commonly mentioned, with a syrup preparation the 
most frequent mode of administration. Other beta-2 agonists, including fenoterol, were 
mentioned much less commonly. The next most popular medication were the 
theophyllines, again with syrups the most common form. Anti-inflammatory medication 
was identified relatively few times: inhaled corticosteroids 9 times, oral corticosteroids 11, 
and sodium cromoglycate 12. The remainder of the medications mentioned included 
antihistamines, antibiotics and various cold and flu' preparations. 
8.3.2. Predictors of recognition and treatment 
Variables examined in relation to asthma recognition, current treatment and inhaler use 
were: demographic (age, sex); medical history (hayfever, eczema, parental asthma); 
socioeconomic (school, household crowding and size, maternal and paternal education 
and occupational/employment status); health care (medical aid, use of private doctor or 
day hospital); and severity (frequent wheeze, speech disturbance, positive BHR). 
Covariates reaching statistical significance in any association (i.e. for any of the three 
outcomes), plus those of a priori interest are presented in Table 8.6. 
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Table 8.5 Number of times asthma medication class mentioned for 


























(n=101) refers to the number of respondents who gave information about 
current medications. As a single respondent could mention multiple 
medications, numbers in table do not refer to respondents. 
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Table 8.6 Predictors of asthma recognition, current treatment and 
inhaler use (n=242) 
Asthma recognition Current treatment Inhaler use 
(n=242) (n=242) (n=112) 
% Prevalence ratio % Prevalence ratio % Prevalence ratio 
(95 % Cl) (95 % Cl) (95 % Cl) 
Age (yrs) 
6-7 62.3 1.3 (1.03 - 1.66) 50.9 1.13 (0.86 - 1.48) 33.9 1.08 (0.63 - 1.87) 
8-11 47.8 45.1 31.4 
Hayfever 
Yes 62.1 1.29 (1.02 - 1.62) 67.4 1.93 (1.48 - 2.51) 40.3 1.83 (1.00 - 3.35) 
No 48.3 34.9 22.0 
Eczema 
Yes 60.3 1.19 (0.94 - 1.52) 59.4 1 .41 ( 1 . 09 - 1 . 84) 36.6 1.24 (0. 72 - 2.12) 
No 50.6 42.1 29.6 
Parental asthma 
Yes 69.1 1.45 (1.16-1.81) 49.7 1.15 (0.84-1.57) 31.3 0.91 (0.50 - 1.65) 
No 47.7 43.3 34.5 
Medical Aid 
Yes 65.5 1.4 (1.11 - 1. 76) 56.1 1.35 (1.03-1.76) 30.4 0.89 (0.51 - 1.54) 
No 46.8 41.7 34.9 
Treated by private doctor 
Yes 60.2 1.45 (1.09 - 1.92) 58.6 1.39 (1.05 - 1.85) 29.3 0. 75 (0.44 - 1.29) 
No 41.6 42.1 38.9 
Treated by day hospital 
Yes 40.0 0.67 (0.49 - 0.90) 38.8 0.65 (0.48 - 0.89) 30.3 0.90 (0.48 - 1.69) 
No 59.9 59.6 33.3 
Socio-economic status of 
school 
High 57.9 1.23 (0.96 - 1.58) 53.3 1.37 (1.03 - 1.83) 32.4 0.98 (0.56 - 1.72) 
Low 47.1 38.8 32.5 
Other children in household 
< 3 59.8 1.23 (0.94 - 1.61) 52.2 1.42 (1.03 - 1.97) 37.4 2.17 (0.93- 5.04) 
> 3 46.3 36.7 17.2 
BHR test 
+ 62.6 1.29 (0.98 - 1.69) 58.2 1.97 (1.35 - 2.89) 33.3 1.53 (0.65 - 3.62) 
48.7 29.5 21.7 
Cl: confidence interval. BHR: bronchial hyeerreseonsiveness 
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Younger children, and those with hayfever or a parental asthma history were more likely 
to be in the recognised asthma group. Having medical aid (insurance) and attendance at 
a private doctor were also associated with recognition, while day hospital attendance was 
associated with non-recognition. 
Similar factors were associated with being on current treatment, with the addition of 
eczema and some socioeconomic variables (higher socioeconomic status school, and 
"smaller'' households [fewer than 4 other children]). A positive BHR test was also 
significantly associated with current treatment. 
Among the smaller group of 112 children on current treatment, the only predictors of 
inhaler use were hayfever and smaller households. 
8.4. Discussion 
The results of this study show that asthma, a common disease, is underrecognised and 
undertreated in this population of Cape Town schoolchildren. This confirms, using a more 
thorough analysis including a home interview, the conclusion arrived at in Chapter 5 
based on the self administered questionnaire. A recent study of child and adult clients of 
pharmacies in Cape Town, a large proportion of whom came from the study area, 
reached a similar conclusion (Bheekie 1998). 
There are certain limitations in a study of this nature. Diagnosis of asthma and 
assessment of its severity are clinical processes; epidemiological definitions can make 
only approximate classifications. Epidemiologic studies may, for example, identify 
infrequently symptomatic children who would not merit diagnosis or treatment because of 
the mildness of their condition. 
For these reasons, a stricter epidemiologic definition than that used in Chapters 5 and 6 
was employed in an attempt to make the group as specific to asthma requiring treatment 
as possible. To qualify, respondents had to acknowledge multiple symptoms typical of 
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asthma and/or a diagnosis of asthma on both of two questionnaires 6 weeks to 3 months 
apart. A positive BHR test was not used to define asthma, as it is relatively insensitive in 
detecting asthma in population studies (Pattemore 1990, Jenkins 1996). (See also Fig. 
1.1). In this study a positive BHR test could, however, be regarded as a marker of severity 
of asthma and of current activity of the child's asthma. 
The first finding was that only about half of the respondents for these symptomatic 
children acknowledged any asthma history, while only a third acknowledged current 
asthma. Recognition should (appropriately) be a function of severity. Surprisingly, while 
the recognised asthma group had a higher proportion of children with a positive BHR test, 
symptom prevalences were equivalent or higher in the unrecognised group. An 
explanation for this may be that the children with greater BHR come to medical attention 
more readily and are treated more vigorously than asthmatic children without BHR. The 
net "treatment effect" may thus be lower prevalences of symptoms among the recognised 
group. 
Labelling of ill-health is a complex phenomenon, reflecting medical practice, parental 
education, parental willingness to accept the diagnosis or the management of the 
problem and explanatory constructs held by parents of cause and natural history 
(Peterson 1991, Jones 1). Practitioners may use less specific diagnoses or be reluctant to 
use the term asthma for fear of alarming parents. "Bronchitis", and to a lesser extent 
"verkoue op die bors" ( chest cold) were the terms other than asthma most commonly 
attributed to medical practitioners by parents in both groups, reflecting belief in an 
infective cause of the symptoms. 
Alternatively, even if asthma is diagnosed by the practitioner, the implications may not be 
effectively conveyed to parents by the medical practitioner, or parents may be reluctant to 
accept the diagnosis or the chronicity of the condition. Fear of prognosis or guilt over 
1 Jones S, Weinberg M, Ehrlich RI, Roberts K. Knowledge, attitudes and practices 
among parents of asthmatic children (unpublished manuscript). 
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perceived neglect of the child may underlie this reluctance. When asked what terms they 
used to describe the child's chest condition, the majority of parents who had 
acknowledged asthma in a direct question, instead offered one of a number of symptoms 
such as "tight chest" or other terms, rather than asthma. 
The importance of diagnosis rests on the hypothesis that specific asthma management is 
more likely to follow if the correct diagnosis is made. This study lends support to this 
hypothesis in that children with recognised asthma were considerably more likely to be on 
current treatment, and especially on daily treatment, than if asthma was not 
acknowledged. The importance of recognition is further borne out by the somewhat lower 
symptom prevalences among these children compared to children in whom asthma was 
not acknowledged. 
The existence of a published guideline based on a graduated approach to treatment 
allows for evaluation of the management items reported by respondents. Although the 
latest guideline (South African Childhood Asthma Working Group 1994) postdates the 
study, earlier guidelines have been published (South African Childhood Asthma Working 
Group 1992). While approximately 90 percent of all symptomatic children had received 
some form of treatment in the last 12 months, this did not appear to conform to the 
recommended protocol. Although the protocol recommended beta-2 agonists as first line 
therapy rather than theophyllines, a sizeable proportion of children on whom specific 
information was provided were on a theophylline preparation. In addition, inhaler therapy 
was used by less than half of the children in the recognised group, and by less than 10 
percent in the unrecognised group. The large majority of children were on some form of 
oral medication, particularly syrups. This preference for oral treatment may be because 
of a fear of inhaler therapy (e.g. a perception that it is addictive or weakens the heart 
[Moosa 1996]) or a preference for compound linctuses or syrups offering "broad-
spectrum" symptomatic treatment. Also, oral medication, although less cost effective, 
appears cheaper per unit purchase. Later guidelines have emphasised that inhaled 
therapy is preferable to oral therapy. Use of syrups, in particular, may make it difficult to 
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achieve the correct dose. 
In the 1991 consensus guideline (South African Childhood Asthma Working Group 1992) 
bronchodilator therapy was recommended only as pm medication, with the addition of 
maintenance inhaled cromoglycate for moderate asthma and steroids for severe asthma. 
In the recognised asthma group, 23 percent were on daily medication. While this would 
include a proportion appropriately on anti-inflammatory treatment such as cromoglycate 
or steroids, given the medications cited in Table 8.6 and the underuse of inhalers, it is 
likely that a sizable proportion of this daily therapy was bronchodilator medication. 
Similarly, it can be inferred that anti-inflammatory treatment was uncommon in the 
unrecognised group. Underuse of anti-inflammatory medication has been associated 
elsewhere with increased morbidity (Gottlieb 1995), and may be one of the factors 
contributing to high asthma morbidity in this population. 
A majority of children overall (59.1%) reported access to treatment from a private general 
practitioner, despite the fact that only 34.9 percent came from families on some form of 
medical aid and that a high proportion were of lower socioeconomic status as reflected 
by education and household variables. A substantial fraction (43%) in the recognised 
group and 22 percent in the unrecognised group had been treated at some time at Red 
Cross Children's Hospital. This accords with other findings that even in low income 
areas, patients may use some combination of private practitioners and the teaching 
hospital in preference to local day hospitals (Mahomed 1995). Treatment at the hospital 
may reflect greater severity of asthma and appropriate referral, but may also include 
inappropriate use of the hospital for primary care (Davidson 1994). 
Although the management of asthma should include the use of a peak flow meter in 
diagnosis, assessment and monitoring of airways obstruction, only about half the 
recognised group and 13.2 percent of the unrecognised group of respondents could recall 
the child ever using a peak flow meter, even with a photographic prompt. With regard to 
home use, however, these meters are relatively expensive (average price as of early 
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1997: approximately R120) and their purchase is not reimbursable by all medical aid 
schemes. 
The home and bedroom environment merits attention in managing asthma because of 
the importance of house dust mite (Van Niekerk 1977, Potter 1991) and environmental 
tobacco smoke in contributing to asthma in this population. Diet is another requisite area 
of management in some cases because of the role of sulphited drinks and foodstuffs in 
triggering asthma in susceptible children (Steinman 1993). The lack of any significant 
difference between the two groups in their responses on the open-ended questions about 
preventive measures may partly be due to the low response rate to these questions, but 
may also reflect a low priority given by medical practitioners to these measures even in 
diagnosed children. 
Amongst potential barriers to recognition and treatment, the absence of medical aid was 
a strong predictor of non-recognition and non-treatment. Medical aid is a marker of 
socioeconomic status and access to private medical care. Such access typically, 
although not invariably, implies better quality care. Apart from medical aid, current 
treatment and inhaler use were less likely in children with some but not all indicators of 
lower socioeconomic class. Overall, these findings seems to confirm the association of 
poor asthma control with lower income status. American studies have suggested that 
children from lower income homes are more likely to use multiple health care providers 
and make heavier reliance on hospital emergency facilities, resulting in fragmented care 
and absence of asthma management plans (Davidson 1994, Evans 1992). Children from 
poorer areas may also be less likely to be on anti-inflammatory medication, contributing to 
greater morbidity and hospitalisation (Gottlieb 1995). Similar factors are likely to operate 
in this population. 
In conclusion, these findings have important implications for a public health asthma 
strategy in South Africa, whether at local or national level. These implications are 
developed in further detail in the next chapter. 
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9.1 Implications of study findings 
This thesis is the record of a study that was conceived in the early 1990s and carried out 
in 1993. The research was part of a growing programme of epidemiologic inquiry into 
childhood asthma, stimulated by rising measures of asthma occurrence and complication 
throughout the developed world, and in some cases where documented, the developing 
world. 
Most of the research published has been from developed countries, although the 
populations studied range from rich to poor. Cape Town, in common with many other 
cities in both developed and developing countries, has rich and poor inhabitants. The 
population studied in this thesis is urban, generally poor, but has access to a well 
developed health care infrastructure including immunisation and medical treatment. 
The questions asked in this thesis have both global and local interest. Global in the sense 
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of contributing pieces to a puzzle that is the same everywhere: what determines asthma 
incidence and severity? Local in the sense of helping to shape indigenous clinical and 
public health efforts: what is the size of our problem, and where should we be putting our 
efforts to solve it? 
Since the classic study comparing children in Cape Town to those in the Transkei in the 
late 1970s, very little population based research into asthma in South Africa has been 
published. Some of the possible reasons for this paucity of asthma research in the public 
health context of South Africa are discussed in section 9.2.1. below. The study making 
up this thesis is thus the most extensive attempt thus far to use epidemiologic tools to add 
to our knowledge about childhood asthma in South Africa: its prevalence, risk factors and 
quality of care. 
The study consisted of four parts, each asking different questions, with part 1 covering 
two questions. Although the findings of each part were discussed critically in the relevant 
chapter, each of these questions is briefly re-visited below in the light of the findings as a 
whole. 
9. 1. 1. Reliability of questions about wheezing and asthma. 
The reliability in this population of the questions derived from the International Study of 
Asthma and Allergies in Childhood (ISAAC) varied somewhat. The results are reassuring 
to the extent that in practice most questionnaire studies have relied for inferences about 
prevalence on the questions that proved the most reliable. These questions were: "has 
your child ever had asthma" (not including a doctor's diagnosis, although this is a 
common variant in other studies) and "in the last 12 months, has your child had wheezing 
or whistling in the chest?". The other symptom questions, which are likely to become 
widespread through their use in the ISAAC project, proved somewhat less reliable. 
The imperfect reliability of the various symptom questions implies misclassification 
(Kelsey 1986) in the asthma scoring system used to define case status for the purposes 
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of Chapters 6, 7 and 8. 
The effect of using only the self-administered questionnaire for case definition in Chapter 
6 would thus have been some degree of misclassification of non-asthmatics as 
asthmatics and vice versa. To the extent that this misclassification was non-differential 
with respect to ETS, its effect would have been to reduce the power of the case control 
study in Chapter 6 to find associations. If anything, the positive findings regarding ETS 
could thus be stronger. 
In Chapter 7, the effect of misclassification would have been to "dilute" the case group 
used for BHR testing with non-asthmatics (who presumably would have had less BHR). 
However, it is difficult to predict the effect of such misclassification in contributing to the 
null or unexpectedly inverse findings. 
An attempt was made to minimise misclassification in Chapter 8 by including only 
subjects meeting the case definition on both questionnaires. Inclusion of non-asthmatics 
would have overstated the degree of underrecognition and undertreatment. 
9.1.2. Prevalence of asthma and wheezing 
The prevalence of asthma or of "asthma/wheeze" depends on the definition, and a 
number of such definitions could be inferred from this study (Table 9.1 ). The strictest 
definition would be one derived from Chapter 8, viz. case status on both questionnaires 
plus a positive BHR test (n = 100; see section 8.3.1.). Adjusting for the sampling that 
was done for the challenge testing, this prevalence (presumably of more severe or active 
asthma associated with a positive BHR test) can be calculated as 7.8%. Without the 
requirement of a positive BHR test, the prevalence based on case status on both 
questionnaires rises to 13.9% (242 I 1 736). 
If one limits the case status to that derived from the self-administered questionnaire only 
(i.e. on one occasion only, as per Chapter 6) the prevalence of asthma rises to 21.1 
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percent (368 / 1736). The highest values are obtained using single symptom 
prevalences, for example any wheeze in the previous 12 months (26 to 34 percent or so 
of children - depending on questionnaire). 
Finally, about 11 percent of children were reported as "ever" having had asthma , the 
variable De Marco (1998) found in an adult population to correlate best with 
independent clinical evaluation of current asthma. 
Table 9.1 Summary of prevalence of asthma/wheeze in whole sample 
using various definitions derived from study 
Self-administered Interview 
questionnaire questionnaire 
Score~ 4 Score~ 4 
Score~ 4 Score> 4 
Score~ 4 
Ever had asthma 
Wheezing in past 
12 months 
Wheezing in past 
12 months 
BHR: Bronchial hyperresponsiveness 
BHR test Prevalence 







*Adjusted for sampling fractions in selecting case and control groups, and in doing 
BHR testing. 
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These high prevalence figures entail a large burden of disease in this community, with 
many dimensions, mostly unmeasured. Despite underdiagnosis, almost all the cases 
identified in Chapter 8 had required treatment from the health care system in the previous 
year. Other than doctor visits, medication costs, much of it for suboptimal treatment, are 
likely to be substantial (Clark 1995). School absence attributable to asthma has been 
shown elsewhere to be considerable (Anderson 1983, Hill 1989), and asthmatic children 
may in turn produce poorer academic performance (Anderson 1983, Fowler 1992). The 
family anxiety and stress associated with having an asthmatic child add further to the true 
burden of the disease (Clarke 1992). 
The question of generalisability of prevalence figures to elsewhere in South Africa is a 
difficult one to answer as there are geographic, environmental, medical care, 
socioeconomic and migration history variables which might affect the expression of 
asthma, its recognition or severity in different populations. Generalisability to populations 
with reasonably similar distributions of these modifying variables in Cape Town and other 
coastal cities is probably justified. More caution is required in regard to inland populations 
because of the influence of climate first identified by Ordman (1971 ). This "coastal 
hypothesis", viz. that asthma is more common at the coast, particularly under of the 
impact of house dust mite allergy, remains to be tested using standardised methods. 
9.1.3. Environmental tobacco smoke and asthma/wheeze 
The main aetiologic hypothesis in this thesis pertained to environmental tobacco smoke. 
The literature was reviewed in some detail in Chapter 3. The findings of this study are 
mostly in accordance with the conclusions of Strachan and Cook in the most 
comprehensive recent review of the question (Cook 1997, Strachan 1998a, Strachan 
1998b ). Specifically, the association in this study between maternal smoking and asthma 
or asthma symptoms was robust. The prevalence nature of the study makes conclusions 
about temporality difficult, but statistical modelling of different "windows" of reported 
maternal smoking suggests that smoking in pregnancy is important. An additional 
postnatal effect is suggested by the association between number of smokers in the 
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household (confirmed by urinary cotinine) and asthma/wheeze, a finding also in 
accord 
with Strachan and Cook's conclusions. 
The mechanism of these effects at the population level remains elusive. Howeve
r, one 
can repeat the conclusion of Chapter 3, viz. that there is now enough evidence for
 public 
health purposes to accept the causality of an association between maternal and pro
bably 
other household smoking and asthma in children. 
9.1.4. Environmental tobacco smoke and bronchial hyperresponsiveness among c
hildren 
with asthma/ wheeze (exacerbation hypothesis). 
Among those children with asthma/wheeze, ETS exposure was not associated with
 
greater BHR. If anything, the association appeared inverse. This was a surprising 
finding 
in view of the biologic plausibility of a positive association and the findings of some
 other 
studies of asthmatic children. However, as Cook and Strachan point out in their 
review, 
the evidence for an association in the published literature is weak, while there is ev
idence 
that this literature itself is subject to publication bias. 
Cross-sectional bias may have been operating in this study if parents of asthmatic
s with 
greater BHR (or its correlates) had adjusted or reduced their smoking so as to de
crease 
the child's exposure. This would in effect be confounding by time dependent varia
tion in 
the exposure under the influence of the outcome. There was some limited eviden
ce for 
this. Other possibilities were discussed in Chapter 7, but their effect remains specul
ative. 
A stronger design would have involved carrying out BHR testing on the whole spe
ctrum, 
i.e. including cases and controls. This would have enabled testing of the hypothesis
 of an 
association between ETS exposure and BHR across the whole population, wh
ile still 
allowing a separate analysis of children with asthma/wheeze only. The decision
 to do 
BHR testing only on children with asthma/wheeze (and thus to test the aggra
vation 
hypothesis ) was an attempt to make best use of a more or less fixed sample s
ize for 
BHR testing enforced by limited resources. 
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However, studying the whole spectrum of cases and controls would not have solved the 
cross-sectional problem of parents of asthmatic children altering their smoking behaviour. 
As pointed out in Chapter 7, a prospective study with multiple measurements of both 
ETS exposure and BHR is needed to answer this question. 
9.1.5. Underrecognition and undertreatment in this population 
This phase of the study was the most local as it addressed phenomena likely to reflect 
local belief and health service practice. The study confirmed the opinions of clinicians 
(Morris 1994, Green 1998) concerning the shortfall in asthma management practices, 
and had the advantage of doing so in a random population sample that included users of 
medical services in the private and public sectors. It also demonstrated that the diagnosis 
of asthma (or acceptance of the diagnosis) does make a difference to management and 
that the deficiencies are greatest in patients dependent on public sector facilities. 
9.2. Public health application of the findings and related research needs. 
9.2.1. Primary prevention of asthma in South Africa 
Childhood asthma is clearly of great concern and interest to primary health practitioners 
and paediatricians in urban and rural areas in South Africa (Luyt 1994, Morris 1994, 
Green 1998, Syabbalo 1990). However, asthma occupies an uneasy position in the public 
health arena in South Africa. Public health in the sense of an organised state response to 
population health and disease has its origins in the need to control infectious disease 
epidemics (Phillips 1990). This is reflected in the list of notifiable diseases under the 
Health Act, 1977, which are primarily infectious (and of which tuberculosis, measles and 
malaria predominate in numbers among the notifiable diseases), and in the category of 
non-notifiable but priority diseases, of which AIDS and sexually transmitted diseases are 
the most prominent. In the face of large disparities in child survival and morbidity 
between rich and poor in South Africa (Bachmann 1996) state programmes directed at 
improving maternal and child health in South Africa have understandably focused on 
improving obstetric care and child survival, promoting optimal growth and reducing 
malnutrition. Amidst the many pressing problems in child health in South Africa, asthma 
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was not, for example, recognised as a priority in a recent policy document on child health 
(RSA 1995). 
Asthma is a chronic disease of high morbidity and low mortality, affecting somewhat older 
children than those at greatest risk in the traditional child survival model. Various 
perceptions that asthma is primarily genetic, allergic or psychological, or a middle class 
disease, may have made the role for an organised public health response seem less 
important to policy makers. Where an environmental cause of asthma is considered, it is 
presumed to be ambient air pollution, responsibility for which was recently transferred 
from the Department of Health to the Environment ministry. 
By contrast, as a result of the large role that pharmacological treatment plays in the 
management of asthma, the pharmaceutical industry has acquired a large stake in the 
organised societal response to asthma. This takes many forms, including funding the 
National Asthma Education Programme, the Allergy Society of South Africa, allergy and 
asthma research (including this study), the development of management guidelines, 
publications, conferences, public lectures, and, through sales representatives, the 
influencing of medical practitioners. This role of the pharmaceutical companies has 
resulted in an emphasis on correct medication regimens, and on mechanistic research to 
identify points in the immunochemical pathway amenable to modification by drugs. In 
comparison, there is little interest in developing effective non-pharmaceutical or public 
health measures to control asthma. 
In considering a public health response, however, it has to be acknowledged that 
probably not enough is known at this stage to develop policies on primary prevention of 
asthma (Burney 1990, Peat 1994). Prospects for primary prevention are obviously limited 
by what is known about the causes of asthma, and among putative causes, by what is 
modifiable. If the "TH1/TH2 hypothesis", of the rise in asthma as a product of declining 
infectious disease and/or more widespread immunisation in infancy, proves correct 
(Cookson 1997, Strachan 1997, Shirakawa 1997, Hopkin 1997, Kemp 1997), the 
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increase in asthma will prove to be one of the costs of improving child survival in the 
modern era. Future solutions such as active modification of the immune system, e.g. 
through immunisation against asthma, have been mooted (Hopkin 1998). 
More environmentally directed options for primary prevention of asthma are limited. Early 
allergen control in susceptible children (as measured by family history) is a prospect that 
has been investigated. An early trial suggested that the incidence of atopic disease in 
infancy can be reduced by measures to limit contact with dietary antigens and house dust 
mite (Arshad 1992). Recent reviews of trials restricting maternal diet in pregnancy 
(Kramer 1998a) and during lactation (Kramer 1998b) have concluded little or no benefit, 
however. 
There is in addition the question of whether such approaches would be effective in the 
population setting of this study. The ability to modify the internal home environment, 
including furnishings, pets and to provide special (or even broadly "healthy") diets 
presupposes a degree of economic comfort, planning of daily household activities and 
continuity of medical support that is probably beyond most of the families of the children 
in this study. 
The one clearly definable and achievable public health measure to prevent asthma is the 
reduction of ETS exposure in children. The attributable fraction for ETS with respect to 
asthma of 14 percent cited for the United States in Chapter 3 was based on a relative risk 
estimate of 1.4. If one takes the prevalence odds ratio of 1.8 from this study as a proxy for 
the relative risk and a background female smoking prevalence of 45% (based on smoking 
in pregnancy [Steyn 19971), the attributable fraction would be 26 percent (Rothman 
1986). 
Estimates of attributable fractions overstate the prospects of prevention. If ETS exposure 
causes certain types of asthma, e.g. wheezing with infection, rather than other types, the 
fraction may be lower. Also, total elimination of exposure is utopian, which sets a lower 
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limit on the proportion that could be prevented. 
Better understanding of the mechanism whereby ETS exposure affects the risk or 
expression of asthma will enable a better estimate of impact of prevention. However, 
ETS exposure in utero, early infancy and childhood has so many other adverse effects 
(US Department of Health and Human Services 1993), that the justification for preventing 
exposure of children to ETS is heavily overdetermined. 
Research is needed to answer the question about the best way to reduce exposure in this 
heavily smoking population. Global programmes to reduce the burden of tobacco are still 
in development (Mackay 1994), and national efforts have borne fruit in the form of 
tougher legislation (RSA 1999). Local application is still lacking, however. 
A separate study arising out of this research (Jordaan, in press) showed that the largest 
contributor to the variance in urine cotinine creatinine ratio among these primary school 
children was maternal smoking. Maternal smoking in fact accounted for 21.8 percent of 
the variance in CCR, equivalent to that from all other sources combined, viz. paternal 
smoking, other smokers and "community contribution" (crudely estimated from overall 
smoking prevalence of parents of children attending the child's school). 
Efforts at reducing ETS exposure among asthmatic children, i.e. secondary prevention, 
have been shown to be effective (Hovell 1994, Whalgren 1997). These interventions 
directed at parents include counselling and monitoring of smoking. With regard to primary 
prevention, i.e. before the child develops asthma, target populations for anti-smoking 
measures within the ambit of the health services include pregnant women attending 
antenatal clinics (Dolan-Mullen 1994) and mothers attending well baby and child growth 
clinics. Outside the health services, workplace programmes may offer a prospect for 
reducing smoking among mothers, as 42 percent of the workforce in the Western Cape is 
female (RSA 1996). Simple advice by medical practitioners has also been shown to have 
some beneficial effect, although small, on cessation by patients (Silagy 1999). 
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Prevention measures need to be based on an understanding of the complexities of 
smoking behaviour by mothers, however. Since a smoking mother often implies the 
presence of a smoking father, smoking in the household rather than that of one member 
needs to be targeted. Sociologically oriented approaches have also shown that smoking 
is a response to role stress and lack of social networks among women (Romano 1991, 
Doyal 1995). 
In the context of schools, pupil education is needed to reduce uptake among the young, 
the parents of tomorrow. Education of teachers is clearly needed as well, since judging 
by what the study team observed during the many school visits, the smoking example is 
all too common among teachers in this community. 
9.2.2. Secondary prevention of asthma 
In the public health model, secondary prevention of asthma includes early diagnosis and 
appropriate management to limit progression of the disease and its complications. 
While underdiagnosis and undertreatment of childhood asthma are real, the reasons are 
speculative. Research is needed to identify barriers to early diagnosis and appropriate 
management. These may include ignorance of or resistance to the diagnosis or some 
aspect of treatment on the part of practitioners, or resistance to the diagnosis or treatment 
on the part of patients. Systemic barriers may include cost of medication, the time 
demands of patient education and follow up care and the difficulty for patients in following 
treatment and avoidance regimens. Such a study of barriers and determinants is currently 
underway in this population (A. Bheekie - personal communication). 
Despite improvements in medication regimens, various aspects of treatment remain 
controversial. The shift from bronchodilators to corticosteroids for maintenance treatment 
is widely accepted in expert guidelines but may still be a source of uncertainty among 
practitioners and patients (Green 1998). Publicity about the danger of bronchodilators in 
certain circumstances may have added to popular perceptions that inhaled therapy is 
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addictive, or weakens the heart or lungs (Moosa 1996, Lim 1996). Uncertainties 
surrounding the effectiveness of specific allergen avoidance measures may make 
practitioners and patients reluctant to invest time and effort in achieving avoidance 
regimens, for example with respect to house dust mite allergen. 
Cost barriers are frequently mentioned with respect to medication, particularly anti-
inflammatory treatment (Watson 1997). In this study, medical insurance, which implies 
access to private practitioners, was a predictor or recognition and treatment. While 
inhaled corticosteroid medication is available at public sector clinics in Cape Town, there 
are constraints on its use. For example, the medication may not be prescribed on 
weekends or after hours, requiring the patient to return during normal clinic hours. Only 
very recently have 100 ug metered dose inhalers, which makes step-up therapy easier, 
been made available in addition to 50 ug dose devices. 
Research done elsewhere suggests that good control on maintenance corticosteroids is 
cost effective (Perera 1995), a lesson to be emphasised in the stocking of public sector 
service dispensaries. Effectiveness of anti-inflammatory treatment requires good follow 
up medical care, however, and pressures of poverty, family disorganisation, and 
overburdened state services may form a significant barrier even where the medication is 
freely available. 
A start to a national strategy of secondary asthma prevention in South Africa has been 
made with the National Asthma Education Programme (Luyt 1994). This needs to be 
supported by local research. A local cost-effectiveness analysis of asthma management 
would be useful for assessing the likelihood of achieving compliance with recommended 
management protocols in low income communities. Also, while there is evidence from 
elsewhere that targeted house dust avoidance measures can reduce symptoms in 
asthmatic children (Durham 1996), the effectiveness of these measures on a large scale 
have yet to be confirmed in this population (Manjra 1994). 
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There is current interest in methods of changing practitioner diagnosis and treatment 
behaviour. Research suggests that simple publication of expert guidelines is ineffective 
(Grimshaw 1993). Outreach education ("academic detailing") visits hold out more promise 
(Soumerai 1990, Grimshaw 1993) and a trial of such intervention is currently under way in 
this population, building on the findings of this thesis. Reorganisation of private medical 
care under the pressure of managed care organisations may be one way in which the 
practice of cost effective asthma management is promoted. 
The findings of this study also have implications for the organisation of primary care 
services. It appears that many families in this population try to cope with the child's 
asthma symptoms through a combination of approaches. These include recourse to 
traditional remedies 1 and broad spectrum chest medications (typically theophylline 
containing syrups), urgent visits to the local general practitioner or an after hours service, 
and occasional referral visits to the children's hospital. 
Currently, the cornerstone of state policy for reorganisation of public health care in South 
Africa is the district based primary health care strategy (RSA 1997). Such a strategy is 
likely to include more primary care facilities offering 24-hour medical care in proximity to 
where people live. While acute asthma care is an essential part of this service, it is not 
enough. To avoid the fragmentation of asthma care that appears to be a feature in this 
community, adequate follow up of acute cases at routine services and better 
communication between private and public sector facilities are needed. 
The high degree of cooperation received from the school system in this study suggests 
that schools may have a role to play in asthma education and care. A school of 600 
pupils is likely to have 60 asthmatic pupils, or alternatively a teacher with 40 pupils in her 
class will have 4 asthmatics among them. There have been initiatives in Australia to 
develop a schools policy for asthma (Thoracic Society of Australia and New Zealand 
Jones S, Weinberg M, Ehrlich RI, Roberts K. Knowledge, beliefs and practices among parents of 
asthmatic children. (Unpublished manuscript). 
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1994). This recognises a role for asthma education at schools focused on improved 
recognition of asthma by staff, encouragement of participation in spa~ by asthmatic 
children, the initial management of acute attacks by teachers and provision of support for 
parents. 
Finally, continued epidemiologic research is needed to monitor the asthma epidemic, to 
suggest or test hypotheses about causes, and to evaluate the effectiveness of health care 
delivery. In the face of competition for research money and effort, the place of such 
epidemiologic research in keeping asthma in the public eye, in improving the quality of life 
of asthmatic children and, in time, in solving the puzzle of its increase, needs to be 
secured. 
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Fax No: (021) 47-8955 
Head of Department: Professor JM.L Klopper. OBE 
SURVEY OF BREATHING PROBLEMS IN CHILDREN: PART 1 
The University of Cape Town and the Medical Research Council 
are doing a survey of 
breathing problems among sub-8 children in Mitchell's Plain. 
The purpose of the study is to measure how many children are
 affected by chest or 
breathing problems, and what treatment they are receiving. 
We are also interested in factors in the environment which m
ay be causing these 
problems. 
The survey has two parts. In this part (PART/), we are asking yo
u please to fill in this 
short questionnaire. 
In PART II, we shall be coming to the schools to examine some o
f the children and our 
nurses will be interviewing these parents at home. 
All of this information is completely confidential to the surve
y team and parents. 
Participation is voluntary. 
The results of the survey will be used to improve the treatment o
f breathing and chest 
problems in children. It will also help us to understand the m
ain causes of these 
ailments, so that we can try to prevent them. 
Thank you for spending a few minutes on this questionnaire. 
Y~elytLlA 
DR R. EHRLICH 
Department of Community Health 
The University of Cape Town 1s committed to p0ticies of equa
l opp0rtunity and affirmative act1oo 
wn1cn are essen11a t to ,ts m1ss1on of promoting cnticat inquiry 
and scholarship. 
PART I: 
1. Child's age at last 
birthday 
2. Is your child a: 









PLEASE THINK BACK OVER THE LAST 12 MONTHS 
4. Has your child had wheezing or whistling in the 
chest in the last 12 months? 
5. How many attacks of wheezing or 
whistling in the che.st has your 


















Please go to the next page 
For office use only 
2 
6. In the last 12 months how often, on 
average, has your child woken YJ2. 
due to chest wheezing or whistling? 
Never 
D 
7. In the last 12 months, has wheezing or whistling in 
the chest ever been so bad that your child 
couldn't talk properly or had to whisper? 
8. In the last 12 months, has your child's chest 
sounded wheezy or whistly, during or 
after running or playing hard? 
9 In the last 12 months has your child had a 
troublesome dry cough in the night that was not 
from a cold or chest infection? 
10. In the last 12 months, has your child had a tight 
chest? 
For office use only 










THE NEXT QUESTIONS ARE ABOUT ANY TIME (EVER) IN THE PAST 
11. Has your child ever had wheezing or _whistling in the 
chest at any time in the past? 
12. Has your child ever had asthma? 
13. Is your child at present taking any regular asthma 
treatment? 
Please go to the next page 
Yes No 
D D 18 0 
Yes No 
0 D 19 0 
Yes No 






PLEASE MAKE SURE YOU HAVE TICKED EVERY QUESTION. 
::::::.: ... ·.;:·:·:=::::.:-·-:-::::::·.: .. 
End of Part I 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Please read on 
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SURVEY OF BREATHING PROBLEMS IN CHILDREN: PART 2 
This second part of the survey will take place in September and October. It will involve 
some but not all of the children from Part 1. This part is also entirely voluntary. 
Interview 
Our nurses would like to visit some of the parents at home to ask you some questions 
about the child's health and home environment. This will take about 20 minutes and 
will be at a time convenient to you. 
Examination of the children at school 
We shall also be coming to the schools to examine some of the children. The 
examination has three steps: 
1. A doctor will listen to each child's chest. 
2. Each child wil be asked to pass some urine. This specimen will be analysed in 
our laboratory for "cotinine". This comes from nicotine, and gives us an idea of 
how much cigarette smoke (if any) the child has absorbed from the environment. 
3. The child will have a "histamine breathing test". In this test the child is first asked 
to blow into a breath recorder. We have found that sub-8 children have no 
problem doing this blowing. 
The child then breathes in a puff of air with a small amount of histamine in it, and 
blows again. This step is repeated 1 or more times if needed with slightly more 
histamine each time. 
Most children will not show positive on this test. However, children with an 
asthmatic tendency on that day will blow out less air. This is a positive test. 
These children will be given two puffs of medication to remove any effects of the 
test. 
This is a safe procedure, and is widely used in many countries as a test for 
asthmatic tendency. Some children may feel a little hoarse and may cough from 
the breathing in and blowing out, but this passes after a short while. 
Letting you know 
Each parent will receive a letter with the full results of the examination. The letter will 
also contain advice for parents and the child's doctor if necessary. Parents will also 
be able to get further advice from our allergy specialist if they want to. 
Please tum over the page 
IF YOU HAVE ANY QUESTIONS, PLEASE PHONE DR R. EHRLICH, UNIVERSITY 
OF CAPE TOWN TEL: 406 6483 OR YOUR PRINCIPAL 
CHILD'S 
NAME: 
NAME of parent or guardian with whom child lives: 




.___ ___ __.I Night: 
If we need to interview the mother (or person who looks after the child), what is the 
best day and time to find you/her at home? 
CONSENT: 
I hereby give D I hereby do not give D 
permission for my child to participate in the survey of breathing problems: 
Signed: ..__ _________ ~I (parent or guardian) 
Date today: 
THANK YOU ONCE AGAIN 
6 
CONSENT TO APPROACH DOCTOR 
1. Which doctor(s) usually treats the child for wheezing/whistling, night cough, t
ight chest or asthma? 
RECORD MORE THAN ONE IF NECESSARY 
Name 
Address 
2. We would like to contact your doctor and ask him/her some questions about t
he treatment 
of the child. 
All the information obtained will be strictly confidential. 
Do you have any objections to us doing this? 
If not, respondant is asked to sign below 
I hereby authorise Dr R. Ehrlich to contact the child's doctor to obtain information ab
out 
the child's history of respiratory symptoms and treatment. This information will be 





Thank you for allowing me to visit you and for spending time answering these questio
ns. 
APPENDIX 2 
MITCHELL'S PLAIN CHILD HEALTH STUDY 
INTRODUCTION TO PARENTS 
1. Thank you for participating in the study by the University of C
ape Town and the Medical Research 
Council. 
2. The aim of the study is 
2 .1 to measure how many sub B children in Mitchell's Plain have ches
t problems and 
2.2 what factors in the environment may be causing these problems. 
3. Today I would like to ask you some questions about your child's h
ealth and household environment . 
4. We shall also be visiting schools to do a histamine test and urine t
est. 
5. All information is strictly confidential. 
6 . All answers are voluntary - if you feel you would prefer not to ans
wer any question, please say so. 
7. If your child is found to need medical attention, we will inform you
. 
8 . The results of the study will be given to the schools and will be av




1. Study num ber 
2 . Name of ch ild 
3 . Date of inte rview (DD MM 
4 . Interviewer no. 
5 . Address of child 
6 . Full name o f respondent 
7. Tel. numbe r of respondent 











10. In the past 
than the re 
1 2 months, has the child lived with someone other 
spondent for more than one month? 






11 . How much 
home durin 
time does the respondent at present spend at the child's 
g a week? 
Away from the home mornings only 1 
Away full weekdays 2 
Away weekday nights or weekends or both 3 
At home all or most of the time 4 
G1 
' I I I I 7 




J 1 s 
j 17 
j 1 a 
12. Is the child cove red by any medical aid or fund? 
I Yes= 
12.1 If Yes 
is it a 
____ J 
1 I No= 2 
Private Medical Aid 
Medical Fund 
Don't know 
8. DEMOGRAPHIC AND HOUSEHOLD 
I 
1 . Sex of child Male = 1 
2. Date of birth (DD MM YY) 
3 . Where was the child born? 
3 
Don't know = 9 
Female = 2 




5. How many adults and children usually live in the same house __ _ 
as the child? (Include the child) 
6 . How many children (under 14 years) live in the house? 
(Include the child) 
7. How many people sleep in your child's 
sleeping room? (Include the child) 
8. How many rooms are there inside the house? 











9. Do you do anyth ing to heat the home? 




9 .1 If YES do you use : 
I No= 2 
1 . Hea ter plugged into electricity? 
2. Gas ? 
3. Para ffin? 
I 
4. Cha rcoal , anthracite or wood fire? 
10. What source/fue I is used to cook with? 
1. Electricity? 
2. Gas? 
3 . Paraffin? 
4. Charcoal, an thracite or wood fire? 
11 . Is there a pet in the child's home? 
1. Cat 
2 . Dog 
3 . Bird 
4 . Other 
4 






























REATMENT C. THE CHILD' SYMPTOMS AND MEDICAL T 
THE NEXT QUESTIONS COVER THE LAST 12 MO NTHS 
1 . In the last 12 months, has the child had 





I No= 2 
1 . 1 Was this ONLY with a cold, or sometimes w hen s(he) did NOT
 have a cold? 
Only with a cold 
Sometimes without a cold 
1.2 How many attacks of wheezing or whistling 






4-1 2 attacks 
More than 12 attacks 
2. In the last 12 months, how often, on average has y 
woken up due to chest wheezing or whistling? 
our child 
Never 




In the last 12 months, has wheezing or whistling in 
ever been so bad that your child couldn't talk 
properly or had to whisper? 
In the last 12 months, has the child's chest 
ever sounded wheezy or whistly, during or 
after running or playing hard? 
In the last 12 months, has the child had a 
troublesome dry cough in the night, that 
was not from a cold or chest infection? 
the chest 
Every week 
I Yes = 
I Yes = 














I No= 2 
I No= 2 








6. In the last 12 months, has the child had 
a tight chest? 
6 
I Yes = 1 
If NO to ALL the questions under section C (nos C. 1-6), skip to 9 
If YES to any of the questions in the above section C , continue 
7. t chest, In talking about these symptoms (wheeze, tigh 
night cough) with your doctor, family or friends 
what name do you use to describe the problem 
. 
? 
THE NEXT FEW QUESTIONS ARE ABOUT TREATMEN T 
I No 
8. During the past 12 months, has the child receiv 
from a doctor for any of the following symptom 
ed any treatment 
s? 
Yes No 
1. Wheezing/whistling in the chest 1 2 
2. Tight chest 1 2 
3. Difficulty sleeping because of cough 1 2 
If NO to all three above, skip to 9 
If YES to treatment of any symptoms, continue 
8. 1. What name(s) did the doctor use to desc ribe 
the child's chest problem? 
8.2. Where did the child go for treatment for this chest problem? 
Yes No 
1. Private doctor 1 2 
2. Day Hospital 1 2 
3. Red Cross Hospital 1 2 
4. Other hospital or clinic 1 2 
5. Other (specify) 1 2 












8.3 Is the child currently on any treatment for any of the following: 
wheezing/whistling i,:i the chest, tight chest. night cough 
or asthma? 
Yes. every day 1 
Yes. some days, when s/he needs it 2 
No 3 
Don't know 9 
If NO, DON 'T KNOW skip to 9 
8.4 If YES what treatment? (Interviewer shows card) 
Yes No Don't know 
1. Tablets 1 2 9 
2. Syrup 1 2 9 
3. Inhaler 1 2 9 
4. Nebulizer (oxygen) 1 2 9 
5. Injection 1 2 9 




9 . Do you know of anything you can do inside the child's bedroom 
to prevent allergy or breathing problems? 
I Yes = 1 I No= 2 
r------------------------J 
J. 










I I I I I 7 
j a 
I j 10 
8 
10. Do you know of anything your child can avoid eatin(J 
or drinkin(J so as to prevent allergy or breathing problems? 
Yes = 1 
r------------------------
l 
If Yes specify 
11 . Has the child ever been asked by a doctor or nurse 
to blow into a peak flow meter? 
(show picture of meter) 
No= 2 
Yes = 1 No= 2 Don ' t know = 9 
THE NEXT TWO QUESTIONS ARE ABOUT ANY TIME (EVER) IN THE PAST 
12. Has the child ever had wheezing or whistling in 
the chest at any time in the past? 
13. Has the child ever had asthma? 
If NO :a ip to 14 
If ', i S continue 
Yes = 1 No= 2 
Yes = 1 No= 2 
13.1 At what age did the asthma begin?---- ------
(birth-1 yr= 0, don't know= 9) 
13.2 Does s/he still have asthma? 
If YES go to 14 
If NO continue 
Yes= 1 No= 2 Don't know = 9 












LAST QUESTION IS ABOUT THE PAST TWO WEEKS 
In the past two weeks, has the child had to go to a 
doctor or clinic with any illness or injury? 
I Yes = 1 I No = 2 I Don't know = 9 
D SALT INTAKE AND DAMP 
1 . When food is cooked for the family, how much salt (Aromat/Fondor) 
is added? 
2 or more teaspoons 
1 teaspoon 
Just a pinch or one shake 
None 
Don't know 
2. Does the child (or anyone else) add extra salt or Aromat/ 
Fondor to the food the child eats? 
No, no extra salt or Aromat/Fondor is added 
Yes, but the child's food is tasted first before adding 
Yes, even before the food is tasted 
Don't know 
ow often did the child eat salty snacks during 3. H 
t 
s 
he last week (i.e. chips, niknaks, salted peanuts, 
alty biscuits, biltong, dried sausage)? 
Never 
1-2 times 



















4 . How often did the child 
during the last week? 
10 
eat cold meats (polony, viennasl 
Never 
1-2 times 
3 or more times 
Don't know 
s there ever been wet or damp spots 5. Within the past year ha 
on surfaces inside the c 
(e .g. walls, ceiling, carp 






I Yes= 1 I No= 2 I Don 't know = 9 
ould or mildew growing 5. Have you ever noticed m 
on any surface (walls, c eiling, carpetsl 
1. In the child ' s bedroo m? 
2. In the living room? 
3 . In the kitchen? 
4. In the bathroom? 
5. In any other inside a 
of the child's home? 
rea 
ooding or water damage 7. Has there been a leak, fl 







I Yes = 1 I No= 2 I 
E SMOKING 
Mother or female "parent" 
1 . Is the female 
parent the 








Don't know = 9 
1 
2 
PPL Y TO THE WOMAN WHO IS THE THE NEXT FEW QUESTIONS A 
MOTHER OR ACTS IN PLACE 0 
2. What was the highest sta 
mother (female parentl 
F THE MOTHER 
ndard completed by the 


















3. Does she currently work? 
Yes = 1 No= 2 Don't know = 9 
r---------------------
i 
3 .1 If NO, Housewife 
is she (al 
Unemployed (looking for work) 2 
Other (specify) -------- 3 
4 . Describe her present or last permanent job ----------
;Jever worked = 0, 00 
5. Does the mother/female parent currently smoke regularly 
(at least one cigarette a day)? 
If NO. skip to 6. 
If YES. continue 
Yes= 1 No= 2 Don't know = 9 
5 .1 What year did she start smoking? _________
_ _ 
5.2 
(Don ' t know = 99) 
How many cigarettes does she smoke daily? -------
(Don't know = 99) 
GO TO QUESTION 7 
6. Did she ever smoke in the past while 
living in the home with this child? 
Yes= 1 No= 2 Don't know = 9 
If NO, skip to 7. 
If YES continue 
6 .1 What year did she start? _______
______ _ 
(Don't know = 99) 
6.2 What year did she stop? __________
___ _ 
(Don't know = 99) 
6.3 How many cigarettes did she smoke daily in the past? __ _ 












THE NEXT TWO QUESTIONS ARE ABOUT THE PERIOD JUST 
BEFORE AND AFTER THE CHILD WAS BORN. 
7. Did the natural mother smoke at any time during 
her pregnancy with this child? 
Yes = 1 No= 2 Don't know = 9 
8. Did the natural mother (or female parent) 
smoke during the first year of life of this child? 
Yes= 1 No= 2 Don't know = 9 
Father or "male parent" 
9. Is there a male parent 
in the household? 
If NO. skip to question 1 5 
If YES continue 
Yes= 1 No= 2 
9.1 How many years has t}e been living in the household? 
(less than 1 yr = 0) 
10. What was the highest standard completed by the father 
(current male parent) 
(Code no. of years of schooling) 
11. Does he currently work? 
Yes = 1 No= 2 Don't know = 9 
r----------------------
J. 
11.1 If NO, 
is he 
Unemployed (looking for work) 
Other (specify) --------











currently smoke regularly (at least one cigarene, cigar, 13. Does he 
pipefull a day? 
If NO, skip to 1 
If YES, continu 
4 
e 
I Yes= 1 
13.1 W hat year did he start smoking? 
(D on't know = 99) 
I No= 2 I 
13.2 H ow many cigarettes does he smoke daily? 
(D on't know = 99, pipe/cigar smokers = 88) 
G 0 TO QUESTION 15 
er smoke in the past while 14. Did he ev 
living int he home with this child? 
Don't know = 9 
I Yes= 1 I No= 2 I Don't know = 9 
male parent smoke in the child's home 15. Did the/a 
during the first year of the ch,1d's life? 
Yes 
No 
No male parent during 1st year of life 
Do not know 
or family members (excluding female and male Other household 
parent of the ch ild) 
other people are there who live in the house 16. How many 
(sleep ther e at least 3 times a week) who currently smoke? 
(Don't kno w = 99, none = 00) 
shares a sleeping room with anyone, do any of these 17. If the child 





I Yes= 1 I No= 2 I Don't know = 9 
j 64 
I I 66 
I I 68 
169 
I 70 
I I 72 
173 
14 
F FAMILY HISTORY 
1. Has the childs' natural mother ever had asthma? 
Yes= 1 No= 2 Don't know = 9 
2. Has the child's natural father ever had asthma? 
Yes= 1 No= 2 Don't know = 9 
3 . Has the child's own brother or sister ever had asthma? 
Yes= 1 No= 2 Don't know = 9 
Card Number 
Study number 
1e past 12 months have you (the respondent) had any 
;e following? 
Wheezing 
Coughing up phlegm 
Tight chest 
Any chest illness 
G CHILD'S PAST HISTORY 
1. Has the child had his/her tonsils out? 
Yes = 1 
2. Was the child breastfed? 
Yes = 1 
3 . Has the child ever had eczema? 
Yes = 1 
4. Has the child ever had hayfever? 







No= 2 Don't know = 9 
No= 2 Don't know = 9 
No= 2 Don't know = 9 















CONSENT TO APPROACH DOCTOR 
1. Which doctor(s) usually treats the child for wheezing/whistling, night cough, tig
ht chest or asthma? 
RECORD MORE THAN ONE IF NECESSARY 
Name 
Address 
2. We would like to contact your doctor and ask him/her some questions about th
e treatment 
of the ch ild. 
All the information obtained will be strictly confidential. 
Do you have any objections to us doing this? 
If not. respondant is asked to sign below 
I hereby authorise Dr R. Ehrlich to contact the child's doctor to obtain information abou
t 
the child's history of respiratory symptoms and treatment. This information will be 





Thank you for allowing me to visit you and for spending time answering these question
s. 
